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1 Summary 
RNA provides a stimulus for innate immunity either by activating the endosomal Toll-like receptors 
(TLRs) 3, 7 and 8 or by triggering cytosolic RNA sensors of the RIG-I-like family (RLRs) or the NALP3-
containing inflammasome. RNA recognition results in the secretion of type-I interferons or 
proinflammatory cytokines. Recognition of RNA is supposed to occur due to the presence of non-self 
structures, such as the abundance of nucleotide modifications, guanosine-uridine-rich sequences, 
double-stranded conformation or the presence of a terminal 5’-triphosphate. However, the exact 
structural requirements for RNA recognition are still largely unknown. Within this work the functional 
and structural interplay between RNA and different receptors within cells of the innate immune system 
was analyzed. In detail, bacterial RNA, synthetic siRNA and in vitro transcribed RNA was 
characterized. 
It can be shown that TLR7 is the responsible receptor for the recognition of siRNA in plasmacytoid 
dendritic cells resulting in induction of type-I interferons which mediate unwanted off-target effects. 
Besides a minor sequence-dependent influence, introduction of nucleotide modifications identified the 
2’-position of the ribose to be crucial for TLR7-mediated immunorecognition. Further, hyperchromicity 
assays and structure prediction give strong evidence that stimulating RNA adopts a duplex structure. 
These findings suggest that immunorecognition takes place within the minor groove of a given RNA 
duplex, thus revealing a possible mechanism of receptor ligand interaction. Confirming this notion, the 
introduction of different nucleotide modifications altering major groove recognition showed no effect on 
immunorecognition. Of note, incorporation of thymidine substitutions was demonstrated to reduce 
immunostimulation without any effect on gene knockdown. These results identify modifications that 
dissect unwanted immunostimulation from RNA interference in siRNA, thus paving the way for more 
precise therapeutic applications. 
Next, the immunostimulatory potential of different prokaryotic RNAs was tested. It could be shown that 
recognition of bacterial RNA differs from all principles described so far. Whereas TLR7 mediated 
recognition in plasmacytoid dendritic cells and NALP3 was responsible for IL-1β secretion, prokaryotic 
RNA was shown to additionally trigger a cytosolic receptor system resulting in the activation of the 
transcription factor NFκB and interleukin-12p40 secretion. Using cells from various knockout mice and 
performing siRNA approaches, all described RNA receptors could be ruled out to be responsible for 
this activation. Immunostimulation by prokaryotic RNA thus mirrors findings previously described for 
cytosolic DNA recognition. 
Finally, ligand specificity of RIG-I was investigated. It could be demonstrated that the 5’-triphosphate 
moiety is not the only target structure for RIG-I but that RNA in double-stranded conformation 
represents a second independent structural feature that activates RIG-I. The sensitivity of RIG-I to 
double-stranded RNA of increasing size was significantly enhanced, indicating that the biological role 
of RIG-I is rather the sensing of long dsRNA instead of recognizing the terminal 5’-end. Further, there 
is strong evidence that RIG-I might bind in a cooperative manner to double-stranded RNA structures 
explaining the significant length-dependency.
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1 Zusammenfassung 
RNA stellt über die Aktivierung der endosomalen Toll-like Rezeptoren (TLRs) 3, 7 und 8 sowie der 
zytosolischen RNA Sensoren aus der Familie der RIG-I-like Rezeptoren oder des NALP3 
Inflammasoms einen Stimulus für das angeborene Immunsystem dar. Die Erkennung von RNA führt 
zur Sekretion von Typ-I Interferonen oder proinflammatorischen Zytokinen. Die Erkennung von RNA 
erfolgt dabei über das Vorhandensein von „Nicht-Selbst“ Strukturen, wie Guanosin-Uridin-reiche 
Sequenzmotive, doppelsträngige Konformation, eine terminale 5’-Triposphatgruppe oder die Art und 
Häufigkeit von Nukleotidmodifikationen. Über die strukturellen Einzelheiten der RNA Erkennung ist 
aber nach wie vor wenig bekannt. In dieser Arbeit wurden die funktionellen und strukturellen 
Wechselwirkungen zwischen RNA und verschiedenen Rezeptoren im angeborenen Immunsystem 
genauer analysiert. Im Einzelnen wurden bakterielle RNA, synthetische siRNA und in vitro 
transkribierte RNA untersucht. 
Es konnte gezeigt werden, dass TLR7 der Rezeptor für siRNA in plasmazytoiden dendritischen Zellen 
ist und dass siRNA über die TLR7 Stimulation zur Ausschüttung von Typ-I Interferonen führen kann, 
welche ungewollte Nebenwirkungen bei siRNA Applikationen bedingen. Neben einem geringen 
sequenzspezifischen Beitrag wurde durch die Einführung entsprechender Modifikationen die 
2’-Position der Ribose als entscheidende Struktur für die Erkennung durch TLR7 identifiziert. 
Hyperchromizitätsanalysen und Strukturvorhersagen wiesen außerdem daraufhin, dass stimulative 
RNA Moleküle doppelsträngige Strukturen annehmen. Der Mechanismus der Erkennung von RNA 
durch TLR7 könnte damit über eine Interaktion des Rezeptors mit der kleinen Furche einer RNA 
Duplex erklärt werden. Unterstützend zu diesen Befunden zeigten Modifikationen der grossen Furche 
keinen Effekt auf die Immunstimulation. Des Weiteren wurde gezeigt, dass die Substitution von Uracil 
durch Thymidin die Immunstimulation durch siRNA deutlich reduzierte, während die gensuppressive 
Funktion unverändert blieb. Die Ergebnisse ermöglichen somit die Synthese von siRNA Molekülen, 
die eine gezielte Applikation ohne Immunaktivierung erlauben. 
Als nächstes wurde die Immunstimulation durch prokaryotische RNA analysiert. Es konnte gezeigt 
werden, dass die Erkennung prokaryotischer RNA von den bisher beschriebenen RNA-
Erkennungsmechanismen abweicht. Neben der Erkennung durch TLR7 in plasmazytoiden 
dendritischen Zellen und der NALP3-vermittelten Interleukin-1β Sekretion, aktivierte prokaryotische 
RNA zusätzlich ein zytosolisches Rezeptorsystem, das zur Aktivierung des Transkriptionsfaktors 
NFκB und zur Sekretion von Interleukin-12p40 führt. Durch Verwendung von knockout Mausmodellen 
sowie durch den Einsatz von siRNA konnten alle bisher beschriebenen RNA Rezeptoren 
ausgeschlossen werden. Die Erkennung prokaryotischer RNA zeigt damit Parallelen zu der kürzlich 
beschriebenen zytosolischen Erkennung von prokaryotischer DNA.   
In einem dritten Teil der Arbeit wurde die Ligandenspezifität von RIG-I charakterisiert. Es konnte 
gezeigt werden, dass eine terminale 5’-Triphosphatgruppe nicht die einzige Erkennungsstruktur in 
viraler RNA darstellt, sondern dass auch die Dopplestrangkonformation von RNA als unabhängiger 
Stimulus für RIG-I fungiert. Die Sensitivität von RIG-I stieg dabei signifikant mit der Länge des 
doppelsträngigen RNA Liganden an. Dies deutet daraufhin, dass die biologische Funktion von RIG-I 
vielmehr die Erkennung doppelsträngiger Strukturen als die Erkennung der 5’-Triphosphatgruppe ist. 
Zudem weist die stark längenabhängige Erkennung auf eine kooperative Bindung von RIG-I an 
Doppelstrangstrukturen hin.
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2 Introduction  
The physiological function of the immune system is defence against infectious microbes. Therefore, it 
has to detect a wide variety of pathogens, ranging from bacteria to viruses. Common concepts in 
immunology imply that a very important feature of the immune system is to distinguish between self 
and non-self structures. In general the immune system can be divided into innate and adaptive 
immunity. Innate immunity represents the first line of defence and consists of cellular and humoral 
defence mechanisms that are in place even before infection. It further activates adaptive immunity. In 
contrast to the innate immune system, adaptive immunity relies on the clonal selection of lymphocytes 
with recombined highly affine receptors as postulated by Burnet. This second response is more 
specific and adapts to an infection, which leads to an increase in defence capabilities with every 
further exposure to the same infectious pathogen. 
2.1 
2.2 
Innate immunity 
Innate immunity represents the phylogenetically oldest way of defence and can be found in all classes 
of animals and plants. The major function of the innate immune system is the initial response to 
microbes which prevents infection and often results in elimination before adaptive immunity develops. 
This response is of generic and rather non-specific manner and does not provide long-lasting or 
protective immunity to the host. The epithelium serves as a physical barrier to invading microbes and 
also secrets soluble cytokines and antimicrobial peptides like defensins. The cellular fraction of the 
innate immune system is composed of circulating cells like neutrophils and natural killer cells that 
recognize microbes that have breached the epithelial barrier and entered host tissues and circulation. 
Upon recognition of microbes, secretion of cytokines and chemokines leads to the recruitment of 
further immune cells. Cells of the innate immune system combat infections by phagocytic destruction 
and secreted antimicrobial factors. Moreover, macrophages and dendritic cells are able to present 
detected microbial components on their surface, thereby activating the adaptive immune system. The 
latter cells have an important interface function bridging innate and adaptive immunity. 
Recognition principles within the innate immune system 
Conserved microbial components, termed pathogen associated molecular patterns (PAMPs) act as 
ligands for the innate immune system1. These patterns represent molecules vital for microbial survival 
which therefore are unlikely to mutate during evolution. Moreover, PAMPs represent molecules that 
share common building principles but differ in detected structural elements. PAMPs are detected by 
pattern recognition receptors (PRRs) which are present in the cytosol or on the surface of cells like 
macrophages and dendritic cells. In contrast to the receptors of adaptive immunity which undergo 
somatic recombination, PRRs are germline encoded and can detect only a limited number of different 
molecular structures. The concept that PRR-mediated detection is restricted to non-self structures2,3 
had to be expanded since it became evident that PRRs are also able to detect host structures under 
certain conditions4. Thus, it has been shown that rather the localization of the ligand (e.g. cytosol) is of 
importance for receptor interaction. 
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2.2.1 Pattern recognition receptors 
PRRs are either attached to the surface, localized in intracellular compartments (e.g. endosomes) or 
present in the cytosol. Due to their molecular structure they can be subdivided into Toll-like receptors 
(TLRs), Retinoic acid inducible gene-I (RIG-I)-like receptors (RLRs) and NOD (nucleotide-binding and 
oligomerization domain)-like receptors (NLRs)5-8. Further proteins with C-type lectin-binding domains 
(CLRs) have various functions but also serve as pattern recognition receptors in innate immunity9. All 
of these receptors are composed of modular domain architecture with a ligand binding domain and 
signalling domains, the latter being regulated either through dimerization and oligomerization or 
conformational changes by enzymatic activities. Subsequently, singalling domains recruit adaptor 
proteins that initiate intracellular signalling (e.g. NFκB or IRF3 activation). 
2.2.1.1 Toll-like receptors 
The Toll protein was first described to play a pivotal role in the development and axis formation of 
Drosophila melanogaster10. However it was demonstrated that loss-of-function mutations within the 
Toll protein result in a higher susceptibility of Drosophila melanogaster to fungal infections, indicating a 
second function, namely as an immune receptor for sensing infections with fungi and gram-positive 
bacteria11,12. The TLRs represent the human homologs to the Toll protein. They are either expressed 
on the cell surface (TLR 1, 2, 4, 5, 6 and 10) or in intracellular compartments, namely endosomes 
(TLR 3, 7, 8 and 9)13-16. TLRs represent the best-described class of PRRs17. To date, in human 10 
TLRs (TLR1-10) and in mouse 12 TLRs (TLR1-9 and 11-13) have been described. They consist of a 
leucine-rich repeat-containing extracellular domain (ECD) which mediates ligand binding, a 
transmenbrane domain connecting the ECD to the cytoplasmic Toll/interleukin-1 receptor (TIR) 
domain required for the initiation of intracellular signalling18. The proximal events of TLR-mediated 
signalling are initiated by TIR-domain-containing adaptor molecules. The endosomally located TLR7, 8 
and 9 utilize the myeloid differentiation primary response protein 88 (MyD88), TLR3 the TIR domain-
containing adaptor inducing IFN-β (TRIF) (also known as TICAM1) as proximal adaptor molecules19,20. 
TLR-mediated MyD88 recruitment activates a conserved inflammatory pathway resulting in the 
activation of mitogen-activated protein (MAP)-kinases and translocalization of NFκB into the  
nucleus21-23. TLR3 signalling by means of TRIF activates IRF3 in a MyD88-independent manner. 
Plasmacytoid dendritic cells (pDCs) represent a subset of immune cells that is specialized on the 
detection of viruses and which is responsible for the exclusive secretion of IFN-α in the peripheral 
blood24. Importantly, pDCs express TLR7 and TLR9 and produce large amounts of type-I interferons 
upon stimulation with the corresponding ligands what contrasts findings in other cell-types25,26. In 
pDCs both, TLR7 and 9, signal via the adaptor molecule MyD88 and activate the constitutively 
expressed transcription factor IRF7 linking MyD88-dependent signalling to IRF7 activation and 
subsequent IFN-α induction in this cell-type24,27. As shown for CpG deoxynucleotides which are 
recognized by TLR9, TLR-mediated recognition in pDCs is enhanced by an increased endosomal 
trafficking compared to myeloid dendritic cells (mDCs)28. 
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2.2.1.2 Cytoplasmic receptors 
Whereas TLRs detect ligands in specific cells such as dendritic cells and macrophages, RLRs and 
NLRs reside in the cytosol and are expressed in a broad range of somatic cells. The RLR family is 
composed of the three members retinoic acid inducible gene-I (RIG-I), melanoma-differentiation-
associated gene 5 (MDA5) and laboratory of physiology and genetics 2 (LGP2) which were originally 
described as RNA helicases29. Besides this function it has been shown that RIG-I and MDA5 
recognize viral components and are able to initiate an immune response30-33. The amino termini of 
RIG-I and MDA5 contain two regions similar to the caspase activation and recruitment domain (CARD) 
and acts as a protein interaction motif to facilitate associations with downstream components. LGP2 
does not harbor this amino-terminal domain and has therefore been reported to be a negative 
regulator for RLR-mediated signalling by ligand sequestration34-36, especially important for 
RIG-I-mediated signalling37,38. The central portion of all three family members shows homologies with 
the DexD/H box RNA helicase family and is implicated in double-stranded RNA binding and ATP-
dependent unwinding39. The carboxy-terminus harbors a regulatory or repression domain that 
interacts with the helicase domain and inhibits signalling by the amino-terminal CARDs6,29,37. RLRs are 
thought to undergo a conformational change upon ligand binding which exposes the CARDs and 
allows multimerization and cell signalling37. Signalling initiation is mediated by the adaptor molecule 
IPS-1 (also known as MAVS, VISA or CARDIF)40-43. The IPS-1 molecule is attached with the 
carboxy-terminus to the mitochondrial membrane41. At its amino-terminus IPS-1 also contains a 
CARD, which is recognized by the activated RIG-I and MDA5 proteins. CARD interactions lead to the 
activation of cytoplasmic kinase complexes and finally to the phosphorylation-mediated activation of 
IRF-3 and NFκB, respectively44. 
With 23 members NLRs represent the largest family of PRRs in humans45. NLRs also show a  
tripartite domain structure that shares high structural and functional similarities to plant resistance 
genes (R-genes)8,46,47. All NLRs harbor a central NACHT domain which is responsible for 
oligomerization and activation of the respective NLR. The phylogenetic history of the respective 
NACHT domains is used for classification of the 23 NLRs8. The NLRs are further grouped in NODs 
and NALPs (also known as PANs or PYPAFs)8,47,48. NODs mediate signalling by an amino-terminal 
CARD which activates NFκB in a similar way to TLRs and RLRs7,46,49 but shows no influence on 
caspase activation50,51. NALPs on the other hand, possess an amino-terminal pyrin (PYR) effector 
domain and have been shown to activate caspase-1 and caspase-5. The carboxy-terminus of all NLRs 
owns an LRR domain which is, similar to TLRs, responsible for ligand binding8. Like RLRs, NALPs 
reside in the cytosol in an inactive and repressed form. Ligand binding promotes a conformational 
change which leads to oligomerization and activation52. Upon activation, NALPs form multimeric 
protein complexes which are termed inflammasomes52-54. Besides NALP3 the inflammasome consists 
of the apoptosis-associated speck-like protein (ASC), Cardinal, NALP2 and pro-caspase-155. ASC 
represents an essential adaptor molecule for inflammasome signalling53,54. ASC acts by PYR-PYR 
domain interaction with the respective NALP and subsequently activates pro-caspase-1 leading to the 
processing of pro-IL-1β and pro-IL-1856,57. Although most of the ligands are unknown so far, NLRs are 
regarded as sensors for intracellular PAMPs in general. Mutations and polymorphisms of NLR genes 
are associated with a higher susceptibility to inflammatory disorders (e.g. Muckle-Wells syndrome), 
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underlining the importance of this receptor class for proper immune function58-61. Additionally, NALP3 
mutations can lead to the excessive secretion of IL-1β and induce necrosis-like death in monocytes by 
a process dependent on ASC62.  
2.2.2 Cooperative recognition in innate immunity 
Although the different receptor classes trigger conserved inflammatory pathways, there is strong 
evidence that PRRs rather complement each other than functioning apart from each other63. NALP-
mediated IL-1β and IL-18 secretion requires induction of pro-IL-1β and pro-IL-18, which is induced by 
stimulation of TLRs52,64-66. TLRs therefore serve as key inducers for inflammasome activation67. On the 
other hand, processed IL-1β and IL-18 recruit MyD88 upon binding to their respective receptors, 
linking cytosolic pathogen sensing to TLR signalling pathways. Further, ASC also activates NFκB 
besides the activation of caspase-1 and caspase-568 leading to the secretion of proinflammatory 
cytokines, similar to TLR-mediated signalling. PAMP-mediated IL-1β and IL-18 secretion therefore 
requires the coordination of the TLR and NLR receptor systems. It has also been shown that 
adenoviral DNA triggers type-I interferons but also induces the secretion of IL-1β in a NALP3 and 
ASC-dependent manner69, linking NLRs to the cytosolic virus recognition which is mainly mediated by 
RLRs. Additionally, the simultaneous triggering of TLRs and NLRs shows rather synergistic than 
additive effects on cytokine secretion indicating cooperation of the different signalling pathways70. 
PAMP recognition gains additional complexity by cell-type-specific expression of different sets of 
PRRs. Virus protection is mediated by the cytosolic residing RLRs as shown in conventional DCs and 
fibroblasts34,71. In contrast, virus recognition in plasmacytoid dendritic cells (pDCs) is mediated 
exclusively by the TLR system instead of the RLRs71. Therefore, TLRs and RLRs, similar to TLRs and 
NLRs, function cooperatively to provide ubiquitous immune protection. 
2.3 Ligands of pattern recognition receptors 
The broad classes of pathogens (e.g. bacteria, viruses and fungi) express molecules that are shared 
across subclasses of pathogens but are ‘foreign’ to the host organism. Most recognized molecular 
structures are expressed on the pathogen’s surface such as lipoteichoic acids which are part of gram-
positive bacterial cell walls and lipopolysaccharides (LPS) of gram-negative bacterial cell walls which 
are sensed by the surface expressed TLR2 and 4, respectively72-75. Besides ‘non-self’ structures 
innate immunity is triggered also by viral structures although all their components are derived from the 
infected host cell and therefore do not represent ‘foreign’ structures. In addition, it becomes evident 
that even endogenous molecules represent triggers for immunorecognition if their intracellular 
distribution is altered due to infectious or inflammatory processes76,77.     
2.3.1 Nucleic acids: pathogen associated molecular patterns  
Besides surface located PAMPs, endogenous molecular structures such as bacterial- or viral-derived 
nucleic acids are recognized by innate immunity. First, unmethylated CpG-rich DNA as it occurs in 
bacteria and is rare in eukaryotic DNA due to extensive cytosine-methylation of CpG dinucleotides has 
been shown to trigger the endosomally located TLR978. The frequency of CpG dinucleotides within 
bacterial DNA correlates thereby with the potential to stimulate TLR979. This reveals a sequence-
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specific recognition by TLR9. Further, non-self DNA is also capable of triggering cytosolic receptors 
like the inflammasome or the recently discovered DNA sensor DNA-dependent activator of IFN-
regulatory factors (DAI)69,80. Besides DNA, it has been shown that also RNA displays a target for 
immunorecognition principles81. Figure 1-1 provides a schematic overview of the major RNA 
recognition pathways leading to the transcription of proinflammatory cytokines or type-I interferons. 
2.3.2 Recognition of RNA  
2.3.2.1 RNA recognition by TLR7/8 
The recognition of RNA-oligonucleotides has been shown by several groups to be mediated by TLR7 
and TLR8 in human and by TLR7 in mouse81. Murine TLR8 has been regarded to be non-functional in 
mice although recent reports show that the receptor can be triggered by cotransfection with 
dT-deoxynucleotides82. RNA recognition by TLR7 and 8 is dependent on the size of the respective 
RNA oligonucleotide and it has been shown that a minimum of 19 nucleotides is required for an 
efficient recognition83. TLR7 and TLR8 are exclusively expressed in endosomal compartments, 
therefore the differentiation between endogenous and non-self RNA molecules has been linked to the 
localization of the respective ligands within the cell. Endogenous RNA molecules (e.g. messenger 
RNA) reside either in the cytosol or in the nucleus and do not enter compartments like endosomes that 
participate in the uptake of exogenous substances. Inhibitors of endosomal maturation or acidification 
(e.g. chloroquine) have been shown to abrogate TLR7 and TLR8-mediated signalling, indicating that 
these receptors require an intact endosomal compartment for functionality84. Sequence analysis 
revealed several possible immunostimulatory sequences, characterized by a high content of 
guanosine (G) and uridine (U) residues, to play a role for recognition. Several studies were performed 
to identify a specific sequence motif which triggers these receptors83-86. All studies revealed that the 
content of uridine residues seems to play an important role for the signalling strength86. The two 
GU-rich sequence motifs 5’-GUCCUUCAA-3’ and 5’-UGUGU-3’ have been identified to possess a 
high potential for immunorecognition83,85. Differences in the responsivness of TLR7 and TLR8 to the 
synthetic ligands resiquimod (R848) and imiquimod (R837) revealed different ligand requirements for 
these two receptors87. Further characterization of immunostimulatory sequences of RNA 
oligonucleotides showed that TLR7 and TLR8 indeed recognize different sequence motifs although 
sharing a high homology in sequence and structure. In contrast to the recognition of GU-motifs by 
TLR7, TLR8 has been shown to detect AU-rich sequence motifs88. However, unlike DNA recognition 
by TLR9, the recognition of a specific sequence seems not sufficient to explain immunorecognition. 
Transfection with eukaryotic RNA containing high amounts of uridine residues and GU-dinucleotides 
resulted in a significant lower cytokine secretion compared to synthetic RNA oligonucleotides. TLR7 
and 8-mediated recognition has therefore additionally been linked to the frequency of nucleotide 
modifications89,90. Some nucleotide modifications (e.g. 2’-O-methyl-modification) which naturally occur 
only in eukaryotes but are absent or show a comparatively low frequency in prokaryotes limit the 
extent of cytokine secretion, whereas other modifications seem to play a minor role for recognition 
(e.g. 5’-methyl-cytosine)89. Studying various modification patterns it was shown that the 2’-position of 
the ribose is critical for immunorecognition principles. Methylation or addition of other chemical 
modifications (e.g. fluoride-addition) led to an abrogation of cytokine secretion in general91-93. TLR7 
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and 8-mediated recognition was not restricted to RNA oligonucleotides but also occured with viral 
RNA94. Bacterial RNA has also been linked to recognition by TLR7 and TLR8 due to its lower content 
of nucleotide modifications89. Small interfering RNA (siRNA) is composed of a double-stranded RNA 
molecule with a length of approximately 21-23 basepairs to avoid non-specific effects on the cellular 
protein metabolism that arise from inducing the double-stranded RNA (dsRNA)-dependent protein 
kinase (PKR)95. However, siRNA has now been discussed as a target structure for TLR-mediated 
recognition. Although siRNA recognition was initially discussed controversially96, it is now clear that 
synthetic siRNA duplexes induce the upregulation on IFN-stimulated genes97-99, potentially leading to 
severe side effects. Harboring stimulatory sequences or immunological relevant nucleotide 
modifications corresponds with immunostimulation in a similar way as described for single-stranded 
RNA oligonucleotides. In most cases immunostimulatory motifs are more effectively recognized by 
innate immunity in the context of single-stranded conformation compared to duplex-structures100. 
Therefore, it is not clear whether siRNA is recognized in a single- or double-stranded conformation. 
However, the intracellular integrity of siRNA has been shown to be not affected during cell access 
indicating that short double-stranded RNA is recognized in a double-stranded conformation101. The 
expression of TLR7 and TLR8 is restricted to professional immune cells linking their respective 
activation rather to the immune system than to a general response to RNA entry. Especially pDCs 
show strong expression levels of TLR7 and TLR9 and are known to produce vast amounts of type-I 
interferons upon viral infections102. Endosomal recognition in pDCs is increased by enhanced 
endosomal trafficking and longer presence in the endosomal compartments28 indicating that mainly 
pDCs are responsible for TLR7-mediated type-I interferon secretion. Ligand receptor interactions have 
not been studied in detail for TLR7 and TLR8 so far, mainly due to a missing crystal structure. 
However, it has been shown that the amino-terminus of TLR9 is cleaved off for receptor activation and 
ligand recognition103,104. Due to the high homology between TLR7, 8 and 9, this has also been 
proposed for RNA sensing103,105.  
2.3.2.2 RNA recognition by TLR3 
Besides the above described TLR7, 8 and 9, TLR3 is also expressed in the endosomal compartments 
of immune cells13. However, in some cell-types (e.g. fibroblasts) TLR3 is also expressed on the cell 
surface106. The expression pattern of TLR3 thus comprises a much broader range of cell-types 
compared to TLR7 and 8. Additionally TLR3 seems to play a role in immunorecognition of non-
immune cells (e.g. keratinocytes)107. The first ligand structure described for TLR3 was long double-
stranded RNA which was demonstrated by a high sensitivity to Poly(IC) representing a synthetic 
analog to double-stranded RNA leading to the activation of NFκB108,109. Long double-stranded RNAs 
are naturally absent in eukaryotic cells but viral RNA has been described to form long double-stranded 
RNA intermediates during the process of replication. Although the recognition of viral RNA by TLR3 
has been discussed controversially110-112, it is now clear that TLR3 participates in the recognition of at 
least some viral RNAs (e.g. west nile virus)69,113. Eukaryotic messenger RNA which tends to form of 
intermolecular duplex-structures has been described as a further target structure for TLR3 if entering 
the endosomal compartments as described for messenger RNA of necrotic or apoptotic cells114. The 
recognition of siRNA has been shown to depend on TLR7 and TLR8; however, a recent study showed 
that also TLR3 participates in siRNA recognition. Activation of TLR3 requires at least 19 nucleotides 
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long dsRNA for activation and shows no signalling by binding to shorter dsRNA molecules. A required 
minimum length of the RNA ligand and additional structure predictions gave strong evidence that 
TLR3 forms dimeric structures upon ligand binding which are essential for activation115,116. Further, 
CD14, a well described PRR in innate immunity, has been shown to enhance TLR3-mediated 
signalling117. The excessive glycosylation of TLR3 plays a pivotal role for ligand recognition. 
Deglycosylation studies and mutational approaches revealed the requirement of N-linked glycosylation 
for the bioactivity of TLR3118.  
 
TLR 3                       TLR 7/8                       
NFκB
Cytokines Type I-Interferons
Inflammasome
(NALP3)
Pro-IL-1β
Pro-IL-18
IL-1β
IL-18
RIG-I/MDA5
IRF3
IPS-1TRIF               MyD88
Caspase-1
bacterial RNA viral RNA
(1)
Non-self dsRNA/ssRNA
(2)
 
Fig.  2-1 Principles of cellular RNA recognition.  
Simplified schematic representation of the major pathways leading to the expression of cytokines and type-I interferons upon 
stimulation with non-self RNA. For the sake of simplicity this illustration shows only the participating receptors and adaptor 
molecules, further NFkB activation by RIG-I and MDA5 and IRF3 activation by TRIF are omitted. (1) Endocytotic pathway: 
Double-stranded (dsRNA) and single-stranded RNA (ssRNA) are recognized by the endosomally located TLR3 and TLR7 and 
TLR8, respectively. Receptor binding leads to the recruitment of the TRIF and MyD88 adaptor molecules and finally to the 
activation of NFκB. NFκB induces both, the secretion of proinflammatory cytokines and the expression of pro-IL-1β and 
pro-IL-18. (2) Bacterial RNA binds to NALP3 which is a part of the inflammasome. Inflammasome activation leads to the 
processing of TLR-induced pro-IL-1β and pro-IL-18 by activated caspase-1 as well as to the activation of NFκB. Viral RNAs are 
recognized by RIG-I and MDA5, respectively, depending on the type of virus. Signalling is mediated by the mitochondrial-
associated adaptor molecule IPS-1 leading to the activation of IRF3 and subsequent type-I interferon secretion. 
 
In contrast to other TLRs, the strucure of the ECD of TLR3 has been resolved by crystallization119,120. 
The ECD shows a horseshoe-shaped overall structure composed of 23 LRRs motifs. LRR motifs have 
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been described firstly 1985 and are characterized by a 24 amino acid long sequence with conserved 
hydrophobic residues that tend to form β-sheets121. Within the regular LRR-structure also irregular 
LRRs (LRR12 and LRR20 in TLR3) have been identified that deviate in terms of length and sequence 
from the LRR-consensus sequence122. These LRRs are characterized by the presence of insertions 
after position 10 or 15 that do not fit in the overall LRR structure and are exposed from the receptor 
surface. The irregular LRR20 has been shown to be important for ligand binding whereas LRR12 is 
not essential for receptor signalling123. The recently published structure of TLR3 with bound double-
stranded RNA ligand confirmed the findings described above116. 
2.3.2.3 RNA recognition by RLRs 
Whereas TLRs detect viral components in specific cells such as dendritic cells and macrophages, 
RLRs sense viral infection in the cytoplasm of most cell-types. RLRs sense viral RNA and their 
activation results in immunological responses including the secretion of type-I interferons and 
proinflammatory cytokines6,29,124. A common feature of antiviral responses to dsRNA in general is the 
induction of type-I interferons125. Studies with knockout mice revealed that RIG-I and MDA5 detect 
specific types of viruses. Interestingly, RLRs induce an interferon response also in somatic cells (e.g. 
fibroblasts)44,71,126. MDA5 has been shown to be activated by picornaviruses whereas RIG-I senses 
many other viruses, including influenza A virus, Sendai virus, vesicular stomatitis virus and Japanese 
encephalitis virus44. This differential recognition is thought to be based on the distinct nonself RNA 
patterns generated by the respective viruses. The molecular mechanisms of the differential recognition 
are not fully understood by now, but several studies uncovered differences in the ligand requirement 
between RIG-I and MDA5. It was observed that RIG-I is selectively activated by transfection with in 
vitro transcribed RNA harboring a 5’-triphosphorylated terminus which is also present in various viral 
RNAs127,128. Once an RNA ligand contains such a terminal triphosphate, a double-stranded 
conformation of the RNA is not required anymore, identifiying the 5’-triphosphate as a target structure 
sufficient to activate RIG-I128. Although the requirement of a 5’-triphosphate for ssRNA recognition by 
RIG-I has been demonstrated for short in vitro transcripts (58 nt or shorter) as well as for single-
stranded viral RNAs (e.g. influenza), the biological relevance of 5’-triphosphate recognition is not fully 
understood127-129. The 5’-end of endogenous (self) RNA is either removed or masked by the addition of 
a cap structure before leaving the nucleus and entering the cytosol. The accessible 
5’-triphosphorylated terminus therefore represents a nonself structure which could indeed display a 
target for immunorecognition. MDA5 is not activated by triphosphorylated structures but has been 
shown to sense selectively Poly(IC)44,130. However, other reports showed that also RIG-I is activated 
by Poly(IC)131. Additionally the requirement of specific stimulatory sequences within viral RNA, 
analogous to TLR-mediated RNA recognition, has been suggested132. Further studies with time-
dependent RNase treatment of Poly(IC) gave strong evidence that in fact the length of the respective 
dsRNA ligand is of importance for the differential recognition of RIG-I and MDA5. Using the respective 
knockout mice models it has been shown that MDA5 binds long dsRNA molecules with a length of 
approximately 2000 basepairs or longer whereas RIG-I senses shorter double-stranded RNA 
molecules up to a length of approximately 2000 basepairs131. These observations separate the ligand 
requirements of RIG-I and MDA5 giving each a distinct role in cytosolic viral RNA sensing. However, 
the molecular mechanism underlying the sensing of nucleotide length is unknown.  
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Further, it is not well understood how nonself double-stranded RNA is physically recognized since 
neither of these helicases contains a known RNA binding motif. Recent biochemical studies revealed 
that the carboxy-terminal domain (CTD) of RIG-I binds to 5’-triphosphorylated RNA whereas binding of 
double-stranded RNA by the CTD has been studied with discriminative results129,130. Crystallization of 
the CTD of RIG-I uncovered a basic cleft which shows a high affinity to 5’-triphosphorylated and 
double-stranded RNA129. Size exclusion chromatography and NMR-based ligand binding studies 
revealed that the CTD is responsible for ligand binding. These results were further supported by 
mutational approaches within the CTD identifying important amino acid residues to be essential for 
RIG-I signalling. As predicted from its primary structure, RIG-I is a ligand-dependent ATPase129,130,133. 
Mutation of the ATP-binding site (K270A) inactivates the ability of RIG-I to trigger antiviral 
signalling6,133. However, RIG-I K270A was still able to bind 5’-triphosphorylated and dsRNA. In vitro 
helicase assays revealed that RIG-I is able to unwind efficiently either dsRNA or RNA/DNA duplexes 
but not dsDNA. For duplex unwinding, a 3’-terminal single-stranded overhang is required129. 
Interestingly, blunt-ended dsRNA, which therefore is resistant to helicase activity, efficiently induced 
type-I interferons. On the other hand, dsRNA harboring a 3’-terminal overhang (>5nt), which are 
susceptible to being unwound, failed to activate interferon associated genes134. These observations 
indicate that unwinding of the dsRNA ligand is not the critical step for triggering an immune response. 
This raises questions about the role of ATP hydrolysis for RIG-I activation. To date, the current opinion 
is that the RNA ligand binds to the CTD and ATPase activity results in a switch of this precomplex into 
its active conformation. This idea is further supported by the identification of a repressor domain 
overlapping with the CTD of RIG-I which is able to interact with the CARD and helicase domain of 
RIG-I and thereby keeping RIG-I in an inactive status37. In addition it has been shown that RIG-I and 
LGP2 form dimers and multimers upon activation, similar to reported dimerization of TLR3 upon ligand 
binding36,116,130. Although the CTD of MDA5 shares high homology to the extensively studied CTDs of 
RIG-I and LGP2, molecular differences responsible for the different ligand requirements have not been 
investigated yet.  
2.3.2.4 RNA recognition by NALP3 
Among the 14 described NALPs, NALP3 has been identified as a further cytosolic RNA sensor. 
NALP3 binds bacterial RNA and promotes the processing of pro-IL-1β and pro-IL-18 by caspase-1 
activation8,55,64,135. Importantly, inflammasome activation by bacterial RNA requires priming with a TLR-
specific stimulus. In contrast to the already described TLRs and RLRs, the ligand spectrum of NLRs is 
more ambiguous. This is demonstrated by the fact that NALP3 is additionally activated by bacterial 
toxins and uric acid65,66. Compared to TLRs and RLRs, RNA recognition by NALP3 follows different 
mechanisms since neither viral RNA nor RNA oligonucleotides have been described as ligands for 
NALP3. Intracellular bacteria (e.g. Francisella tularensis) have been reported to activate the 
inflammasome in a manner dependent on type-I interferon signalling136. Similar findings have been 
made for bacterial DNA which is sensed in a CpG-dependent manner by TLR9 in the endosome. 
However, independent of a specific sequence, bacterial DNA also triggers a cytosolic receptor78,137. 
Additionally silica crystal-induced lysosomal damage induces inflammasome activation by the release 
of self-components, restricted in healthy cells to the endosome (e.g. cathepsins) indicating that the 
ligands for NALP3 might include host-derived structures76. To date, the molecular mechanism of 
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NALP3-mediated ligand recognition is not fully understood but it is evident that the role of NALP3 is 
the sensing of ligands within the cytosol leading to a proinflammatory response. Table 2-1 summarizes 
the RNA receptors described above, their respective ligands and the responsible target structures. 
 
Table  2-1  Overview of cellular RNA receptors and their respective ligands 
Receptor Described ligands Target structure Activation 
TLR3 dsRNA, Poly(IC) Double-strandness NFκB, IRF3 
TLR7 ssRNA, siRNA, R837, R848 GU-rich RNA sequences NFκB, (IRF7 in pDCs) 
TLR8 ssRNA, siRNA, R848 AU-rich RNA sequences NFκB 
RIG-I Viral RNA, Poly(IC) Double-strandness (up to 2 kbp in length), 5’-triphosphate NFκB, IRF3 
MDA5 Viral RNA, Poly(IC) Double-strandness (longer than 2 kbp) NFκB, IRF3 
NALP3 Bacterial RNA unknown NFκB, Caspase-1 
 
2.4 RNA interference 
RNA interference (RNAi) is a pathway involved in cellular defence against viral invasion, transposon 
expansion, and post-transcriptional regulation138-140. This evolutionarily conserved phenomenon is 
observed in nearly all eukaryotes and represents a unique form of post-transcriptional gene silencing. 
The original phenotypic observations of RNAi were made by researchers working on plant and fungal 
genetics141. However, major strides in the underlying mechanisms of RNAi were performed by Andrew 
Fire, Craig Mellow and colleagues working with Caenorhabditis elegans142. They observed that 
injection of double-stranded RNA (dsRNA) induced sequence-specific reduction of messenger RNA 
with complementary sequence to the injected dsRNA. In further studies the RNAi pathway was also 
described for mammalian cells143,144. Since these observations, several groups have contributed to 
elucidating the RNAi pathway, depicted in Figure 1-2.  
In nature, RNAi is initiated when the host cell encounters a long dsRNA transcribed from a virus, 
mobilized transposons or an inappropriately transcribed sequence. Additionally, a newly identified 
class of regulatory, non-coding microRNAs (miRNAs) induce RNA interference145,146. The miRNAs are 
synthesized in the nucleus as large precursor forms. An enzyme known as Drosha mediates 
processing of the primary miRNA transcripts into pre-miRNAs which size approximately 70 nt147. After 
being exported to the cytoplasm, the RNase III-like enzyme DICER is responsible for cleavage of the 
pre-miRNA into small interfering RNA duplexes (siRNA) of 19-25 bp in length with characteristic 3’-
dinucleotide overhangs148-150. The siRNA is incorporated into the RNA-induced silencing complex 
(RISC). An RISC-associated helicase activity unwinds the duplex, thus enabling either of the two 
strands to independently guide target mRNA recognition151,152. The degree of complementarity 
between the guide strand and the target mRNA determines whether mRNA silencing is achieved by 
siRNA-mediated specific cleavage of the mRNA153 or is mediated by translational repression154,155   
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Fig.  2-2 The RNAi pathway 
The pathway is triggered by dsRNA which share a 
sequence-specific homology with an mRNA. The 
dsRNA molecule is cleaved by the RNase III-like 
enzyme DICER resulting in the generation of 21-25 nt 
long siRNA duplexes. The siRNAs are incorporated 
into RISC. RISC is activated by ATP and probes the 
target mRNA for complementary sequences. Upon 
recognition RISC mediates mRNA cleavage and 
subsequently gene silencing.    
 
2.4.1 Small interfering RNA as molecular tool for gene-suppression 
While RNAi was commonly used for functional gene studies in plants, Caenorhabditis elegans and 
Drosophila melanogaster, attempts to induce RNAi in mammalian cell lines using long dsRNA had 
only limited success156,157. This was due to the induction of an interferon response which resulted in a 
general inhibition of protein synthesis and eventual cell death158,159. It was shown that long dsRNA 
activates 2’-5’-oligoadenylate synthetase (OAS1) which induces sequence-independent RNA 
degradation by activating RNaseL159. The dsRNA-dependent protein kinase (PKR) is also involved in 
dsRNA sensing. PKR phosphorylates the eukaryotic translation initiation factor EIF2A upon activation 
by long dsRNA leading to translational repression. Further, PKR was shown to activate NFκB160.  
Tuschl’s group was the first to demonstrate that short synthetic duplexes mimicking natural 19-25 nt 
siRNAs could be introduced into mammalian cells eliciting sequence-specific mRNA degradation. The 
new concept in their work was the observation that these 21mer siRNA molecules were short enough 
to bypass PKR- and OAS-mediated recognition and therefore did not lead to the general shutdown of 
protein synthesis149,161. Additional studies showed that the silencing effect is relatively stable, 
persisting through several cell divisions and up to 10 days in mammalian cells.  Due to higher 
efficiency of siRNAs compared to traditional methods like antisense oligonucleotides or    
ribozymes162-164 and the ease of usage, siRNA applications have rapidly become a standard technique 
in life sciences. Furthermore, siRNAs hold the potential for therapeutic gene inhibition in various 
diseases165,166.  
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2.5 Objectives of this work 
As outlined in the chapters above, RNA represents a ligand for various immunorecognition principles. 
TLRs as well as cytoplasmic receptors have been described to be triggered by RNA molecules, which 
harbor different features that are recognized as non-self structures. Although some receptor ligand 
interactions could be identified already, essential parts of RNA immunorecognition remain unclear so 
far. This study aimed to characterize the interaction of different RNA ligands with the respective 
immunoreceptors.   
The first part of the work should be the design of siRNA molecules which avoid the activation of innate 
immunity. The immunostimulatory portential of siRNA was to be assessed by measuring the induction 
of IFN-α in human PBMCs. In parallel RNAi efficiency should be determined by gene-suppression of 
different reporter genes in HEK293T cells. Focus should be laid on possible immunostimulatory 
sequences as well as the influence of nucleotide modifications. Moreover, the formation of intra- and 
intermolecular structures and their contribution to immunorecognition, as already described for DNA 
immunorecognition principles, should be investigated.   
In a second part, immunorecognition of prokaryotic RNA should be analyzed. Therefore it should be 
assessed whether bacterial RNA stimulates innate immunity. Furthermore, responsiveness to bacterial 
RNA should be examined in different cells. Differences in the immunostimulatory potential of RNA 
purified from different bacterial species should be investigated. It was intended to identify structures 
which are responsible for the recogniton by the immune system, paralleling recognition principles for 
bacterial DNA. 
Finally, using different in vitro tanscribed RNA ligands as analogs for viral RNA the precise ligand 
specificity of the cytosolic RNA sensor RIG-I should be examined. The influence of the terminal 
5’-triphosphate as well as the presence of double-stranded conformation of the ligand on RIG-I-
mediated signalling should be investigated. Single- or double-stranded-, in vitro transcribed RNA 
bearing either a 5’-triphosphate or not should be used for transfection of Huh7.5 cells overexpressing 
functional RIG-I and therefore being sensitive to RIG-I activation. Increasing the size of the RNA 
ligands should clarify the relevance of double-strand recognition compared to the recognition of the 5’-
structure which in turn might help to elucidate differences to the homologous molecule MDA5. 
Clarifying of these issues should help to advance the understanding of the immunorecognition of RNA 
and probably disclose the interplay of TLR and cytosolic receptor systems.   
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3 Materials and Methods  
3.1 Materials 
3.1.1 Chemicals and enzymes 
3.1.1.1 Chemicals and reagents 
If not stated otherwise, all solvents and chemicals were purchased from the following companies: 
Merck (Darmstadt) and Sigma-Aldrich (Taufkirchen) with a purity of “pro analysi”. Specific reagents are 
listed in Table  3-1. 
Table  3-1 List of essential materials and suppliers used in this study 
32-[P]-GTP [10 µCi/µl] Perkin Elmer, Walham, USA 
Biocoll (1.09 g/ml) Biochrom AG, Berlin 
Coelenterazine PJK, Kleinblittersdorf 
DEPC Sigma-Aldrich, Taufkirchen 
DNA loading dye (6x) MBI Fermentas, St. Leon-Rot 
dNTPs MBI Fermentas, St. Leon-Rot 
DOTAP transfection reagent Roth, Karlsruhe 
Effectene transfection reagent Qiagen, Hilden 
EDTA Sigma-Aldrich, Taufkirchen 
EGTA Sigma-Aldrich, Taufkirchen 
FCSa Biowest, Nuaillé, France 
Lipofectamine™ 2000 Invitrogen, Karlsruhe 
Luciferine PJK, Kleinblittersdorf 
S-LPS (Salmonella minnesota) Ulrich Seydel, Forschungszentrum Borstel 
Methylthiazoltetrazolium (MTT) Sigma-Aldrich, Taufkirchen 
Poly(C) Sigma-Aldrich, Taufkirchen 
Poly(I) Sigma-Aldrich, Taufkirchen 
Poly(IC) Sigma-Aldrich, Taufkirchen 
R837 (imiquimod) Invivogen, Toulouse, France 
R848 (resiquimod) Invivogen, Toulouse, France 
RiboLock™ RNase Inhibitor MBI Fermentas, St. Leon-Rot 
RNA loading dye (2x) MBI Fermentas, St. Leon-Rot 
rNTPs MBI Fermentas, St. Leon-Rot 
 
3.1.1.2 Enzymes 
Enzymes used throughout this study are listed in Table  3-2. 
Table  3-2 List of essential enzymes and suppliers used for this study 
AccuTaq™ LA DNA Polymerase Sigma-Aldrich, Taufkirchen  
Agarase MBI Fermentas, St. Leon-Rot 
DNase I MBI Fermentas, St. Leon-Rot 
Lysozyme (chicken egg white) Sigma-Aldrich, Taufkirchen 
Lyticase (Arthrobacter luteus) Sigma-Aldrich, Taufkirchen 
Restriction endonucleases (div.) MBI Fermentas, St. Leon-Rot 
RNase A Sigma-Aldrich, Taufkirchen 
Shrimp Alkaline Phosphatase (SAP) MBI Fermentas, St. Leon-Rot 
T4 DNA Ligase MBI Fermentas, St. Leon-Rot 
T7 RNA polymerase MBI Fermentas, St. Leon-Rot 
                                                     
a FCS batch number: S04224S1810, Endotoxin content: 0.2 EU/ml
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3.1.2 Kits 
Purchased kits used for this study are listed in Table  3-3. 
Table  3-3 List of purchased kits and suppliers  
Absolute SYBR Green RoxMix ABgene House, Epsom, UK 
BD OptEIATM Human ELISA Set                                           
(IL-8, IL-6, TNF-α) 
BD Biosciences Pharmingen, Heidelberg 
BD OptEIATM Mouse ELISA Set (IL-12p40, IL-1β) BD Biosciences Pharmingen, Heidelberg 
Dual-Luciferase Reporter Assay System Promega, Madison, USA 
High Pure RNA Isolation Kit  Roche, Mannheim 
JETSTAR / LFU Plasmid Mini/Maxiprep Kit Genomed GmbH, Löhne 
JETQUICK PCR Purification Spin Kit Genomed GmbH, Löhne 
JETQUICK Gel Extraction Spin Kit Genomed GmbH, Löhne 
Matched Antibodies (Module Set)(human IFN-α) Bender MedSytems, Vienna, Austria 
µMACS Streptavidin Kit Miltenyi Biotech, Bergisch Gladbach 
QIAxcelRNA control kit Qiagen, Hilden 
QuantiChrom™ ATPase/GTPase Assay Kit Bioassay systems, Hayward, USA 
Quant-iT RNA Assay Kit Invitrogen, Karlsruhe 
RevertAidTM First Strand cDNA Synthesis Kit MBI Fermentas, St. Leon-Rot 
RNeasy Mini/Maxi Kit Qiagen, Hilden 
One ShotTM Top Ten chemically competent E.coli Invitrogen, Karlsruhe 
 
3.1.3 Buffers and solutions 
Selected buffers and solutions for cell culture, nucleic acid, protein and ELISA work are listed in Table 
 3-4, Table  3-5, Table  3-6 and Table  3-7, respectively. 
3.1.3.1 Cell culture 
Table  3-4 List of commonly used buffers and solutions 
β-galactosidase lysis buffer 100 mM β-mercaptoethanol; 9 mM MgCl2; 0.125% NP40; 0.15 mM CPRG 
β-galactosidase stop solution 300 mM glycin; 15mM EDTA 
Luciferase assay buffer   phosphate 25 mM glycyl-glycin (pH 7.8); 15 mM potassium-buffer (pH 7.8); 15 mM 
magnesiumsulfate; 4 mM EGTA;1 mM DTT; 2 mM ATP 
Luciferase lysis buffer 1% (v/v) Triton X-100; 25 mM glycyl-glycin (pH 7.8); 15 mM magnesiumsulfate; 4 
mM EGTA; 1mM DTT 
Luciferase substrate solution 1:5 dilution of 1 mM luciferine solution with 25 mM glycyl-glycin (pH 7.8) 
Renilla substrate solution Luciferase assay buffer without DTT and ATP; 1.5 µM coelenterazine 
Trypsin solution 0.05% trypsin; 0.02% EDTA 
Trypan blue solution 2 mg/ml trypan blue in 1x PBS 
Penicillin/Streptomycin (100x) 10.000 U/ml penicillin G; 10 mg/ml streptomycin; 0.9% (w/v) NaCl 
Water To avoid microbial contaminations, all buffers, solutions and media for cell culture 
were prepared with pyrogen-free water 
10x PBS 80 mM di-sodiumhydrogenphosphate; 20 mM sodium-di-hydrogenphosphate; 1.4 M 
NaCl; pH 7.4 
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3.1.3.2 Nucleic acid work 
Table  3-5 List of commonly used buffers and solutions 
TAE (50x) 2 M Tris-OH; 1 M acetic acid; 0.05 M EDTA 
TBE (10x) 0,89 M Tris-OH; 0.89 M boric acid; 0.02 M EDTA 
TE 10 mM Tris-HCl (pH 8.0); 1 mM EDTA 
PCR reaction buffer (5x) 750 mM Tris-HCl (pH 8.8); 200 mM (NH4)2SO4; 0.1% (v/v) Tween 20 
In vitro transcription buffer (5x) 200 mM Tris-HCl (pH 7.9); 30 mM MgCl2; 50 mM DTT; 50 mM NaCl; 10 mM 
spermidine 
Ethidium bromide solution 10 mg/ml ethidium bromide in H2O 
Water 
 
Buffers and solutions used in conjunction with RNA were prepared with DEPC-treated 
water ( 3.2.2.1).  
Y1 buffer 70% (v/v) ethanol ; 1 M saccharose ; 0.1 M EDTA; pH 7.4; supplemented with 0.1% 
(v/v) β-mercaptoethanol and 100 U/ml lyticase 
 
3.1.3.3 Protein work 
Table  3-6 List of commonly used buffers and solutions 
Acrylamid stock solution 30% acrylamid and bisacrylamid solved 29:1 
ATPase assay buffer (2x) 100 mM Tris-HCl (pH 7.4); 6 mM magnesiumchloride; 6 mM DTT; 2 mM EGTA; 1 
mM ATP 
Blocking buffer (western blot) 1x PBS; 0.5% (w/v) Tween20; 3% milk powder 
Coomassie staining solution 0.25% (w/v) coomassie brilliant blue R-250; 50% (v/v) methanol; 10% (v/v) acetic 
acid 
Destain solution 5% (v/v) methanol; 5% (v/v) acetic acid 
SDS PAGE sample buffer (6x) 600 mM Tris-HCl (pH 8.8); 15 mM EDTA ; 0.3% (w/v) bromophenolblue; 30% (w/v) 
sucrose; 9% (w/v) SDS; 6% (v/v) β-mercaptoethanol 
Semidry blotting buffer 48 mM Tris; 39 mM glycin; 0.00375% (w/v) SDS; 20% (v/v) methanol 
Separating gel buffer 1.5 M Tris-HCl (pH 8.8); 0.4% (w/v) SDS 
Stacking gel buffer  1 M Tris-HCl (pH 6.8); 0.8% (w/v) SDS 
Running buffer 25 mM Tris-OH (pH 8.3); 192 mM glycin; 10% (v/v) methanol 
 
3.1.3.4 ELISA 
Table  3-7 List of commonly used buffers and solutions 
Coating buffer (pH 9.5) 0.1 M Sodiumcarbonate: 8.4 g NaHCO3; 3.6 g Na2CO3; adjusted to pH 9.5; ad 1000 
ml H2O 
Coating buffer (pH 6.5) 0.2 M Sodiumphosphate: 11.8 g Na2HPO4; 16.1 g NaH2PO4; adjusted to pH 6.5; ad 
1000 ml H2O 
Blocking buffer 1x PBS; 10% (v/v) FCS 
Wash buffer 1x PBS; 0.05% (v/v) Tween20 
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3.1.4 Primer for quantitative real-time RT-PCR 
Primers were designed with the software Primer3 (http://frodo.wi.mit.edu). If possible primers were 
placed on exon/intron boundaries to avoid amplification of genomic DNA. For this reason, only 
monoexonic genes were sensitive to amplification from genomic DNA (Table  3-8, Table  3-9). 
Table  3-8 Primer sequences for the amplification of human transcripts 
Gene Sequence 5’-3’ Product (cDNA) 
Product 
(genomic DNA)b
Amplicon 
position  
Data basec
β-Actin 
fw  AGAGCTACGAGCTGCCTGAC 
rv  AGCACTGTGTTGGCGTACAG 
183 bp - 
786 
969  
NM_001101 
MDA5 
fw  CTGCTGCAGAAAACAATGGA 
rv  TTGAGGACCATCAACTTGTGA 
201 bp - 
680  
879  
NM_022168 
NALP3 
fw  CCGAAGTGGGGTTCAGATAA 
rv  TTCAATGCACTGGAATCTGC 
183 bp - 
1020 
1202  
NM_004895.3 
NOD1 
fw  CTCCTTCGTCCTGCATCACT 
rv  CAGCTCTTCGCTTAGCACCT 
172 bp - 
2510  
2682 
NM_006092 
NOD2 
fw  ATCTTCACACCGTCCCAGAG 
rv  GAAGCGAGACTGAGCAGACA 
189 bp - 
624 
913  
NM_0022162 
RIG-I 
fw  CCCTGGTTTAGGGAGGAAGA 
rv  TCCCAACTTTCAATGGCTTC 
188 bp - 
249 
436  
NM_014314.2 
TLR3 
fw  GTGCCAGAAACTTCCCATGT 
rv   ATGTGATTAAATTCTTCTGCTTGA 
173 bp - 
383  
555  
NM_003265 
TLR7 
fw  AATGTCACAGCCGTCCCTAC 
rv  TTATTTTTACACGGCGCACA 
185 bp 185 bp 
782  
966  
NM_016562 
TLR8 
fw  TCCTTCAGTCGTCAATGCTG 
rv  CGTTTGGGGAACTTCCTGTA 
167 bp 167 bp 
219  
385  
NM_016610 
 
Table  3-9 Primer sequences for the amplification of murine transcripts 
Gene Sequence 5’-3’ Product (cDNA) 
Product     
(genomic DNA)b
Amplicon 
position 
Data basec
β-Actin 
fw  CCCTGTGCTGCTCACCGA 
rv  ACAGTGTGGGTGACCCCGTC 
186 bp - 
383  
568  
NM_007393 
MDA5 
fw  TGCTGAGAAGGATTGTGCAG 
rv  CAGCAGGCAGAAGACACTCA 
183 bp - 
734  
916  
NM_027835 
NALP3 
fw  ACCAGCCAGAGTGGAATGAC 
rv  CCTGCTTCTCACATGTCGTC 
167 bp - 
489  
655  
NM_145827 
RIG I 
fw  AGGATGAGGAGGTGCAGTACA 
rv  TGGCTTCACAAAGTCCACAG 
165 bp - 
106  
270  
NM_172689 
TLR3 
fw  CTGCACGAACCTGACAGAAC 
rv  CGCAACGCAAGGATTTTATT 
198 bp 198 bp 
728  
925  
NM_126166 
TLR7 
fw  CCTGTTCTACTGGGGTCCAA 
rv  GCCTCAAGGCTCAGAAGATG 
167 bp 167 bp 
493  
659  
NM_133211 
 
                                                     
b No amplifcation of genomic DNA due to extended size by exon/intron structure 
c National Center for Biotechnology Information (NCBI: www.ncbi.nlm.nih.gov)
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3.1.5 Primer for in vitro transcription 
In order to generate in vitro transcripts of increasing length with similar sequences, one forward primer 
for all transcripts was designed to bind at position 1271 of TLR3 within pcDNA3-hTLR3. The forward 
primer contained a 5’-overhang with the promoter site for T7 polymerase. The respective reverse 
primer bind with increasing distances. The reverse primer contained a 3’-overhang with the final 6 
nucleotides of the T7 RNA polymerase promoter sequence, which is part of every transcription 
product. Primer for complementary transcripts were designed the same way vice versa. For 40 bp in 
vitro transcripts, sense 5’-GGG AGA TAG GTG GCC CAA CCA AGA GAA AGC ATC ATC TCC CTA 
TAG TGA GTC GTA TTA-3’ and antisense 5’-GGG AGA TGA TGC TTT CTC TTG GTT GGG CCA 
CCT ATC TCC CTA TAG TGA GTC GTA TTA-3’ DNA oligonucleotides, containing the T7 RNA 
polymerase promoter site on each respective 5’-end, were purchased in HPLC purity from MWG-
Biotech (Ebersberg) and annealed as described ( 3.2.2.14), resulting in the template DNA for in vitro 
transcription. Strategy for in vitro transcription reaction is summarized in Fig.  3-1. Primer used for in 
vitro transcription are listed in Table  3-10. 
 
T7 promoter
*
fw1:
rv1:rv2:
T7 promoter
*
fw2:
PCR
T7 promoter
In vitro transcription
*
pcDNA3-hTLR3
Template DNA
sense  transcript
antisense  transcript
T7 promoter
5‘
5‘3‘
3‘
(1)
(2)
(3)
*
 
Fig.  3-1 Summary of in vitro transcription  
PCR was performed either with fw1/rv1 primer or with fw2/rv2 using pcDNA3-hTLR3 as template (1). PCR products 
representing templates for in vitro transcription contain each a T7 promoter sequence (2). In vitro transcription results in 
transcripts of exclusively complementary sequences depicted as sense and antisense transcripts, respectively (3). *, depicts 
the starting point of transcription. To obtain transcripts of increasing length rv1 and fw2 primer were designed to bind further 
downstream of pcDNA3-hTLR3.    
 
Table  3-10 Primer sequences for in vitro transcription 
In vitro 
transcript Orientation 
Product 
size 5’-3’ Sequence
d
fw1 sense - TAATACGACTCACTATAGGGAGATGATGCTTTCTCTTGGTTGGGC 
rv1-100 sense 100 GGGAGATCTCCATTCCTGGCCTGTGA 
rv1-200 sense 200 GGGAGAGCATCAGTCGTTGAAGGCTTG 
rv1-400 sense 400 GGGAGAACCACCAGGGTTTGCGTGTTT 
rv-1600 sense 1600 GGGAGAGAACTTCAGGGTCAGCTTGC 
rv2 antisense - GGGAGATGATGCTTTCTCTTGGTTGGGC 
fw2-100 antisense 100 TAATACGACTCACTATAGGGAGATCTCCATTCCTGGCCTGTGA 
fw2-200 antisense 200 TAATACGACTCACTATAGGGAGAGCATCAGTCGTTGAAGGCTTG  
fw2-400 antisense 400 TAATACGACTCACTATAGGGAGAACCACCAGGGTTTGCGTGTTT  
fw2-1600 antisense 1600 TAATACGACTCACTATAGGGAGAGAACTTCAGGGTCAGCTTGC 
                                                     
d T7 promoter sequences is underlined, transcription start position is depicted in red; transcribed T7 promoter sequence 
depicted in bold letters
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3.1.6 Plasmids 
Plasmids for reconstitution experiments and reporter assays are listed in Table  3-11. 
Table  3-11 List of relevant recombinant plasmids and source used in this study 
Plasmid name Basic vector Insert Source 
pEF-SEM pcDNA3 Neomycin resistance, EF1α promotor H. Häcker, TU Munich 
pEGFP-N1 pEGFP Enhanced green fluorescent protein 
(eGFP), CMV promoter 
BD, Heidelberg 
pSV-β-gal control vector pSV LacZ gene, SV40 promoter/enhancer Promega, Madison, USA 
pCDNA3-hTLR3 pcDNA3 
 
Human TLR3-YFP, CMV promotor T. Espevik, NTNU, Trondheim, Norway 
pCDNA3.1-hTLR7 pcDNA3.1 
 
Human TLR7, CMV promotor S. Bauer, University Marburg 
pCDNA3.1-hTLR8 pcDNA3.1 
 
Human TLR8, CMV promotor S. Bauer, University Marburg 
pCDNA3.1-mTLR7 pcDNA3.1 
 
Murine TLR7, CMV promotor S. Bauer, University Marburg 
pISRE-Luc pLuc 
 
Firefly luciferase reporter, ISRE 
promotor 
Stratagene, La Jolla, USA 
p6NFκB-Luc pGL3 
 
Firefly-luciferase reporter, 6xNFκB 
promotor 
C. Kirschning, TU Munich 
pGL3B/561 pISG56 Firefly-luciferase reporter, ISG56 
promoter 
G.Sen, Lerner Research Institute, 
Cleveland, USA  
pRL-SV40 pRL Renilla-luciferase, SV40 enhancer, 
CMV promoter 
Promega, Madison, USA 
 
3.1.7 Markers 
Molecular markers used for electrophoresis are listed in Table  3-12. 
Table  3-12 Molecular markers used for this study
RiboRuler RNA Ladder (100-1000 bp)  MBI Fermentas, St. Leon-Rot 
RiboRuler RNA Ladder (200-6000 bp) MBI Fermentas, St. Leon-Rot 
GeneRuler DNA Ladder #323 (100-3000 bp) MBI Fermentas, St. Leon-Rot 
GeneRuler DNA Ladder #333 (100-10000 bp) MBI Fermentas, St. Leon-Rot 
Page Ruler Prestained Protein Ladder plus MBI Fermentas, St. Leon-Rot 
 
3.1.8 Oligonucleotides 
3.1.8.1 Deoxynucleotides 
As RNA-independent control ligand, unmethylated CpG DNA oligonucleotides were used, which have 
been shown to trigger exclusively TLR9. All deoxynucleotides were purchased with HPLC purity from 
MWG-Biotech (Ebersberg) and are listed in Table  3-13 
Table  3-13 List of CpG deoxynucleotides relevant in this study 
Name 5’-3’ Sequencee
CpG D19 GGtgcatcgatgcaGGGGGG 
CpG 1668 TCCATGACGTTCCTGATGCT 
CpG 2216 GGgggacgatcgtcGGGGGG 
                                                     
e PTO modified oligonucleotides are depicted in capital letters; unmodified oligonucleotides in small letters. 
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3.1.8.2 Ribonucleotides 
Ribonucleotides were either in-house synthesized and HPLC purified by a) Kerstin Giessler 
(Department of Organic Chemistry, University Karlsruhe) as described in167 or b) purchased in HPLC 
purity at IBA (Göttingen). RNA oligonucleotide sequences are listed in Table  3-14. 
Table  3-14 List of ribonucleotides relevant for this study 
Name 5’-3’ Sequencef Sourceg
RNA40 GCCCGUCUCUGUGUGACUC b) 
EGFP1s GCAAGCUGACCCUGAAGUUCAU  a) b) 
EGFP1s (dT) GCAAGCdTGACCCdTGAAGdTdTCAdT  a) 
EGFP1as GAACUUCAGGGUCAGCUUGCCG  a) b) 
EGFP1as (dA) GdAdACUUCdAGGGUCdAGCUUGCCG a) 
EGFP1as (dC) GAAdCUUdCAGGGUdCAGdCUUGdCdCG a) 
EGFP1as (dG) dGAACUUCAdGdGdGUCAdGCUUdGCCdG a) 
EGFP1as (dU) GAACdUdUCAGGGdUCAGCdUdUGCCG a) 
EGFP1as (mA) GmAmACUUCmAGGGUCmAGCUUGCCG a) 
EGFP1as (mC) GAAmCUUCAGGGUmCAGmCUUGmCmCG a) 
EGFP1as (mU) GAACmUmUCAGGGmUCAGCmUmUGCCG b) 
EGFP1as (nG) nGAACUUCAnGnGnGUCAnGCUUnGCCnG a) 
EGFP1as (m5C) GAAm5CUUCAGGGUm5CAGm5CUUGm5Cm5CG a) 
EGFP1as (dT) GAACdTdTCAGGGdTCAGCdTdTGCCG a) 
EGFP1as (dT-A) GAACdTdTCAGGGUCAGCUUGCCG a) 
EGFP1as (dT-B) GAACUUCAGGGdTCAGCdTdTGCCG a) 
EGFP1as (dT-C) GAACUUCAGGGUCAGCdTdTGCCG a) 
EGFP2s ACUACAACAGCCACAACGUCUA b) 
EGFP2as GACGUUGUGGCUGUUGUAGUUG a) b) 
EGFP2as (dT-A) GACGdTdTGdTGGCUGUUGUAGUUG a) 
EGFP2as (dT-B) GACGUUGUGGCdTGdTdTGdTAGdTdTG a) 
EGFP2as (dT) GACGdTdTGdTGGCdTGdTdTGdTAGdTdTG a) 
EGFP3s GAGCAAAGACCCCAACGAGAAG b) 
EGFP3as UCUCGUUGGGGUCUUUGCUCUG b) 
BGs CUACACAAAUCAGCGAUUUU a) b) 
BGas AAAUCGCUGAUUUGUGUAGUU a) b) 
BGas (dT) AAAdTCGCdTGAdTdTdTGdTGdTAGdTdT a) 
 
3.1.8.3 siRNAs 
All siRNAs were purchased in HPLC purity from MWG-Biotech (Ebersberg). Sequences shown in 
Table  3-15 confer to the respective passenger-strand of the siRNA. The siRNAs, targeting the reporter 
genes enhanced green fluorescent protein (EGFP) or β-galactosidase (BG) (siEGFP1-3, siBG) as well 
as the control siRNA (siCon) were designed, regarding published siRNA-efficiency rules168-170. All 
other siRNAs were validated by MWG-Biotech. Sequences of the respective passenger-strands are 
listed in Table  3-15.
                                                     
f Bold letters indicate modified oligonucleotides; d: deoxynucleotides; m: 2’-O-methylation; m5C: 5’-methylcytosine; nG: 7’-
deaza-guanosine 
g a) In-house synthesized by Kerstin Giessler, University Karlsruhe; b) purchased at IBA, Göttingen 
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Table  3-15 List of relevant siRNAs used in this study 
Name 5’-3’ Sequence  Target gene 
siEGFP1 GCAAGCUGACCCUGAAGUUCAU EGFP 
siEGFP2 ACUACAACAGCCACAACGUCUA EGFP 
siEGFP3 GAGCAAAGACCCCAACGAGAAG EGFP 
siBG CUACACAAAUCAGCGAUUUU BG 
siCon GCAAGCUGACCCUGAAGUUCAU No target 
siRIG-I ACGGAUUAGCGACAAAUUUAA Human RIG-I protein 
siTLR3 ACUUAAAUGUGGUUGGUAAUU Human Toll-like-receptor 3 
 
3.1.9 Antibodies 
Antibodies used for the indicated applications are listed in Table  3-16, Table  3-17 and Table  3-18. 
Table  3-16 List of antibodies for flow-cytometry  
Species Source Fluorescent-label Antigen Clone 
Anti-mouse BD (Heidelberg) PE B220/CD45R RA3-6B2 
Anti-mouse BD (Heidelberg) FITC CD11c HL3 
 
Table  3-17 Antibodies used for murine interferon-α ELISA 
Species Source Antigen Final concentration 
Anti-mouse PBL (Piscataway, USA) Interferon-α 2 ng/ml 
Anti-mouse PBL (Piscataway, USA) Interferon-α 2 ng/ml 
Anti-rabbit Cell signalling (Boston, USA) Rabbit IgG 4 ng/ml 
 
Table  3-18 Antibodies used for western blot analysis 
Species Source Antigen Final concentration 
Rabbit Acris (Herford) human RIG-I 0.5 µg/ml 
Anti-rabbit Acris (Herford) Rabbit IgG 0.5 µg/ml 
 
3.1.10 Bacteria and cell culture 
3.1.10.1 Prokaryotic cells 
NEB-5α high efficiency competent E.coli were used for plasmid transformations (genotype: 
fhuA2∆(argF-lacZ)U169 phoA glnV44 Φ80 ∆(lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 hsdR17) 
(New England Biolabs, Ipswich, USA). Bacteria used for RNA isolation are listed in Table  3-19. 
Table  3-19 List of bacterial species and sources  
Bacterial species Source Culture mediah
Escherichia coli ATCC 25922 a) 
Moraxella catarrhalis Isolate from patient b) 
Proteus mirabilis Isolate from patient a) 
Pseudomonas aeruginosa ATCC 27853 a) 
Bacillus subtilis ATCC 6051 b) 
Enterococcus faecalis ATCC 29212 a) 
Listeria monocytogenes ATCC 15313 b) 
Staphylococcus aureus ATCC 25923 a) 
Staphylococcus epidermidis ATCC 14990 a) 
Streptococcus pneumoniae ATCC 49619 b) 
                                                     
h a) Bacterial species were grown in LB media (3.1.10.3) b) Bacterial species were grown in BHI media (3.1.10.3). 
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3.1.10.2 Eukaryotic cells 
HEK293T  
Human embryonic kidney171 cells expressing the SV40 large T-antigen. Cells were cultured in DMEM 
( 3.1.10.3) and passaged approximately twice a week. 
Huh7-clone Huh7.5 
Human hepatoma cell line Huh7 derived clone Huh7.5 was received from M.Binder, University 
Heidelberg . Huh7.5 cells expressing functional RIG-I protein were generated and described by 
M.Binder previously .
172
173
PBMC 
Peripheral blood mononuclear cells were isolated from voluntary healthy donors as described in 
 3.2.1.1. 
FLT3L-derived dendritic cells174-176
Bone marrow-derived plasmacytoid dendritic cells (CD11c+; B220+) were generated as described in 
 3.2.1.1. The used mouse strains are described in  3.1.11. 
GMCSF-derived dendritic cells177
Bone marrow-derived myeloid dendritic cells (CD11c+; B220-) were generated as described at  3.2.1.1. 
The used mouse strains are described in  3.1.11. 
Yeast 
Candida albicans (ATCC 90028) was received from the Department of Medical Microbiology and 
Hygiene, University Heidelberg and cultured in LB-medium.  
3.1.10.3 Media 
Bacteria 
LB: 10 g/l tryptone, 5 g/l yeast extract, 5 g/l NaCl; 1.5% agar-agar added for solid media. 
BHI: 6 g/l brain-heart infusion, 6 g/l cattle tissue, 5 g/l NaCl, 3 g/l glucose, 2.5 g/l Na2HPO4, 14.5 g/l 
gelatine. 
SOC: 20 g/l tryptone, 5 g/l yeast extract, 8.56 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 20 mM glucose  
Mammalian cells 
DMEM (Dulbecco’s modified eagle media): supplemented with 10% (v/v) heat-inactivated FCS; 
penicillin G (100 IU/ml); streptomycin sulfate (100 IU/ml).  
RPMI 1640 (Rosswell Park Memorial Institute): for murine dendritic cells, supplemented with 10% (v/v) 
heat inactivated FCS; 50 mM β-mercaptoethanol; penicillin G (100 IU/ml); streptomycin sulfate (100 
IU/ml).  
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Differentiation media: For culturing of human PBMCs, RPMI 1640 was supplemented with 2% (v/v) 
autologous serum. Medium was supplemented with 5% (v/v) GM-CSF or 0.1% (v/v) FLT3L-containing 
supernatant for the generation of GM-CSF-derived dendritic cells and FLT3L-derived-dendritic cells, 
respectively. 
OptiMEM: defined medium formulation with reduced serum (GIBCO #31985). 
3.1.11 Mouse strains 
C57BL/6 mice were purchased from Charles River Laboratories (Wilmington, MA USA), TLR7 and 
TLR9-deficient mice (TLR7-/-, TLR9-/-) were obtained from Stefan Bauer (University Marburg), 
Interferon-α/β receptor-deficient mice (IFNAR1-/-) were obtained from Heike Weighardt (University 
Düsseldorf), Apoptosis-associated speck-like protein-deficient mice (ASC-/-) were obtained from 
Vishva Dixit (Genentech, San Francisco, USA), lps2 mice carrying a mutation in the TRIF adaptor 
protein were obtained from Marina Freudenberg (University Freiburg). Mice were breeded under 
specific pathogen free (SPF) conditions. Breeding and monthly control for infections were performed 
according to the list of GV-SOLAS 1995. Killing and dissection of mice were approved and 
experiments were properly recorded and reported to the regional commission Tübingen. 
3.2 Methods 
3.2.1 Cell biology 
3.2.1.1 Cell culture of mammalian cells 
Cells were grown as monolayers in cell culture dishes or in cell culture flasks (Greiner Bio-One, 
Frickenhausen) in fully supplemented DMEM culture media. Cells were split twice a week by washing 
with 1x PBS and detaching by 5 minutes incubation with trypsin solution. Pipetting the cell suspension 
up and down sheared the cells and a single cell suspension was yielded. Cells were split dependent 
on cell type and actual growth conditions, usually a ratio between 1:5 and 1:8 was chosen. All 
mammalian cells were incubated at 37oC and 5% CO2 in humidified atmosphere. To determine the cell 
number of a cell suspension, 10 µl of cell suspension was mixed with 90 µl trypan blue solution which 
stains exclusively dead cells. Cell numbers were determined with a Neubauer cell counting chamber. 
Isolation of human PBMCs (peripheral blood mononuclear cells) 
Human peripheral blood mononuclear cells (PBMCs) were isolated from whole blood of young healthy 
voluntary donors. Isolation was performed by standard Ficoll-Hypaque density centrifugation. Blood 
was diluted 1:2 with PBS, underlaid by Biocoll (Biochrom, Berlin) and centrifuged at 485x g for 20 
minutes. PBMCs were washed twice with PBS and resuspended in complete medium (RPMI1640, 
supplemented with 2% heat-inactivated autologous serum). PBMCs were plated at 4x105 cells/well in 
a 96-well flat bottom plate for stimulation assays. 
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Generation of primary bone marrow-derived dendritic cells 
GM-CSF-derived dendritic cells were prepared from female, 4- to 10-week-old mice as described by 
Inaba177 with minor modifications. Briefly, bone marrow was collected from femurs and tibiae. Cells 
were placed in 70 cm2 tissue-culture flasks in differentiation medium ( 3.1.10.3). After 24 h non-
adherent cells were collected, washed and counted. 107 of these cells were seeded into 175 cm2 
tissue-culture flasks in differentiation medium. At day 5 fresh differentiation medium was added and at 
day 9 non-adherent, immature dendritic cells (CD11c+, B220-) were harvested. Culture supernatant of 
the plasmacytoma X63 cell line which produces murine GM-CSF was used as a source of GM-CSF 
(supplied by M.Lutz, University Würzburg). FLT3L-derived dendritic cells were prepared the same way 
as described above. 1.5x107 cells were seeded into 75 cm2 tissue-culture flasks and supplemented 
with 10 µl FMS-like tyrosine kinase 3 ligand (Flt3L)-containing supernatant (supplied by S.Bauer, 
University Marburg). The same volume of Flt3L was added again after four days. Eight days after 
dissection of the mouse, immature pDC-like dendritic cells (CD11c+, B220+) cells were harvested. 
Dendritic cells were plated at 2x105 cells/well in a 96-well flat bottom plate for further stimulation 
assays. 
3.2.1.2 Cell culture of prokaryotic cells and yeast 
Bacteria and yeast were grown in specific media (Table  3-19) in a shaker (225 rpm) at 37oC. For 
quantitative RNA isolation ( 3.2.2.7) cells were cultured in 100 ml culture media and harvested within 
the mid log-phase growth. The number of colony forming units was determined by detecting the 
absorption at 600 nm (McFarland, 1 McF = 3 x 108 CFU/ml)178. The average time to reach mid-log 
growth for the used microorganisms is listed in Table  3-20. 
Table  3-20 List of used species and time to reach mid log-phase growth 
Species mid log-phase reached after [h] 
Candida albicans 12-15h 
Bacillus subtilis 3-4h 
Escherichia coli 3-5h 
Enterococcus faecalis 7-8h 
Listeria monocytogenes 12-15h 
Moraxella catarrhalis 9-14h 
Proteus mirabilis 3-5h 
Pseudomonas aeruginosa 4-6h 
Staphylococcus aureus 3-5h 
Staphylococcus epidermidis 12-15h 
Streptococcus pneumoniae 14-17h 
 
For plasmid preparation cells were grown overnight in culture media supplemented with the 
appropriate antibiotics. Cells were centrifuged at 4500 rpm (Multifuge 3 S-R, Heraeus Instruments, 
Hanau) at 4oC. Plasmid preparations were performed with the JETSTAR kit ( 3.1.2) according to the 
manufacturer’s protocol.
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3.2.1.3 Liposome based transfection of eukaryotic cells 
Lipofectamine2000 
Transfection of cells with Lipofectamine2000 transfection reagent was performed according to the 
manufacturer’s protocol. Cells were seeded 24 h prior transfection and transfected at a confluence of 
approximately 70%. Culture medium was exchanged 4 h post transfection procedure. 
Effectene 
Cells were transfected with Effectene transfection reagent according to the manufacturer’s protocol. 
Cells were seeded 24 h prior transfection and transfected at a confluence of 80%. Culture media was 
not changed for the experiments. 
3.2.1.4 Luciferase reporter assays 
For all reporter assays Firefly luciferase activity was normalized to Renilla luciferase activity on a per 
well basis. Values are typically expressed as fold-induction over mock treated or Poly(C) treated cells, 
alternatively luciferase activity is expressed in relative light units (RLU). Values are given as the mean 
of duplicate measurements. Error bars are presented as the SD. 
ISG56 reporter assay 
Huh7.5 cells were seeded in a 24 well format (1x105 cells/well). 24 h later, cells were cotransfected 
with pGL3/B561 and pRL-SV40 ( 3.1.6) in a ratio of 3:1 using Effectene transfection reagent. 6 h post 
transfection cells were stimulated by transfection of defined in vitro transcribed RNAs using 
Lipofectamine2000 according to the manufacturer’s recommendations. All RNAs were filled up to 1 µg 
with Poly(C) to ensure similar total RNA:Lipofectamine2000 ratios. 16 h after stimulation, medium was 
removed and cells were lysed with ice-cold luciferase lysis buffer in the plate (200 µl/well). Firefly 
luciferase activity was measured for 20 s in a Lumat LB9507 luminometer (Berthold, Freiburg) after 
injection of 200 µl luciferase substrate solution. Renilla luciferase activity was determined by injection 
of 100 µl Renilla substrate solution and subsequent measuring for 10 s in the same luminometer. 
NFκB reporter assay 
HEK293T cells were seeded in a 24 well format (1.5x105 cells/well). After 24 h cells were 
cotransfected with p6xNFκB-Luc and pRL-SV40 ( 3.1.6) in a ratio of 1:2 using Lipofectamine2000. 
6-8 h after transfection cells were stimulated with variable amounts of RNA oligonucleotides or 
bacterial RNA using DOTAP as transfection reagent ( 3.2.1.5). 16 h after stimulation cells were lysed 
and Firefly and Renilla luciferase activities were measured using the Dual Luciferase Reporter Assay 
System ( 3.1.2).  
3.2.1.5 Cell stimulation 
Stimulation with RNA oligonucleotides or bacterial RNA was performed using DOTAP transfection 
reagent according to the manufacturer’s protocol. RNAs were encapsulated with DOTAP in a 
1:2.5 (w/v) ratio. 16 h after transfection either cell free supernatants were analyzed for cytokine and 
  26  
   Materials and Methods 
interferon secretion using sandwich ELISA or cells were lysed and luciferase activity was measured as 
described above. For ISG56 reporter assays RNAs were encapsulated with Lipofectamine instead of 
DOTAP. 
3.2.1.6 Enzyme-linked immunosorbent assay (ELISA) 
To determine the quantities of secreted cytokines or interferons cell free supernatants were removed 
and analyzed by sandwich ELISA. Supernatants were diluted with 1x PBS, supplemented with 
10% (v/v) FCS. Assays were performed according to the manufacturer’s protocols. Detection of 
murine Interferon-α was adapted to the protocol of murine IL-12p40 ELISA using separately 
purchased antibodies specific for murine interferon-α (PBL, Piscataway, USA) ( 3.1.9) in the same 
concentrations as recommended in commercially available ELISA kits ( 3.1.2). Buffers used for human 
interferon-α ELISA were also used for the analysis of murine interferon-α. Analysis was performed in 
duplicates and all experiments were performed at least three times if not indicated otherwise. 
Cytokines were detected by measuring the absorbance at 490 nm with a 650 nm reference in a 
photometer (SUNRISE Absorbance reader, Tecan, Salzburg, Austria). Cytokine concentrations were 
calculated using a standard dilution of the respective recombinant cytokines. Finally, concentrations 
were calculated with the Magellan V 5.0 software (TECAN, Salzburg, Austria).       
3.2.1.7 MTT-assay 
Viability of stimulated cells was determined by MTT-assay. MTT substrate is reduced by various 
mitochondrial dehydrogenases resulting in a change of substrate colour. After removing cell free 
supernatants for cytokine detection, MTT solution was prepared according to the manufacturer’s 
recommendations and added to culture medium in a ratio of 1:20 (v/v). Cells were incubated for 1 h at 
37oC and absorbance at 550 nm with 650 nm reference wave length was measured in a photometer 
(SUNRISE Absorbance reader, Tecan, Salzburg, Austria) adapting a 4 parameter fit regression 
analysis. 
3.2.1.8 Flow cytometry (FACS) 
Staining of surface molecules 
To determine the purity of bone marrow-derived dendritic cells characteristic surface molecules were 
stained with fluorescence-labelled antibodies ( 3.1.9). Approximately 2.5x105 cells were washed with 
1x PBS, supplemented with 2% (v/v) FCS. Cell suspension was adjusted to a volume of 100 µl and 
incubated with the respective antibody for 20 minutes on ice. After washing twice with 1x PBS, cells 
were analyzed in a flow cytometer (FACS Canto, BD, Heidelberg). Cells were identified and gated by 
size and granularity according to forward/sideward scatter characteristics. Mean fluorescence intensity 
(MFI) of the respective 20x103 living cells was analyzed for expression of the respective fluorochrome 
(expressed as percentage of positive cells). Unstained and isotype stained cell controls were used to 
gate for the respective fluorochrome. 
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Determination of gene-silencing activity 
1.5x105 HEK293T cells were plated in DMEM supplemented with 10% (v/v) FCS per well of a 24-well 
culture plate. The following day cells were cotransfected either with 400 ng pEGFP-N1 encoding 
enhanced green-fluorescent-protein (EGFP) or with 500 ng pSV-β-galactosidase control vector 
encoding β-galactosidase together with the respective siRNA in the indicated concentration according 
to the Lipofectamine2000 protocol for DNA siRNA cotransfections. After 24 h cells were washed with 
1x PBS and reporter gene expression was analyzed. Expression of EGFP was determined by flow 
cytometry (FACS Canto, BD, Heidelberg) in the FITC channel (530/30 nm). Mean fluorescence 
intensity (MFI) of 20,000 live cells gated according to forward/side scatter characteristics was 
detected. The β-galactosidase activity was determined by incubation of the cells for 4 hours at 37oC in 
β-galactosidase lysis buffer. Reaction was stopped by addition of β-galactosidase stop solution and 
optical density was measured at 570 nm with 650 nm reference wave length. 
3.2.1.9 siRNA transfection 
For RNAi-mediated gene-silencing of endogenously expressed genes 1x105 cells were seeded in a 24 
well format. 24 h later cells were transfected with 10 nM of the respective siRNA using 
Lipofectamine2000 according to the manufacturer’s protocol. After 72 h cells were transfected again 
the same way. Next day gene-silencing was validated by quantitative real-time RT-PCR. 
3.2.2 Molecular biology 
3.2.2.1 DEPC-treated water 
Water used for RNA-related work was treated with DEPC to eliminate contaminations with RNases. 
Briefly, 1 ml DEPC was added to 1 l H2O and stirred for 15 minutes. For RNase inactivation water was 
autoclaved by standard procedure. 
3.2.2.2 Transformation of competent bacteria 
For transformation 50 µl competent E.coli ( 3.1.10.1) were mixed with 5-10 µl of 100-200 ng/µl plasmid 
DNA and incubated at least 20 minutes on ice. After incubation of the bacteria at 42oC for 30 seconds, 
1 ml SOC media was added and bacteria were incubated at 37oC on a shaker (225 rpm) for 1 h. 
Thereafter 50-100 µl cell suspension was pipetted on a agar plate containing the appropriate 
antibiotic. Colonies were grown overnight at 37oC. 
3.2.2.3 Plasmid preparation 
Preparation of plasmid DNA from bacteria was performed using silica membrane based spin column 
kits (mini) ( 3.1.2) according to the manufacturer’s protocol. In general, approximately 5 ml of an 
overnight cell suspension were used for mini preparations. For larger plasmid DNA preparations ion-
exchanger columns (maxi) ( 3.1.2) were used according to the manufacturer’s protocol. Plasmid DNA 
was eluted in 200 and 500 µl water, respectively. 
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3.2.2.4 DNA sequencing 
Sequencing was performed commercially by GATC (Konstanz). 2-3 µg plasmid DNA was analyzed 
with either standard or specifically designed primer. Results were validated by aligning with the 
theoretical sequences using the alignment program CLUTALW2 (www.ebi.ac.uk/Tools/clustalw2). 
3.2.2.5 Quantitative RT-PCR 
RNA preparation 
Total RNA preparation was performed using the High Pure RNA Isolation kit (Roche, Mannheim) 
according to the manufacturer’s protocol. RNA preparation included a DNase I digestion. The eluted 
RNA was either stored at –80oC or directly used for cDNA synthesis. 
cDNA synthesis 
Synthesis of cDNA was performed with the RevertAid first strand cDNA synthesis kit using the 
RevertAid™ M-MuLV Reverse Transcriptase (Fermentas, St.Leon-Rot). Messenger RNA was 
amplified using Oligo(dT)18 primers according to the manufacturer’s protocol. The cDNA was finally 
diluted with H2O in a ratio of 1:5.        
SYBR green based quantitative RT-PCR (qRT-PCR) 
The cyanid fluorescent dye SYBR-green which interferes with double-stranded DNA was used for 
DNA quantification. For qRT-PCR the Absolute SYBRgreen RoxMix kit (ABgene House, Epsom, UK) 
was used and gene specific primer pairs were ordered from Operon (Cologne) ( 3.1.4). 2.5 µl template 
cDNA, 12.5 pmol forward and reverse primer, 12.5 µl SYBR Green Rox Mix were used for each 25 µl 
PCR reaction. Reactions and detection were performed in the 7900 HT Fast Real-Time PCR System 
(AB Applied Biosystems, Darmstadt) in a 96 well format (program: 95oC 15 min; 40x [95oC, 15sec; 
60oC, 1min]). 
Each gene was typically measured in duplicates in each cDNA sample. Automatic detection of 
baseline and threshold values was used and the determined Ct values were substracted from the Ct 
values of an endogeneous constitutively expressed reference gene (β-actin) resulting in a ∆Ct for each 
target gene. Relative expression (rE) was calculated as rE = 1/(2∆Ct) and PCR reactions were verified 
for similar efficiencies. For reaction specificity, “no reverse-transcriptase” and “no template” controls 
were performed with each reaction. Additionally the dissociation curves of each target gene were 
analyzed. 
3.2.2.6 Gel electrophoresis 
For DNA visualization standard agarose gel electrophoresis procedure was performed. DNA sample 
was mixed with 6x DNA loading dye and applied to 1-2% 1x TAE agarose gel electrophoresis (run at 
approximately 120 V). For RNA agarose gel electrophoresis it had to be ensured that no 
contaminating RNases were present, therefore all buffers and solutions were prepared with 
DEPC-treated water. The electrophoresis chamber was incubated with 3% (v/v) H2O2 for 30 minutes 
and washed with 100% ethanol before usage. 1-2 µg ethidiumbromide was added to the agarose gels 
for UV-based detection of the respective nucleic acids (infinity video documentation system 3000, 
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Peqlab, Erlangen). RNA samples were mixed with 2x RNA loading dye and preheated to 70oC for 10 
minutes to avoid second stucture formation prior application to the gel electrophoresis. 
3.2.2.7 Quantitative purification of RNA 
All RNA purifications described below included an on-column DNase I digestion ensuring that no 
residual genomic DNA was present in the RNA preparations. 
Eukaryotic RNA 
Total RNA isolation from HEK293T cells was performed with the RNeasy mini kit according to the 
animal cell protocol of the manufacturer. 1.2x107 HEK cells were taken for each purification. Candida 
albicans RNA isolation was performed the same way. Due to the cell wall 5x1010 cells from mid log-
phase growth were incubated for 30 minutes at room temperature with Y1 buffer containing 100 U/ml 
lyticase. RNA from the resulting spheroblasts was purified with the animal cell protocol of the 
manufacturer. 
Prokaryotic RNA 
1.5x1011 bacteria were taken from mid log-phase growth and lysozyme digested for 30 minuntes. 
Gram-positive bacteria were treated with 1x TE, supplemented with 40 mg/ml lysozyme, whereas 
gram-negative bacteria due to the thinner cell wall were treated with 1x TE, supplemented with 
10 mg/ml lysozyme. After lysozyme digestion RNA purification was performed with the RNeasy mini kit 
according to the bacterial RNA isolation protocol of the manufacturer. 
Viral RNA 
Viral RNA was prepared from supernatants of cultured Huh-7 cells infected with vesicular stomatitis 
virus (VSV). Briefly, superantant was cleared by table-top centrifugation and filtration through a 
0.45 µm syringe tip filter. Virus particles were then pelleted by ultracentrifugation for 2 h at 100.000x g 
(RCF max) through a 25% sucrose cushion and viral RNA was extracted using the NucleoSpin RNA II 
kit (Macherey-Nagel, Düren) according to the manufacturer‘s recommendations. Hepatitis C virus 
(HCV) genome length positive and negative sense RNAs were prepared by in vitro transcription of the 
construct Con1∆GDD, referring to the full-length Con1 genome (AJ238799) bearing the inactivating 
GDD deletion, and annealed to form a double-stranded hybrid as described173. 
3.2.2.8 Isolation of E.coli 16S ribosomal RNA 
Isolation of E.coli 16S rRNA from total E.coli RNA preparations was performed using a 3’-biotinylated 
capture DNA, containing a 15 nucleotide long spacer between the complementary sequence and the 
3’-end (5’-CGT TTA CGG CGT GGA CTA CCA GGG TAT CTA ATC CAC AGA CAC AGA GTA C-
biotin-3i). 40 µg of total RNA was denaturated for 5 minutes at 75oC, incubated with the capture DNA 
in a molar ratio of 1.5:1 and slowly cooled down to the calculated annealing temperature of 62oC. 
Annealing was performed for 10 minutes in TEN buffer (TE buffer supplemented with 100 mM NaCl). 
                                                     
i Capture DNA: consisting of a 34 nucleotide sequence complementary to 16S rRNA of E.coli, a 15 nucleotide spacer sequence 
depicted in italic and a 3’-Biotin.   
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Subsequently, the RNA/DNA duplex was incubated with µMACS Streptavidin beads (Miltenyi, 
Bergisch Gladbach, Germany) according to the manufacturer’s recommendations and purified using a 
µMACS magnet-attached column. After 3 times washing with 1x TE, RNA was eluted by denaturation 
of the DNA/RNA duplexes with preheated RNase-free water (approximately 90oC). 
3.2.2.9 Polymerase chain reaction (PCR) 
PCR was performed according to general protocols using Accu Taq LA DNA polymerase. Annealing 
temperatures for standard cloning purposes was 5oC under calculated annealing temperatures, 
elongation times were 60 sec per 1000 bp. PCR products were directly purified using the JETQUICK 
PCR Purification Spin Kit. 
3.2.2.10 In vitro transcription 
For generation of in vitro transcripts of defined length standard PCR using pcDNA3-hTLR3 as 
template DNA was performed with primers containing the T7 RNA polymerase promoter site ( 3.1.5). 
PCR products were purified as described above and annealed ( 3.2.2.14). 
The in vitro transcription had a final reaction volume of 100 µl, containing 20 µl in vitro transcription 
buffer, 6.25 µl rNTPs (25 mM each), 50 U RiboLock, 5-10 µg template PCR product and 60 U T7 RNA 
polymerase. After 2 h incubation at 37oC additional 60 U T7 RNA polymerase were added and 
reaction was continued for another 2 h. Transcription reaction was terminated by adding 
1 U RNase-free DNase/µg template DNA and further 30 minutes incubation at 37oC. For in vitro 
transcripts of 200 bp or shorter transcription reaction was extended for another 2 h.  
To label the 5’-triphosphate of in vitro transcripts, γ32[P]-GTP was added to the in vitro transcription 
reaction in a γ32[P]-GTP: GTP ratio of 1:100 – 1:500. Since the triphosphate group is cleaved off 
during RNA extension the radiolabel remains only at the free 5’-end of each molecule. Afterwards, the 
sample was cleared from non-incorporated radioactive nucleotides by using a microspin 25 column-
based gel filtration (GE Health Care, Munich) according to the manufacturer’s protocol.  
3.2.2.11 Purification of in vitro transcripts  
In vitro transcripts were purified to avoid protein contaminations and to ensure the absence of side 
products of varying lengths. In vitro transcription products were therefore separated by gel 
electrophoresis using 1-3% low-melting agarose dependent on the expected product size. Transcripts 
of the expected size were excised with a scalpel from the gel. Gel slices were melted for 10 minutes at 
70oC, cooled down to 42oC and agarose was degraded by incubation with 1 U agarase/100 mg gel for 
30 minutes. Ammoniumacetate was added to a final concentration of 2.5 M and residual agarose was 
precipitated by centrifugation at 13000 rpm for 10 minutes. Then 2/3 volumes of acidic water saturated 
phenol (Roth, Karlsruhe) were added to the supernatant and incubated for 10 minutes on ice. After 10 
minutes of centrifugation (10000 rpm) at 4oC, the supernatant was extracted with 1 volume chloroform. 
RNA–containing supernatant was mixed with 10% (v/v) ammoniumacetate and 2 volumes ice-cold 
ethanol, following incubation for 2 h at –80oC and final precipitation by centrifugation (13000 rpm) at 
4oC for 45 minutes. Finally RNA was dissolved in RNase-free water. 
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Due to their small size 40 nucleotide transcripts were purified by gel filtration using NAP-5 spin-
columns (GE Healthcare, Munich) according to the manufacturer’s protocol. 
3.2.2.12 RNA digestion 
RNA was denatuated for 5 minutes at 95oC to ensure single-stranded conformation and primary 
structure formation of the respective RNA sample. For digestion RNA samples were incubated with 10 
µg RNaseA/µg RNA for 3 h at 65oC. 
3.2.2.13 RNA dephosphorylation 
Bacterial messenger RNA and in vitro transcribed RNA contain a triphosphorylated nucleotide at the 
very 5’-end. To remove the terminal 5’-triphosphate RNA samples were dephosphorylated using 
shrimp alkaline phosphatase (SAP). RNA samples were incubated for 30 minutes at 37oC with 
0.5 U SAP/pmol 5’-end of the RNA samples. After 30 minutes another 0.5 U SAP/pmol 5’-end RNA 
was added and incubated for another 30 minutes. Reaction was terminated by heating the reaction 
mixture for 10 minutes at 65oC. The amount of 5’-ends in pmol was calculated as: 
Amount of 5’-ends [pmol] = (RNA [g] x [nt]/ (RNA length x 330 g/mol x nt)) x 1012 pmoles/mol.  
The efficiency of triphosphate removal was controlled by dephosphorylation of 5’-32[P]-radiolabelled 
in vitro transcripts ( 3.2.2.10). In vitro transcripts were therefore cleared from non-incorporated 
nucleotides by using a microspin 25 column-based gel filtration (GE Health Care, Munich) according to 
the manufacturer’s recommendations. Samples were further either SAP- or mock-treated, 
respectively. After a second gel filtration, the remaining radiolabeled nucleotides were detected in a 
liquid scintillation counter (Beckman Coulter LS6500, Krefeld). 
3.2.2.14 Annealing to duplexes 
To generate double-stranded RNA or DNA duplexes, sense and complementary antisense strand 
were mixed at equimolar concentrations in annealing buffer (20 mM HEPES, 50 mM NaCl, pH 7.4), 
heated to 90oC for 5 minutes, followed by slowly cooling down to room temperature.  
3.2.2.15 Quantification and validation of RNA samples 
All RNA preparations were quantified with the Qubit Fluorometer (Invitrogen, Karlsruhe) using the 
Quant-iT RNA Assay Kit. This method is based on an RNA-specific fluorescent dye and allows 
quantification of concentrations as low as 1 ng/ml. Quality and integrity of the RNA preparations were 
determined by QIAxcel capillary gel electrophoresis (Qiagen, Hilden, Germany) according to the 
manufacturer’s protocol. 
3.2.3 Biochemistry 
3.2.3.1 Recombinant expression of human RIG-I protein 
Recombinant protein expression and purification was performed by M.Binder (Department of 
molecular Virology, University Heidelberg) using the Bac-to-Bac Baculovirus expression system 
(Invitrogen, Karlsruhe). Briefly, human RIG-I protein was cloned in the pFastBac-DualGFP vector 
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under the control of a polyhedron (PH) promoter, whereas the GFP protein was controlled by the p10 
promoter. The glutathione-S-transferase tag (GST) was cloned from pGEX 6p1 to the N-terminus of 
the RIG-I protein and a cleavage site for Prescission protease (Invitrogen, Karlsruhe) was introduced 
between the GST-tag and the RIG-I protein by PCR method. Next, the pFasBac-DualGFP vector 
containing the GST-tagged RIG-I protein was transformed in a DH10Bac E.coli strain, where the 
vector is recombined to a bacmid. Once the recombinant bacmid was isolated, it was transfected into 
the oocyte insect cell line Sf9. Baculovirus containing supernatant was collected after Sf9 cells 
showed strong GFP expression which was reached approximately after 72 h. Supernatant was 
passaged 3 times, thereby increasing the number of infected Sf9 cells constantly. Finally, 3 times 
passaged supernatant was used to infect 20x 15 cm2 cell culture plates of confluent Sf9 cells (1.5 ml 
supernatant/15 cm2 cell culture plate). 
3.2.3.2 Purification of recombinant expressed human RIG-I protein 
Cells were centrifuged and cell pellets were taken up and resuspended in 4x 10 ml binding buffer (150 
mM NaCl, 50 mM Tris, 1 mM DTT, 1 mM MgCl2, supplemented with 1 Complete Protease Inhibitor 
Cocktail tablet (Roche, Mannheim). Cell pellets were lysed by freeze/thawing for 3 times by switching 
between 20oC water bath and liquid nitrogen, resulting in the complete lysis of the cells. Cell 
suspension was centrifuged at 14000 rpm, 15 minutes, 4oC, and cleared supernatant was mixed with 
2 ml of Glutathione 4B Sepharose Beads (GE Health Care, Krefeld). Additionally 0.1 U/µl Micrococcus 
S7 Nuclease was added to eliminate possible DNA or RNA contaminations. The sepharose beads 
were incubated for 3 h, 4oC on a rotating shaker and separated by centrifugation with 500x g for 5 
minutes. Next, sepharose beads were washed 3 times with binding buffer and resuspended in 500 µl 
binding buffer, supplemented with 20 U GST-tagged Prescission protease. Protease cleavage was 
performed overnight at 4oC. Finally, RIG-I containing supernatant was separated from the sepharose 
beads by filter spin columns (GE Health Care, Krefeld). Protein concentration was determined by the 
Qubit fluorometer, using the Quant-IT protein assay kit (Invitrogen, Karlsruhe). RIG-I containing 
supernantant was mixed with 50% (v/v) glycerol, aliqoted and stored at -70oC.    
3.2.3.3 SDS-PAGE  
For protein analysis cell pellets were lysed in SDS-PAGE sample buffer and denaturated at 98oC for 
10 minutes. The samples were loaded on a 10% polyacrylamide gel and run at constant current for 
approximately 4 hours (30 mA for a 15x 15 cm gel). For PAGE a vertical gel chamber was used. As a 
reference a prestained protein marker ( 3.1.7) was used. Proteins from the gel were either visualized 
by Coomassie staining or further analyzed by Western Blotting ( 3.2.3.4). For staining the gel was 
incubated for 30 minutes in Coomassie staining solution and directly incubated with destain solution at 
37oC until the staining intensity seemed appropriate.  
3.2.3.4 Western blot analysis 
Proteins from SDS-PAGE ( 3.2.3.3) were blotted to methanol-activated PVDF membranes (Millipore, 
Billerica, USA) by semidry blotting procedure with 1 mA/cm2 for at least 1 hour. Membranes were 
incubated overnight in blocking buffer, and then membranes were incubated with primary antibody 
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( 3.1.9). After washing three times with 1x PBS supplemented with 0.05% (v/v) Tween, the membrane 
was incubated with horseradish peroxidase-conjugated secondary antibody ( 3.1.9). After three further 
washing steps with 1x PBS supplemented with 0.05% (v/v) Tween bound antibodies were detected by 
chemoluminescence using enhanced luminol (ECL plus, Amersham, Freiburg). Chemoluminescence 
was detected with a cooled CCD-camera device (Chemi-Smart 2000, Peqlab, Erlangen) and analyzed 
with the Chemi-Capt software (Vilber Lomat, Eberhardzell).    
3.2.3.5 ATPase Assay   
Functionality of recombinant human RIG-I protein was analyzed by detection of ATPase activity. 
Therefore the QuantiChrom™ ATPase/GTPase Assay Kit (Bioassay systems, Hayward, USA) was 
used according to the manufacturer’s protocol. The reaction mixture had a final volume of 20 µl. First, 
2 µl human RIG-I [110 ng/µl], which corresponds to 2 pmol recombinant protein, was mixed with 
varying concentrations of ligand RNA and 2x ATPase reaction buffer, either containing 1 mM ATP or 
not. Mixture was incubated for 20 minutes at 37oC. Finally 180 µl detection solution was added and 
freed pyrophosphate was detected by absorbance at 620 nm in a photometer (SUNRISE Absorbance 
reader, Tecan, Salzburg, Austria). 
3.2.4 Statistical analysis, data transformations and structure predictions 
Data were analyzed by GraphPad Prism 4.03 program (GraphPad Software, San Diego, USA). 
Significant differences were assessed by analysis of variance (ANOVA) to compare three or more 
groups followed by Dunnett’s test to compare selected groups. In all figures * represents p-values 
<0.05. Means of triplicates were used for linear regression analysis with GraphPad Prism 4.03 
program.  
Structure predictions for RNA oligonucleotides in monomeric and dimeric conformation were 
calculated with the Mfold program (www.mfold.bioinfo.rpi.edu)179. 
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4 Results  
4.1 Characterization of siRNA-mediated immunostimulation 
It had been shown that single-stranded RNA oligomers induce a type-I interferon response in a TLR7- 
and TLR8-dependent manner81,180 . Results from several further groups showed that also short, 
synthetic, double-stranded RNAs such as siRNAs are able to mount a type-I interferon response in 
human PBMCs97-99 which was mediated by the activation of human pDCs. A general aim of this work 
was to identify these immunorecognition principles and to try to separate siRNA-mediated RNA 
interference from immunostimulation. This would allow the generation of more specific siRNAs for 
therapeutic applications. 
4.1.1 RNA oligonucleotide mediated immunostimulation 
As a starting point, RNA-mediated immunostimulation had to be confirmed and characterized. 
Therefore we analyzed interferon-α (IFN-α) secretion by a recently published immunostimulatory 
single-stranded RNA oligonucleotide (RNA40) of 20 nucleotides in length81. RNA40 was either 
encapsulated with the transfection reagent DOTAP in order to facilitate cellular uptake and endosomal 
delivery or was directly applied to the cells. Upon transfection of isolated human PBMCs with RNA40 
encapsulated RNA40 showed a robust and dose-dependent secretion of interferon-α (IFN-α). In 
contrast, application of RNA40 to the cells without transfection reagent did not result in any detectable 
IFN-α secretion (Fig.  4-1 [A]). To further address the question of cellular delivery of RNA, 
oligonucleotide RNA40 containing a phosphothioate-modified sugar-phosphate backbone (PTO) was 
designed and used to transfect human PBMCs. For DNA oligonucleotides it had been shown earlier 
that introduction of phosphothioate into the sugar-phosphate backbone (PTO) was sufficient to 
increase cellular delivery and to activate immunorecognition principles181 thereby avoiding the need of 
any transfection reagent formulation. We assumed that this mechanism could also be assigned to 
RNA mediated immunostimulation. DOTAP complexed RNA40, carrying a PTO-modified backbone, 
resulted in a dose-dependent IFN-α secretion in human PBMCs. However, RNA40-PTO showed a 
slightly reduced immunostimulatory potential compared to the unmodified RNA40 oligonucleotide. 
Transfection of RNA40-PTO without DOTAP did not result in any detectable IFN-α secretion. This 
suggested that the mechanisms of RNA and DNA uptake as well as the induced immunostimulation 
are different. TLR7-dependent recognition of single-stranded RNA oligonucleotides had been 
demonstrated earlier81, however, profound characterization of siRNA recognition had not yet been 
done. We therefore generated murine GM-CSF-derived dendritic cells (mDCs) from wild type and 
TLR7-/- mice. As an activation marker for murine dendritic cells secretion of interleukin-12p40 
(IL-12p40) was analyzed. 
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Fig.  4-1 Influence of transfection agent and PTO-backbone modification on RNA-mediated IFN-α secretion in PBMCs 
Human PBMCs were transfected with single-stranded RNA oligonucleotide RNA40 either complexed with DOTAP or not. [A] 
Unmodified RNA40 or [B] PTO-backbone modified RNA40 was used. IFN-α secretion was detected by ELISA (n=3, mean ±SD),  
(*, p<0.05 as compared to the RNA oligonucleotide without DOTAP). 
 
Upon transfection of equal concentrations of encapsulated siRNA and the thereof derived single-
stranded RNA oligonucleotides, strong induction of IL-12p40 secretion was detected in wild type DCs 
(Fig.  4-2). The single-stranded RNAs displayed a higher induction of IL-12p40 compared to the 
annealed siRNA duplex. To compare the cytokine secretion of cells derived from wild type and TLR7-/- 
mice, IL-12p40 secretion was normalized to the strictly TLR4-dependent ligand LPS. In TLR7-/- mDCs 
IL-12p40 secretion upon transfection with single-stranded and annealed siRNA was significantly 
reduced. The TLR7-specific control resiquimod (R848) showed no IL-12p40 secretion in TLR7-/- cells 
as expected. The TLR3-specific control Poly(IC)109 showed equal amounts of secreted IL-12p40 in 
wild type compared to TLR7-/- cells.   
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Fig.  4-2 Relevance of TLR7 for siRNA  
 induced immunostimulation 
Murine GM-CSF-derived dendritic cells of wild 
type and TLR7 knockout mice were prepared and 
stimulated with either 1 µg/ml siRNA targeting 
EGFP or with 1 µg/ml of the thereof derived sense 
(s) and antisense (as) strands. RNA molecules 
were encapsulated with DOTAP prior to 
transfection. 1 µg/ml R848 served as TLR7-
specific control, 100 ng/ml LPS and 25 µg/ml 
Poly(IC) served as TLR4-specific and TLR3-
specific controls, respectively. IL-12p40 secretion 
was detected by ELISA and values were 
normalized to LPS for better comparability (n=3, 
mean ±SD), (n.d., not detected, *, p<0.05 as 
compared to the wild type control). 
 
4.1.2 Immunostimulation of fuctional siRNAs 
To investigate the siRNA-mediated immunostimulation in more detail, it was necessary to establish a 
model system which enabled the study of siRNA-mediated immunostimulation and siRNA-mediated 
RNA interference. For this reason siRNAs were designed which targeted the two reporter genes 
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enhanced green-fluorescent protein (EGFP) and β-galactosidase (BG). For analysis of 
immunostimulation, human PBMCs were isolated from healthy donors and transfected with RNA 
oligonucleotides, encapsulated with the transfection reagent DOTAP. Upon transfection of these 
siRNAs and the corresponding sense (s) - and antisense (as) -strands human PBMCs secreted large 
amounts of IFN-α (Fig.  4-3 [A]). It could be observed that the transfected RNA molecules showed 
significant differences in their ability to induce IFN-α secretion. In contrast to RNA-induced IL-12p40 
secretion in mDCs (Fig.  4-2) the amounts of secreted IFN-α in human PBMCs upon transfection with 
siRNA were comparable to single-stranded RNA. To confirm the gene-silencing activity of the tested 
siRNAs, HEK293T cells were cotransfected with either the EGFP-encoding reporter plasmid pEGFP-
N1 or the β-galactosidase-encoding reporter plasmid pSV-β-gal control vector and the respective 
siRNAs. Gene-silencing activity of the siRNA targeting EGFP was determined by flow-cytometry and 
fluorescence microscopy, respectively. Β-galactosidase activity was analyzed by β-galactosidase 
assay (Fig.  4-3  [B]+[C]). Both siRNA duplexes showed a silencing activity of approximately 90%, 
compared to cells which were only transfected with the respective reporter plasmids. 
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Fig.  4-3  IFN-α secretion upon transfection with functional 
 siRNAs 
[A] Human PBMCs were transfected with 1 µg/ml of siRNA 
targeting EGFP (black bars) and 1 µg/ml of the thereof derived 
sense (s)- and antisense (as)-strands or with 1 µg/ml siRNA 
targeting BG (gray bars) and 1 µg/ml of the thereof derived 
single-stranded RNA oligonucleotides. RNAs were complexed 
with DOTAP. 1 µg/ml Loxoribine (white bar) served as TLR7-
dependent positive control. IFN-α secretion was determined by 
ELISA (n=3, mean +SD). (n.d., not detected, *, p<0.05). [B] 
HEK293T cells were transfected with pEGFP-N1 (black bars) or 
β-galactosidase (gray bars) reporter plasmids and 
cotransfected with 5 nM of the indicated siRNAs. Reporter gene 
activity was determined by flow-cytometry or β-galactosidase 
reporter assay, respectively (n=3, +SD). Values were 
normalized to the respective vector only control. [C] EGFP-
expression in transfected HEK293T cells was additionally 
analyzed by fluorescent microscopy 24 h after cotransfection of 
pEGFP-N1 and 5 nM control siRNA (siCon) or siEGFP1, 
respectively. 
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4.1.3 Analysis of immunostimulatory sequence motifs 
Previously, IFN-α secretion upon transfection with RNA oligonucleotides was linked to not precisely 
defined immunostimulatory sequence motifs. However, sequences with high amounts of uridine 
residues86 or high numbers of guanosine-uridine dinucleotides83 were identified as superior inducers of 
IFN-α secretion. To analyze the possible influence of these immunostimulatory sequence motifs on 
siRNA-mediated IFN-α secretion, three different siRNAs were designed, all of them targeting EGFP. 
Assuming that the presence of certain sequence motifs was responsible for IFN-α secretion, siRNAs 
were designed that contained either high or low amounts of uridine- or guanosine-uridine dinucleotides 
in either strand of the respective siRNA duplex. Transfection with the three passenger-strand and the 
three leading-strand RNA oligonucleotides derived of these siRNAs showed obvious differences in 
terms of IFN-α secretion (Fig.  4-4).  RNA oligonucleotides with low amounts of either uridine residues 
or guanosine-uridine dinucleotide stretches (EGFP2s, EGFP3s) showed a low ability to induce IFN-α 
in human PBMCs. However, RNA sequence EGFP3as covered with 10 uridine residues over a total 
length of 22 nucleotides showed lower amounts of secreted IFN-α, compared to RNA oligonucleotides 
with equally distributed nucleotides (EGFP1s, EGFP1as).  The presence of high numbers of 
guanosine-uridine dinucleotides did also not result in a higher IFN-α secretion. RNA with a total size of 
22 nucleotides, containing 5 guanosine-uridine dinucleotides (EGFP2as) showed a rather moderate 
IFN-α induction compared to sequences containing only 1 dinucleotide within their sequences 
(EGFP1s and EGFP1as).  
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Fig.  4-4  RNA sequence-dependent IFN-α 
 secretion 
Human PBMCs were transfected with 1 µg/ml 
of the indicated single-stranded RNA 
oligonucleotides derived from siRNAs targeting 
EGFP. The number of uridine residues and 
guanosine-uridine (GU)-dinucleotides within 
the respective sequences is depicted below. 
IFN-α secretion was determined by ELISA 
(n=3, mean +SD).  
 
 
4.1.4 Analysis of nucleotide modifications and their effects on   
  immunostimulation 
The presence of naturally occuring nucleotide modifications has been proposed to be relevant for 
RNA-mediated immunorecognition89. The 2’-position of the ribose is apparently not absolutely required 
for RNA interference activity182 leading to the speculation that the introduction of non-canonical 
nucleotides could separate immunostimulation from gene-silencing activity183. We assumed that the 
recognition principles of the immune system causing the siRNA-mediated side effects are highly 
specific to discriminate between self and non-self RNA molecules. In contrast, the enzymatic system 
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of the RNAi machinery which targets a high number of different substrate RNAs of different origin 
might be less discriminating. The choice of modifications that we introduced was governed by the 
consideration that the modified RNA oligonucleotides were structurally changed at positions that were 
likely to play a role for immunorecognition but show only negligible effects on the propensity to form 
double-stranded duplexes necessary for RNA interference.  
4.1.4.1 Influence of modifications at the 2’-position of the ribose 
The 2’-position of the ribose was considered to be critical for immunorecognition as it is the position 
where DNA and RNA structurally differ. Two types of modifications were included at this position, 
those that lack the 2’-oxygen (deoxy derivates) and those that feature a methyl-group at this position 
(2’-O-methyl derivates). The former would miss a functional group, the latter would sterically be very 
demanding and thereby possibly preventing receptor binding. Based on the sequence EGFP1as which 
was both immunostimulatory and showed strong RNA interference activity (Fig.  4-3) modified 
derivates were synthesized. All ribonucleotides of one given nucleobase were replaced by their 
2’-deoxy counterpart (dA, dU, dC and dG). Additionally, 2’-O-methyl derivates of adenosine (2mA), 
uridine (2mU) and cytosine (2mC) were prepared (Fig.  4-5). 
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Fig.  4-5  Structures of modified ribonucleotides used in this study 
[A] 2’-deoxy derivates of adenosine (dA), cytosine (dC), uridine (dU) and guanosine (dG). [B] 2’-O-methyl-derivates of 
adenosine (2mA), cytosine (2mC) and uridine (2mU). [C] Nucleobase modifications of cytosine: 5’-methyl-cytosine (m5C), 
uridine: thymidine (dT) and guanosine: 7’-deaza-guanosine (nG). Modifications are depicted in bold letters. 
 
First, the 2’-deoxy derivates of the single-stranded sequence EGFP1as were tested. RNA 
oligonucleotides were formulated with DOTAP as before and tested for IFN-α secretion from human 
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PBMCs over a concentration range from 0.01 to 1 µg/ml (Fig.  4-6). Again a dose-dependent IFN-α 
secretion was observed which varied between 900 and 1400 pg/ml due to donor heterogenity. 
EGFP1as carrying dU modifications showed a significantly decreased immunostimulatory activity. 
Residual IFN-α was only detectable at the highest applied concentration of 1 µg/ml of RNA. 
Diminished IFN-α secretion was also detected for dC-modified EGFP1as, however, the reduction was 
far less than for dU-modified EGFP1as. Substitution of the other two nucleobases (dA, dG) showed no 
alteration in IFN-α secretion (Fig.  4-6 [A]).  
Next, the 2’-O-methyl derivates of EGFP1as were tested. For derivates carrying 2mA or 2mU modified 
nucleotides IFN-α secretion was completely abrogated. Even at the highest concentration of 1 µg/ml 
no IFN-α was detectable, exceeding the inhibitory effect of the dU derivate. In contrast, 2mC-modified 
EGFP1as showed no significant alteration in immunostimulation (Fig.  4-6 [B]). 
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Fig.  4-6 Influence of nucleotide modifications on RNA-
mediated immunostimulation 
Human PBMCs were transfected with the RNA oligonucleotide 
EGFP1as in the indicated concentrations. EGFP1as was either 
transfected unmodified or with 2’-deoxy  (dU, dC, dG and dA) 
[A], 2’-O-methyl (2mU, 2mC and 2mA) [B] or with the 
nucleobase modifications 7-deaza-guanosine (nG), 5’-methy-
cytosine (m5C) or with thymidine (dT) [C] incorporated. IFN-α 
secretion was measured by ELISA (n=3, mean ±SD, *, 
p<0.05). Values were normalized to IFN-α secretion of 1 µg/ml 
control RNA EGFP1as. 
 
4.1.4.2 Immunostimulation with base-modified derivates 
In parallel to backbone modifications nucleobase modified EGFP1as were tested. In contrast to 
backbone modifications which mediate recognition within the minor groove of any given duplex 
nucleobase modifications affect the recognition within the major groove. The major groove is the site 
most frequently involved in sequence-specific interactions between DNA and proteins. Either 
thymidine (dT) was replaced for all uridine residues or 5’-methyl-cytosine (m5C) replaced the cytosine 
residues within EGFP1as. Both modifications possess an additional methyl-group at the nucleobase 
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and were therefore regarded as structurally more demanding. Additionally, guanosine residues were 
replaced by 7’-deaza-guanosine (nG) which lacks a nitrogen group at the nucleobase (Fig.  4-5 [C]). 
Neither nG-modified nor m5C-modified EGFP1as oligonucleotides showed any alteration in IFN-α 
secretion upon transfection of human PBMCs compared to the unmodified EGFP1as. However, 
dT-modified EGFP1as showed reduced IFN-α secretion, comparable to the dU-derivate (Fig.  4-6 [C]). 
4.1.5 Gene-silencing activity of modification-containing siRNAs 
4.1.5.1 Thymidine-containing siRNAs show no alteration of gene-silencing activity 
Next, it has to be assessed whether the immunostimulatory relevant modifications affect the activity of 
the corresponding siRNA duplex in terms of gene-silencing activity. EGFP1as and the four derivates 
(dU, 2mA, 2mU and dT) showing decreased immunostimulation were annealed to the unmodified 
complementary sequence (EGFP1s). HEK293T cells were cotransfected with the different siRNAs and 
pEGFP-N1 encoding the EGFP reporter gene. Additionally, a control siRNA (siCon) with a non-
genomic sequence was used to control for sequence-specific RNA interference. The efficiency of 
siRNA was tested over a concentration range from 1.5 nM up to 15 nM. The unmodified siEGFP1 
showed highly efficient gene-silencing activity. EGFP expression was not inhibited but even slightly 
increased upon cotransfection with the control siRNA (siCon), demonstrating that the detected gene- 
silencing effects were sequence-specific. Higher plasmid transfection efficiency by cotransfection with 
non-specific RNA might be the explanation for the observed increase of EGFP expression. Among the 
modified siRNAs only the dT-containing siRNA displayed silencing activity comparable to the 
unmodified siRNA. In contrast, dU- and 2mU-containing siRNAs suppressed EGFP expression much 
less with inhibition of 43% and 38% at 1.5 nM concentration, respectively. By increasing the siRNA 
concentration ten-fold gene-silencing activity was improved but still not as efficient as the unmodified 
siRNA. 2mA-modified siRNA showed even at the highest concentration low gene-silencing activity 
(Fig.  4-7).  
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Fig.  4-7 Gene-silencing using 2’-deoxy- and 2’-O-methyl-
 modified siRNA duplexes 
HEK293T cells were transfected with EGFP expressing vector 
pEGFP-N1 (gray bar). Additionally, annealed siRNA targeting 
EGFP composed of an unmodified strand in sense orientation 
and unmodified (s/as), thymidine (s/dT)-, deoxy-uridine (dU)-, 
2’-O-methyl-uridine (s/2mU)- or 2’-O-methyl-adenosine 
(s/2mA)- modified antisense strand was added (black bars) in 
increasing concentrations of 1.5 nM, 7.5 nM and 15 nM. A 
control siRNA (siCon) was used to test for specificity of gene-
silencing. Values are normalized to the EGFP expression of 
the vector control. EGFP expression was analyzed by flow 
cytometry (n=3, mean +SD) and mean fluorescence intensity 
is displayed as compared to the vector only control.   
4.1.5.2 Thymidine residues separate immunostimulation from gene-silencing 
Thymidine modification displayed the favorable residue to reduce IFN-α secretion in human PBMCs 
and additionally barely affected gene-silencing activity. To determine whether these observations were 
specific for the tested siRNA (siEGFP1) or hold true for siRNAs in general, two further siRNAs, 
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targeting either EGFP at another position (siEGFP2) or β-galactosidase (siBG), were included in the 
experiments. Leading-strands of these two siRNAs contained a high amount of uridine nucleotides 
and guanosine-uridine dinucleotides allowing for immunostimulation. Uridine residues in the respective 
leading-strands were again replaced by thymidine residues. The modified RNA oligonucleotides were 
applied to human PBMCs and IFN-α secretion was analyzed (Fig.  4-8 [A]-[C]). We observed a strong 
dose-dependent IFN-α secretion upon transfection with all unmodified RNA oligonucleotides. In all 
cases introduction of thymidine residues reduced  
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Fig.  4-8 Thymidine modified siRNAs separate immunostimulation from gene-silencing 
[A]-[C], Human PBMCs were transfected with the single-stranded RNA oligonucleotides EGFP1as [A], EGFP2as [B] and 
BGas [C] either unmodified or dT-modified in the indicated concentrations. IFN-α secretion was determined by ELISA, (n=2, 
mean ±SD). [D], HEK293T cells were transfected with reporter plasmids encoding EGFP and β-galactosidase (gray bars). 5 
nM annealed siRNA duplexes composed of unmodified sense strand (s/as) and thymidine-containing antisense strand (s/dT) 
and directed against EGFP (siEGFP1, siEGFP2) or β-galactosidase (siBG) were tested for gene-silencing activity. Values 
were normalized to the vector only control (n=3, mean +SD).    
 
IFN-α secretion strongly, showing only for the highest concentration of 1.5 µg/ml a low IFN-α 
secretion. These results confirmed our hypothesis that thymidine residues display a modification that 
reduces IFN-α secretion in general. Next, siRNA duplexes, containing the modified leading-strand 
were generated by annealing to unmodified passenger-strand and gene-silencing activity was 
analyzed by reporter gene knockdown (Fig.  4-8 [D]). Reporter gene expression of EGFP and 
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β-galactosidase was suppressed in HEK293T cells by siRNAs carrying dT modifications comparable 
to unmodified siRNA. These results confirmed that thymidine modifications reduce IFN-α secretion but 
retain gene-silencing activity for more than one sequence implicating a general principle. 
4.1.6 Effect of thymidine residues in both strands of the siRNA duplex 
We clearly demonstrated that uridine replacement by thymidine residues reduced IFN-α secretion 
significantly and that residual IFN-α secretion was only observed at high concentrations. Moreover, 
thymidine residues in the leading-strand of a siRNA did not affect RNA interference. However, the 
passenger-strand of siEGFP1 by itself showed also strong IFN-α secretion upon transfection (Fig. 
 4-3). We therefore assumed that possibly the remaining immunostimulation was mediated by 
unmodified passenger-strand. To further decrease IFN-α secretion we generated a thymidine-
containing passenger-strand for siEGFP1. Annealing of modified leading- and modified passenger-
strand resulted in a siRNA containing thymidine modifications in both strands. Transfection of human 
PBMCs with siRNA carrying dT modifications in both strands reduced IFN-α secretion further as 
compared to the siRNA carrying dT modifications only in the leading-strand. IFN-α secretion was only 
detectable at concentrations above 0.3 µg/ml (Fig.  4-9 [A]). Next, we had to examine whether this 
siRNA was still as effective in terms of gene-silencing as the unmodified siRNA. Cotransfection of 
pEGFP-N1 reporter plasmid and the respective siRNAs in HEK293T cells showed no alteration of 
gene-suppression activity (Fig.  4-9 [B]). Concentrations necessary for efficient gene-silencing 
(0.03-0.1 µg/ml) were far below any concentration of residual IFN-α secretion. 
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Fig.  4-9 Effect of thymidine modifications in sense- and antisense-strands of a siRNA duplex 
Human PBMCs were transfected with annealed siRNA (siEGFP1) that was composed of unmodified strands (s/as) and 
thymidine modifications in the leading-strand (s/dT) or containing thymidine modifications in either strand (dT/dT) in the 
indicated concentrations. IFN-α secretion was measured by ELISA (n=3, mean ±SD) [A]. HEK293T cells were transfected with 
pEGFP-N1 reporter plasmid or cotransfected with 5 nM of the annealed siRNAs and tested for gene-silencing activity. Control 
siRNA (siCon) served as specificity control and untransfected HEK293T cells (none) were tested for autofluoresence. Gene-
silencing activity was analyzed by flow cytometry (n=3, mean +SD). 
  
4.1.7 Antagonistic effects on RNA-induced interferon-α secretion 
It had been reported before that 2’-O-methyl derivates of RNA oligonucleotides act as TLR7-
antagonists184. However, from the results above it seemed unlikely that thymidine modifications act in 
a dominant-negative manner on TLR7-signalling. To address this issue we repeated stimulation 
experiments with siRNA duplexes from above but also included the 2’-O-methyl-modified adenosine 
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and uridine residues in the leading-strand of siEGFP1. Again, we detected a reduced IFN-α induction 
by siRNA carrying thymidine residues in the leading-strand. The siRNA duplex containing 
2’-O-methyladenosine in the leading-strand showed completely abrogated IFN-α secretion (Fig. 
 4-10 [A]). This indicated that the 2’-O-methyladenosine-modified RNA strand was able to suppress the 
signalling of the active unmodified passenger-strand of the siRNA duplex in contrast to thymidine-
modified siRNA. Surprisingly, the abrogation of IFN-α secretion was not observed when transfecting a 
siRNA carrying 2’-O-methyluridine in the leading-strand. Although showing a decrease in IFN-α 
secretion immunostimulation was still higher than for thymidine-modified siRNA. To further investigate 
the dominant-negative behavior of 2’-O-methyladenosine-modified RNA oligonucleotides, human 
PBMCs were cotransfected with unmodified and modified EGFP1as strands both in the antisense 
conformation thus avoiding the formation of a double-stranded duplex. The presence of 
2’-O-methyladenosine suppressed the activity of the otherwise stimulative unmodified EGFP1as 
completely (Fig.  4-10 [B]). In contrast, thymidine-modified EGFP1as did not alter the 
immunostimulatory potential of the cotransfected unmodified EGFP1as. Thymidine residues therefore 
represent a modification, which in contrast to 2’-O-methyladenosine, acts as an immunological silent 
but not dominant-negative modification.   
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Fig.  4-10 2’-O-methyladenosine modified, but not thymidine modified RNA strands possess antagonistic activity 
[A] Human PBMCs were transfected with annealed siRNA (siEGFP1) that was composed of unmodified strands (s/as), 
thymidine (s/dT), 2’-O-methyluridine (s/2mU) and 2’-O-methyladenosine (s/2mA) modifications in the leading (antisense) 
strand. IFN-α secretion was measured by ELISA (n=3, mean ±SD), (*, p<0.05 as compared to the unmodified siRNA). [B] 
Human PBMCs were transfected with unmodified RNA oligonucleotide EGFP1as (as). The indicated modified oligonucleotides 
also in antisense orientation were added in equal concentrations. IFN-α secretion was measured by ELISA (n=3, mean ±SD), 
(*, p<0.05 as compared to unmodified EGFP1as with addition of unmodified EGFP1as).  
4.1.8 Secondary structure formation of RNA oligonucleotides 
Our results as well as data from the literature81,83,86 suggest that uridine residues are critical for TLR7-
mediated immunorecognition. Furthermore, uridine plays a pivotal role in the formation of 
intramolecular duplexes since it can form hydrogen bonds with guanosine and adenosine residues185. 
We therefore investigated the secondary structure formation of the immunostimulatory RNA 
oligonucleotide EGFP1as. EGFP1as was subjected to UV monitored thermal denaturation. Indeed, the 
resulting melting curve exhibited two sigmoidal transition points. The first was observed just below 
room temperature the second at approximately 50oC. In contrast, thymidine-modified EGFP1as 
showed only the latter one. The altered propensity to form partial double-stranded structures might be 
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due to the additional, sterically demanding methyl-group of the thymidine residues (Fig.  4-11). To 
further validate the hypothesis of secondary structure formation for immunostimulation, we performed 
the same experiment with EGFP3s, an RNA oligonucleotide with very low immunostimulatory potential 
(Fig.  4-11). We obtained a much broader transition with reduced hyperchromicity, comparable to the 
control Poly(C), which is unable to form any secondary structures (Fig.  4-11). 
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Fig.  4-11 UV-melting curves  
Transition of EGFP1as and thymidine modified [A] and transition of EGFP3s and Poly(C) [B] was detected at 260 nm 
wavelength. Oligoribonucleotide concentration was 3.5 µM in 1x PBS. Concentration of Poly(C) was adjusted to the same 
molarity.   
 
The results of the hyperchromicity experiments were further validated using the structure prediction 
program Mfold179. Structure prediction analysis was performed for RNA oligonucleotides regarding 
intramolecular secondary structures (unimolecular folding) and intermolecular secondary structures 
(dimerization). Structure predictions underlined that EGFP1as might form secondary structures. The 
predicted structures showed that the immunostimulatory RNA oligonucleotide EGFP1as bears the 
ability to form uridine-containing duplex structures in the monomeric and dimeric conformation (Fig. 
 4-12). 
[A]                                   [B]
 
Fig.  4-12 Predicted secondary structure of EGFP1as 
Predicted structure of unimolecular folding [A] and dimerization [B] of RNA oligonucleotide EGFP1as as calculated with Mfold 
software. Sequences were entered with or without the corresponding pairing partner together with the following conditions: 142 
nM [1 µg/ml] of strand concentration and 150 mM NaCl.   
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In contrast, prediction for the non-immunostimulatory RNA oligonucleotide EGFP3s showed no 
tendency to form any significant duplex structures (data not shown). Structure predictions of eight 
further RNA oligonucleotides showed that sequences with high immunostimulatory activity always 
formed stem/duplex structures with incorporated uridine residues (structure predictions not shown).  
4.1.9 Positional influence of thymidine modifications on immunostimulation 
To address the issue whether immunostimulation is induced by uridine residues within stem/duplex 
structures uridine residues were replaced by thymidine residues in the immunostimulatory RNA 
oligonucleotides EGFP1as and EGFP2as at selected positions (Fig.  4-13). Modifications were either 
inserted in predicted duplex/stem structures (EGFP1as(dT-B), EGFP1as(dT-C), EGFP2as(dT-B)) or in 
sequence stretches with no predicted propensity for structure formation (EGFP1as(dT-A), EGFP2as 
(dT-A)), resulting in RNA oligonucleotides with partially substituted thymidine residues. Transfection of 
human PBMCs resulted in a dose-dependent IFN-α secretion upon transfection with the unmodified 
RNA oligonucleotides. IFN-α secretion was slightly reduced upon partial introduction of thymidine 
residues but was still elevated for all RNA oligonucleotides compared to the completely thymidine 
modified RNA oligonucleotides (Fig.  4-13). The most significant reduction for partial substitution with 
thymidine residues in IFN-α secretion for EGFP1as was detected for EGFP1as(dT-A), which carried 
thymidine residues in predicted single-stranded stretches, whereas the strongest reduction in IFN-α 
secretion for EGFP2as was obtained for EGFP2as(dT-B), containing thymidine residues exclusively in 
duplex/stem structures.  
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Fig.  4-13 Effect of partially thymidine-modified RNA oligonucleotides on IFN-α secretion  
[A] Human PBMCs were transfected with unmodified RNA oligonucleotide EGFP1as, GAACdTdTCAGGGUCAGCUUGCCG 
(EGFP1as(dT-A)), GAACUUCAGGGdTCAGCdTdTGCCG (EGFP1as(dT-B)),  GAACUUCAGGGUCAGCdTdTGCCG 
(EGFP1as(dT-C)) and totally thymidine-modified (dT). Positions of thymidine modifications are depicted as dT. IFN-α secretion 
was determined by ELISA (n=3, mean ±SD), (*, p<0.05 as compared to unmodified EGFP1as). [B] RNA oligonucleotide 
EGFP2as was used for transfection either unmodified, partially thymidine-modified   GACGdTdTGdTGGCUGUUGUAGUUG 
(EGFP2as(dT-A)) or GACGUUGUGGCdTGdTdTGdTAGdTdTG (EGFP2as(dT-B)) or totally thymidine-modified (dT). Positions 
of thymidine modifications are depicted as dT in bold letters. IFN-α secretion was determined by ELISA (n=3, mean ±SD), (*, 
p<0.05 as compared to unmodified EGFP2as). 
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4.1.10 Summary 
It could clearly be shown that thymidine-modified RNA oligonucleotides significantly reduced IFN-α 
secretion in human PBMCs. Annealed siRNA duplexes with thymidine-modified antisense strand also 
decreased IFN-α secretion without affecting gene-silencing activity. This can be regarded as a general 
principle since it was tested for three different functional siRNA sequences. Introducing thymidine 
modifications in either strand of a siRNA duplex reduced IFN-α secretion further without any 
detectable influence on RNA interference. In contrast 2’-O-methyladenosine-, 2’-O-methyluridine- and 
2’-deoxyuridine-modified RNA oligonucleotides reduced IFN-α secretion but showed lower efficiency in 
gene-silencing. Further, 2’-O-methyladenosine-modified but not thymidine-modified RNA 
oligonucleotides possessed antagonistic activity. We further show strong evidence that secondary 
structure formation mediates RNA-mediated immunostimulation. However, the presence of uridine 
residues in stem/duplex displays not the only target structure for immunorecognition principles.    
4.2 Immunorecognition of prokaryotic RNA 
RNA of prokaryotic origin has been suggested to be recognized as a non-self structure186. In contrast 
to the recognition principles of RNA oligonucleotides such as siRNAs ( 4.1.2) and viral RNA only little is 
known about bacterial RNA recognition. TLRs could be involved due to (i) the decreased extent of 
nucleotide modifications in prokaryotic RNA as compared to eukaryotic RNA, (ii) positive sensing of 
nucleotide modifications that are absent in eukaryotic RNA or (iii) presence of sequence patterns 
specific for prokaryotic RNA. Furthermore, the cytosolic RNA-helicases RIG-I and MDA5 might detect 
bacterial RNA due to the fact that (i) prokaryotic messenger RNA is 5'-triphosphorylated thereby 
representing a possible target structure for RIG-I187  or (ii) because ribosomal RNA forms secondary 
structures that display partial double-stranded conformation188. In this study we were interested to 
identify the mechanisms how bacterial RNA is recognized by the innate immune system. We 
addressed the question whether recognition of bacterial RNA is species-dependent and whether it 
follows the same recognition principles described for RNA oligonucleotides or viral RNA.  
4.2.1 Purification and validation of prokaryotic RNA 
Before transfecting cells with bacterial RNA, RNA was purified and controlled by capillary 
electrophoresis. For all experiments only RNA with an optical density quotient 260/280 nm of 2.0 or 
higher and with high integrity was used (Fig.  4-14). RNaseA-treated RNA and isolated 16S ribosomal 
Escherichia coli RNA was validated the same way. All RNA preparations showed high integrity and the 
expected ribosomal RNA pattern. Smaller size of 23S rRNA of Proteus mirabilis is congruent to the 
published sequence (www.ncbi.nlm.nih.gov). Besides the ribosomal RNA molecules several fragments 
of smaller size were detected. These fragments are cleavage products of 23S ribosomal RNA as 
already described189 and not unspecific degradation products. These cleavage products are species-
specific and were always detected in the same pattern for a given species. Digestion with RNaseA 
showed a complete loss of the signal, proving complete digestion of the Escherichia coli total RNA. 
The presence of residual fragments of 25 nt in size or smaller cannot be ruled out due to the detection 
limit of the capillary electrophoresis. However, as it has been reported that immunorecognition 
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requires a minimum length of the RNA ligand of 19 nt length190, RNase digestion was regarded as 
complete. Isolated E.coli 16S ribosomal RNA showed the expected size and no further residual RNA 
molecules.   
E.c. C.a.M.c.P.a.P.m.S.e.S.a.L.m.E.f.B.s.
23S
16S
[A]
18S
28S
*
E.c. +R 16S
23S
16S
5S
*
[B]
 
Fig.  4-14 Capillary electrophoresis image 
[A] Total RNA preparations of Bacillus subtilis (B.s.), Enterococcus faecalis (E.f.), Listeria monocytogenes (L.m.), 
Staphylococcus aureus (S.a.), Staphylococcus epidermidis (S.e.), Proteus mirabilis (P.m.), Pseudomonas aeruginosa (P.a.), 
Moraxella catharralis (M.c.), Escherichia coli (E.c.) and the yeast Candida albicans (C.a.) were analyzed by capillary 
electrophoresis. The prokaryotic ribosomal 16S and 23S RNAs and the eukaryotic 18S and 28S ribosomal RNAs are depicted, 
*, indicates the 25 nt calibration marker. [B] RNase digested total E.coli RNA preparation (+R) and isolated y 16S ribosomal 
RNA (16S) were compared to total E.coli RNA preparation (E.c.). 5S, 16S and 23S ribosomal RNA are depicted, *, indicates the 
internal calibration marker.  
 
4.2.2 Bacterial RNA induces a type-I interferon response in human PBMCs 
4.2.2.1 Characterization of prokaryotic RNA-induced type-I interferon secretion  
The total RNA preparations of five gram-positive bacterial species (Bacillus subtilis, Enterococcus 
faecalis, Listeria monocytogenes, Staphylococcus aureus and Staphylococcus epidermidis) and four 
gram-negative bacterial species (Escherichia coli, Moraxella catharralis, Pseudomonas aeruginosa 
and Proteus mirabilis) as well as RNA from Candida albicans as a eukaryotic control were formulated 
with DOTAP to increase endosomal delivery and tested for interferon-α (IFN-α) secretion of human 
PBMCs. IFN-α secretion in PBMCs is exclusively mediated by the activation of plasmacytoid dendritic 
cells, possibly via TLRs24. We observed a robust IFN-α secretion upon transfection of 1 µg/ml with all 
tested prokaryotic RNA preparations (Fig.  4-15 [A]). Transfection was performed in decreasing 
concentrations which reduced IFN-α secretion dose-dependently (data not shown). Species-specific 
IFN-α secretion varied between 700 and 1400 pg/ml. In contrast, Candida albicans RNA showed 
comparable weak immunostimulatory activity with secretion of 200 pg/ml IFN-α. Besides RNA, 
bacterial lysates contain a lot of different immunostimulatory molecules, such as LPS or CpG DNA. To 
exclude the possibility that immunostimulation was rather an effect of contaminations in the 
preparations than due to the RNA, all samples were digested by incubation with RNaseA. Digest 
efficiency was controlled by visualizing samples through automated capillary gel electrophoresis 
(shown for E.coli RNA in Fig.  4-14 [B]). 
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Fig.  4-15 Effects of bacterial RNA on IFN-α secretion in human PBMCs 
[A] Human PBMCs were transfected with 1 µg/ml of total RNA preparations of Bacillus subtilis (B.s.), Enterococcus faecalis 
(E.f.), Listeria monocytogenes (L.m.), Staphylococcus aureus (S.a.), Staphylococcus epidermidis (S.e.), Escherichia coli (E.c.), 
Moraxella catharralis (M.c.), Pseudomonas aeruginosa (P.a.), Proteus mirabilis (P.m.) and the yeast Candida albicans (C.a.). 
RNAs were complexed with DOTAP prior to transfection. RNA was either untreated or digested with RNaseA. 1 µg/ml R848 and 
1µM CpG DNA oligonucleotide 2216 (CpG) served as TLR7-specific and TLR9-specific positive controls for pDC activation. [B] 
Human PBMCs were transfected with either Escherichia coli total RNA or isolated 16S ribosomal RNA over the indicated 
concentration range. IFN-α secretion was measured by ELISA (n=3, mean ±SD). (n.d., not detected, n.t., not tested). 
 
RNaseA treatment resulted in complete abrogation of IFN-α secretion (Fig.  4-15 [A]). Moreover, LPS a 
major and highly potent stimulus from gram-negative bacteria did not induce IFN-α which is consistent 
with the absence of TLR4 on plasmacytoid dendritic cells (pDCs)191. Next, we took into account that 
80% of the total cellular RNA consists of the ribosomal RNA fraction90 and isolated E.coli 16S 
ribosomal RNA (Fig.  4-14). Transfection with equal amounts of E.coli 16S ribosomal RNA and E.coli 
total RNA showed no alteration in IFN-α secretion over the tested concentration range. This indicates 
that ribosomal RNA represents the major immunostimulatory fraction within total bacterial RNA 
preparations (Fig.  4-15 [B]). 
4.2.2.2 Interferon-α secretion in PBMCs depends on endosomal recognition 
Next, we assessed whether bacterial RNA induces IFN-α in a manner dependent on TLR7 as it has 
been described for RNA oligonucleotides and viral RNAs83,87,192. Human PBMCs were transfected with 
different amounts of Escherichia coli and Staphylococcus aureus total RNA preparations as well as 
with RNA40 oligonucleotide, a well defined ligand for TLR7 activation81. For all RNAs a robust and 
dose-dependent IFN-α secretion was observed which was abrogated upon RNaseA treatment. 
Cotransfection with 2’-O-methyl-adenosine modified RNA oligonucleotide (2mA), which has been 
shown to act as a TLR7- and TLR8-specific inhibitor167 ( 4.1.7) led to a complete abrogation of IFN-α 
secretion (Fig.  4-16 [A]). In contrast, cotransfection of 2mA with the TLR9-specific ligand CpG2216 did 
not alter IFN-α secretion, confirming the specificity of the inhibitor. Further, human PBMCs were 
incubated with increasing concentrations of chloroquine, which inhibits endosomal acidification and 
therefore inhibits signalling of the endosomally localized TLRs 3, 7 and 8. Chloroquine treatment 
resulted in a significant concentration-dependent reduction of IFN-α secretion upon transfection with 
bacterial RNA (Fig.  4-16 [B]) and CpG2216. These results indicate that bacterial RNA-mediated IFN-α 
secretion in human PBMCs depends on intact TLR7 signalling.   
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Fig.  4-16 TLR7-mediated IFN-α secretion upon bacterial RNA transfection 
[A] Human PBMCs were transfected with Escherichia coli and Staphylococcus aureus total RNA or RNA40 oligonucleotide with 
decreasing concentrations from 1 µg/ml to 100 ng/ml. RNAs were either untreated, RNaseA-treated (+RNase) or cotransfected 
with inhibitory oligonucleotide 2mA (+2mA) at equal concentrations. 1 µM CpG2216 served as TLR9-specific positive control. [B] 
Human PBMCs were pre-incubated for two hours at 37oC with increasing concentrations (0 nM, 3 nM, and 30 nM) of 
chloroquine (Cq) and transfected with Escherichia coli and Staphylococcus aureus RNA. IFN-α secretion was detected by 
ELISA (n=2, mean +SD), values are depicted either in concentration [A] or depicted as compared to the untreated control [B]. 
(n.d., not detected). 
 
4.2.2.3 Bacterial RNA triggers signalling pathways apart from TLR7 
In addition to IFN-α secretion upon bacterial RNA transfection, we also observed a robust, dose-
dependent TNF-α secretion in human PBMCs which is induced besides TLR7 by TLR8 which is 
strongly expressed in monocytes (Fig.  4-17). Cotransfection of 2mA and RNA40 led to a complete loss 
of TNF-α secretion, which again confirms the TLR7- and TLR8-dependent recognition of RNA 
oligonucleotides. Despite the complete reduction of secreted IFN-α, cotransfection of 2mA and 
bacterial RNA did not alter the amount of secreted TNF-α (Fig.  4-17 [A]). TNF-α secretion upon 
transfection with the TLR4-specific control LPS was not altered by cotransfection with the TLR7 
inhibitor 2mA. RNaseA digestion proved that the major immunostimulatory fraction was bacterial RNA. 
Residual TNF-α secretion might be due to contaminations within the preparation, which trigger 
different pattern-recognition receptors expressed on the different cell-types within the human PBMC 
preparation. Additionally, chloroquine treatment did not alter bacterial RNA-induced TNF-α secretion 
similar to LPS which triggers the surface-located TLR4 (Fig.  4-17 [B]). These results implicate that 
TNF-α secretion upon transfection with bacterial RNA is independent of endosomal maturation and 
therefore independent of nucleic-acid sensing TLRs since all of them are endosomally localized13-15. 
Bacterial RNA recognition obviously differs from the recognition mechanisms described for RNA 
oligonucleotide with respect to TNF-α production in human PBMCs. 
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Fig.  4-17 Bacterial RNA-induced TNF-α secretion in human PBMCs 
[A] Human PBMCs were transfected with Escherichia coli and Staphylococcus aureus total RNA or RNA40 oligonucleotide with 
decreasing concentrations from 1 µg/ml to 100 ng/ml. RNAs were either untreated, RNaseA-treated (+RNase) or cotransfected 
with inhibitory oligonucleotide 2mA (+2mA) at equal concentrations. 100 ng/ml LPS served as TLR4-specific positive control. [B] 
Human PBMCs were pre-incubated for two hours at 37oC with increasing concentrations (0 nM, 3 nM, and 30 nM) of 
chloroquine (Cq) and transfected with Escherichia coli and Staphylococcus aureus RNA. TNF-α secretion was detected by 
ELISA (n=2, mean +SD), values are depicted either in concentration [A] or depicted as compared to the untreated control [B]. 
 
4.2.3 Bacterial RNA induces IL-12p40 in murine dendritic cells 
To further characterize the recognition mechanisms of bacterial RNA, it was necessary to study RNA 
stimulation in mice to make use of the published knockout mice. For this reason either FLT3L-derived 
pDC-like cells or GM-CSF-derived mDC-like cells were generated and either IFN-α or IL-12p40 as 
respective activation markers were detected. FLT3L-derived pDC-like dendritic cells are murine 
analogs to human pDCs characterized by TLR7 and TLR9 expression and enhanced endosomal 
trafficking. GM-CSF-derived mDC-like cells are regarded as analog to human myeloid dendritic cells. 
The generated cells showed a purity of 85% or higher as determined by flow cytometry (data not 
shown).  
4.2.3.1 Bacterial species-specific recognition 
GM-CSF-derived mDC-like cells showed a strong secretion of IL-12p40 upon transfection with 
Escherichia coli total RNA. IL-12p40 secretion was significantly reduced upon RNA digestion with 
RNaseA, indicating that the observed immunostimulation was mainly caused by the RNA itself. 
Eukaryotic RNA preparations from HEK293T cells and the yeast Candida albicans did not induce any 
detectable IL-12p40 (Fig.  4-18 [A]). Additionally, it was tested whether transfection procedure or 
RNase treatment altered the viability of the cells by MTT-assay. Neither RNA transfection nor RNaseA 
treatment changed the viability of the cells compared to the untreated cells (Fig.  4-18 [B]).  
  51  
   Results 
E
.c
.
+R
N
as
e
C
.a
.
H
E
K
29
3
P
ol
y(
IC
)
R
84
8
Bl
an
k0
100
200
300
400
n.
d.
n.
d.
[A]
n.
d.
IL
-1
2p
40
 [n
g/
m
l]
 m
ed
iu
m
E
.c
.
+R
N
as
e
R
N
as
e 
on
ly
H
E
K
29
3
P
ol
y(
IC
)
R
84
80
20
40
60
80
100
120
140[B]
Ab
so
rb
an
ce
55
0 n
m
  [
%
 o
f c
on
tro
l]
 
B
.s
.
E
.f.
L.
m
.
S
.a
.
S
.e
.
E
.c
.
M
.c
.
P
.a
.
P
.m
.
C
.a
.
LP
S
B
la
nk
0
50
100
150
200
Inducer RNA
[1µg/ml]
    gram-positive              gram-negative
[C]
n.
d.
n.
d.
n.
d.
IL
-1
2p
40
 [n
g/
m
l]
Fig.  4-18 Bacterial RNA-induced IL-12p40 secretion 
 in GM-CSF-derived dendritic cells 
[A] GM-CSF-derived dendritic cells were transfected with 
1 µg/ml Escherichia coli total RNA (E.c.) encapsulated with 
DOTAP either untreated or RNaseA-digested. 1 µg/ml 
HEK293T total RNA and 1µg/ml Candida albicans total 
RNA served as eukaryotic RNA controls. Poly(IC) and 
R848 served as TLR3- and TLR7-specific ligand controls. 
IL-12p40 secretion was measured by ELISA (n=3, mean 
+SD, n.d., not detected). [B] Cells of the same experiment 
were tested 16 hours post-transfection for viability by MTT-
assay. Values are displayed as compared to the untreated 
control. [C] 1 µg/ml of total RNA of Bacillus subtilis (B.s.), 
Enterococcus faecalis (E.f.), Listeria monocytogenes 
(L.m.), Staphylococcus aureus (S.a.), Staphylococcus 
epidermidis (S.e.), Escherichia coli (E.c.), Moraxella 
catharralis (M.c.), Pseudomonas aeruginosa (P.a.) and 
Proteus mirabilis (P.m.) was used for transfection of GM-
CSF-derived dendritic cells. Candida albicans RNA served 
as eukaryotic RNA control. 100 ng/ml LPS served as 
TLR4-specific control. IL-12p40 secretion was measured 
by ELISA (n=3, mean +SD). (n.d., not detected). 
 
Next, GM-CSF-derived dendritic cells were transfected with the same panel of bacterial total RNA 
preparations as already used above. Upon transfection with bacterial RNA, GM-CSF-derived dendritic 
cells secreted large amounts of IL-12p40 (Fig.  4-18 [C]). It was evident that all RNA preparations 
derived from gram-negative species showed a much higher immunostimulatory potential compared to 
the RNA preparations derived from gram-positive bacterial species. It is very likely that this 
observation is a synergistic effect of residual amounts of LPS within the preparations of gram-negative 
bacteria triggering additionally TLR4, which is highly expressed on GM-CSF-derived dendritic cells193. 
 
4.2.3.2 Recognition of bacterial RNA is TLR7-dependent in murine pDCs but independent of 
  TLR7 in murine mDCs 
To further investigate the different recognition mechanisms indicated by IFN-α and TNF-α secretion in 
human PBMCs, we generated FLT3L-derived dendritic cells from wild type and TLR7-/- mice, which 
can be regarded as in vitro analogs to human plasmacytoid dendritic cells175,176. We observed a strictly 
TLR7-dependent IFN-α secretion upon transfection with Escherichia coli total RNA, comparable to the 
immunostimulatory RNA oligonucleotide RNA40 (Fig.  4-19 [A]). Surprisingly and in sharp contrast to 
FLT3L-derived dendritic cells, Escherichia coli total RNA induced IL-12p40 was independent of TLR7 
in GM-CSF-derived dendritic cells (Fig.  4-19 [B]). IFN-α could not be detected in GM-CSF-derived 
  52  
   Results 
dendritic cells (data not shown). Again, RNaseA digestion proved that secretion of IFN-α in pDCs and 
IL-12p40 in mDCs was dependent on RNA. These results confirmed the above findings in human 
PBMCs, showing that there are at least two different recognition mechanisms in bacterial RNA 
recognition. One is the TLR7-dependent induction of IFN-α in pDCs, the other one is a 
TLR7-independent induction of IL-12p40 in mDCs. The latter might be influenced by additional 
contaminants in the preparation, however, bacterial RNA is the major immunostimulatory component. 
Importantly, R848 induced IL-12p40 secretion was still TLR7-dependent, confirming the functionality of 
the TLR7-/- mice and further strengthening the different recognition principles of bacterial RNA.  
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Fig.  4-19 Relevance of TLR7 for bacterial RNA recognition 
[A] Murine FLT3L-derived dendritic cells or [B] GM-CSF-derived dendritic cells of wild type (black bars) or TLR7-/- (white bars) 
mice were transfected with 1 µg/ml of total Escherichia coli RNA. IFN-α and IL-12p40 were detected by ELISA, respectively. 
RNA40 and R848 served as TLR7-specificity controls. CpGD19 and Poly(IC) served as TLR9- and TLR3-specific ligands, 
respectively (n=3, mean +SD). (n.d., not detected, *, p<0.05 as compared to the wild type control).  
 
4.2.3.3 Bacterial RNA mediated IL-12p40 secretion is TLR-independent 
To investigate a possible influence of the remaining nucleic acid sensing TLRs on bacterial RNA 
recognition, we generated GM-CSF-derived dendritic cells from lps2-mice which harbor a point 
mutation in the TRIF molecule and can therefore be considered as deficient in TLR3-signalling, as well 
as cells from TLR9-knockout mice. Transfection with Escherichia coli total RNA showed no differences 
in IL-12p40 secretion between wild type and knockout cells. The controls Poly(IC), a specific TLR3-
dependent ligand as well as CpG1668, a TLR9-specific ligand failed to induce IL-12p40 secretion in 
the respective knockout cells (Fig.  4-20 [A]+[B]). These findings further show that bacterial RNA is 
recognized independently of nucleic acid sensing TLRs in immune cells with the exception of 
plasmacytoid dendritic cells. Participation of murine TLR8 has not been addressed in this study since 
it has been shown that murine TLR8 does not respond to RNA stimulation and was therefore regarded 
as non-functional81,194,195. However, chloroquine treatment did not alter bacterial RNA-induced 
IL-12p40 secretion in GM-CSF-derived dendritic cells (Fig.  4-20 [C]). This observation excludes 
additionally the participation of nucleic-acid sensing TLRs in bacterial RNA recognition. In contrast to 
CpG1668 bacterial RNA-induced IL-12p40 secretion is induced independently of endosomal 
maturation or functionality.  
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Fig.  4-20 Influence of nucleic-acid sensing TLRs 
 on bacterial RNA recognition 
GM-CSF-derived dendritic cells of wild type (black 
bars) and [A] lps2 and [B] TLR9-/- mice were 
transfected with 1 µg/ml Escherichia coli total RNA. 
RNaseA digestion was performed to ensure 
detection of RNA-specific effects. Poly(IC) and 
CpG1668 served as specificity controls for the 
respective knockout cells. IL-12p40 secretion was 
measured by ELISA (n=3, mean +SD). (n.d., not 
detected, *, p<0.05 as compared to the wild type 
control). [C] GM-CSF-derived dendritic cells were 
incubated for 1 hour with increasing concentrations 
of chloroquine (0 nM, 5 nM, 10 nM) prior to 
transfection with the indicated inducers. IL-12p40 
secretion was determined by ELISA (n=2, 
mean +SD), (n.d., not detected). 
 
4.2.3.4 Viral RNA receptors are dispensable for bacterial RNA recognition 
RIG-I and MDA5 recognize cytoplasmic viral RNAs by detecting 5’-triphosphorylated termini or short 
double-stranded RNAs in case of RIG-I or long double-stranded RNA molecules for MDA5127,131. Both 
structural features are present in bacterial total RNA preparations187,196. Therefore Huh7.5 based cell 
lines expressing functional RIG-I and MDA5 were analyzed173. Cells were transfected with an ISG56 
reporter plasmid indicating IRF3 activation. Viral and bacterial RNA was encapsuled with 
Lipofectamine to ensure cytoplasmic translocation. RIG-I expressing Huh7.5 cells gained 
responsiveness to the RIG-I-specific viral RNA ligand vesicular stomatitis virus RNA (VSV RNA) 
(Fig. 4-21). Furthermore, RIG-I and MDA5 expressing cells also showed sensitivity to a double-
stranded hepatitis C virus transcript (HCV RNA). Both receptors responded to the RNA ligands as 
expected. The respective transfected receptors were therefore considered to be functional. The cell 
lines further displayed sensitivity to Poly(IC) which had a size distribution of 200-2000 nt as 
determined by capillary electrophoresis (data not shown). However, even when transfecting 500-fold 
higher amounts of E.coli RNA than the respective viral RNA we did not observe any detectable IRF3-
activaton (Fig. 4-21). Interestingly, RIG-I and MDA5 reconstituted cells did only activate the IRF3 
reporter but not the NFκB reporter (data not shown) and this activation pattern does not fit to the 
strong NFκB response observed upon bacterial RNA stimulation. These results show that bacterial 
RNA, although sharing certain structural features with viral RNA, is not a ligand for the known viral 
RNA sensor proteins. 
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Fig. 4-21  No influence of RIG-I and MDA5 on  
 bacterial RNA recognition 
Huh-7.5 cells expressing non-functional RIG-I were 
reconstituted with plasmids encoding RIG-I and MDA5, 
respectively. Cells were transfected with viral RNA 
(VSV, 0.1 µg/ml, HCV, 0.01 µg/ml), bacterial RNA 
(E.c.low, 1 µg/ml, E.c.high, 5 µg/ml) or 0.5 µg/ml 
Poly(IC). Poly(C) (5 µg/ml) served as the negative 
control. All RNAs were complexed with LF2000 prior to 
transfection. Huh-7.5 without RIG-I or MDA5 showed no 
detectable IRF3 activation upon transfection with the 
indicated RNAs. IRF3 activation was determined by 
Dual Luciferase Reporter Assay (n=3, mean+SD). (n.d., 
not detected). 
 
4.2.3.5 ASC and interferon α/β receptor are required for bacterial RNA-induced IL-1β  
  secretion but dispensable for IL-12p40 secretion 
Besides uric acid and bacterial toxins, also bacterial RNA has been reported to be a ligand for NALP3 
leading to inflammasome activation65,66,135. Inflammasome activation results in the processing of 
pro-IL-1β and pro-IL-1855. Further, it has been shown that NALP3 induces NFκB in a manner 
dependent on the ASC adaptor protein68. To investigate a possible influence of the inflammasome on 
the observed IL-12p40 secretion, GM-CSF-derived dendritic cells of wild type and ASC-/- mice were 
generated. ASC represents an essential adaptor molecule for inflammasome signalling54. ASC-/- cells 
can therefore be regarded as non-functional in terms of inflammasome signalling. As reported before, 
we observed a strict ASC-dependent IL-1β secretion in GM-CSF-derived dendritic cells upon 
stimulation with Escherichia coli and Staphylococcus aureus total RNA (Fig.  4-22 [A]). RNase 
digestion reduced IL-1β secretion, showing that the observed effects were dependent on bacterial 
RNA. However, bacterial RNA induced IL-12p40 secretion was independent of the ASC protein (Fig. 
 4-22 [B]), indicating that the ínflammasome does not participate in the observed IL-12p40 secretion. In 
contrast to bacterial RNA-induced IL-12p40 secretion, RNase treatment reduced IL-1β to a lower 
extent indicating that contaminations within the preparation induce IL-1β but not IL-12p40 secretion.  
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Fig.  4-22 Differential requirement for ASC in bacterial RNA-mediated IL-1β and IL-12p40 secretion 
GM-CSF-derived dendritic cells were generated from wild type and ASC-/- mice. Cells were stimulated with 1 µg/ml Escherichia 
coli and Staphylococcus aureus total RNA. RNA was additionally digested with RNaseA. [A] IL-1β and [B] IL-12p40 secretion 
was measured by ELISA (n=2, mean +SD). (n.d., not detected, *, p<0.05 as compared to the wild type control, n.s., not 
significant as compared to the wild type control). 
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Activation of the inflammasome by cytosolic bacteria has been shown to be dependent on intact type-I 
IFN signalling136. To assess whether type-I IFN signalling is required for bacterial RNA-mediated 
IL-12p40 secretion, GM-CSF-derived dendritic cells of wild type and IFN α/β receptor-deficient 
(IFNAR1-/-)-knockout mice were prepared. IL-1β secretion upon bacterial RNA transfection was 
dependent on IFNAR1 and therefore dependent on type-I-IFN signalling (Fig.  4-23 [A]). However, 
bacterial RNA-mediated IL-12p40 secretion was not altered in the absence of functional IFNAR1 (Fig. 
 4-23 [B]). Again, RNaseA digestion clearly demonstrated that the observed effects were attributable to 
RNA and not induced by residual contaminations. 
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Fig.  4-23 Differential requirement for type-I IFN signalling in bacterial RNA-mediated IL-1β and IL-12p40 secretion 
GM-CSF-derived dendritic cells were generated from wild type and IFNAR1-/- mice. Cells were stimulated with 1 µg/ml 
Escherichia coli (E.c.) and Staphylococcus aureus (S.a.) total RNA. RNA was additionally digested with RNaseA. IL-1β [A] and 
IL-12p40 [B] secretion was measured by ELISA (n=3, mean +SD). (n.d., not detected, *, p<0.05 as compared to the wild type 
control, n.s., not significant as compared to the wild type control). 
 
4.2.4 Bacterial RNA induces an immune response in non-professional  
  immune cells 
To confirm the TLR-independent recognition described above, HEK293T cells which lack functional 
TLRs with the possible exception of TLR3 were transfected with plasmids encoding for TLR3, 7 and 8, 
respectively. Cells were transfected with Escherichia coli total RNA and NFκB activation was 
determined by Dual Luciferase Assay. Surprisingly, strong NFκB activation was already observed in 
control vector-transfected cells (Fig.  4-24 [A]). In contrast, NFκB activation was strongly enhanced 
upon transfection with the respective TLR-specific controls. Poly(IC) and R848 showed elevated levels 
of NFκB activation in TLR3 and TLR7/8 transfected cells, respectively. However, bacterial RNA-
mediated NFκB activation was not further enhanced by transfection of any of the RNA-sensing TLRs 
3, 7 or 8. Basal sensitivity of control vector-transfected upon Poly(IC) transfection could be mediated 
by basally expressed TLR3 or RIG-I in HEK293T cells (Fig.  4-24 [B]). 
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Fig.  4-24 TLR-mediated recognition of bacterial RNA 
[A] HEK293T cells were transfected with plasmids encoding the indicated human TLRs or empty vector. 8 h post-transfection, 
cells were stimulated with 10 µg/ml Escherichia coli total RNA, 25 µg/ml Poly(IC) and 1 µg/ml R848, respectively. NFκB 
activation was determined by Dual Luciferase Assay (n=3, mean +SD). [B] RT-PCR of untreated HEK293T cells to determine 
endogenous expression of RNA-sensing receptors. Values were normalized to the house-keeping gene GAPDH (n=3, mean 
+SD). (n.d., not detected). 
 
To exclude the participation of the basally expressed RNA-sensing receptors TLR3 and RIG-I, we 
used an experimental approach based on siRNAs targeting TLR3 and RIG-I, respectively. SiRNA-
mediated gene-suppression was evaluated by quantitative RT-PCR and showed a reduction of at least 
85% of messenger RNA transcription compared to non-genomic control siRNA-treated cells (Fig. 
 4-25 [A]). Transfection of siRNA-treated cells with bacterial RNA altered NFκB activation only 
marginally, excluding TLR3 and RIG-I as the responsible receptors for bacterial RNA. Thus, even non-
professional immune cells are able to respond to bacterial RNA in a manner independent of any 
known RNA receptor. 
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Fig.  4-25 Relevance of endogenously expressed RNA-sensors in HEK293T cells on bacterial RNA recognition 
[A] HEK293T cells were transfected twice with 10 nM of the indicated siRNAs. Gene-silencing was validated 72 h post-
transfection by RT-PCR. Gene expression is displayed as values normalized to siCon-treated gene expression (n=3, mean 
+SD). [B] HEK293T cells treated with the indicated siRNAs were transfected with 10 µg/ml Escherichia coli total RNA 72 h after 
the first siRNA transfection. NFκB activation was determined by Dual Luciferase Assay, values are normalized to NFκB 
activation of control siRNA-treated cells (n=3, mean +SD). 
4.2.4.1 Species-specific recognition in HEK293T cells 
Transfection with the whole panel of bacterial RNAs from the experiments above confirmed the 
immunorecognition of bacerial RNA in HEK293T cells. Surprisingly, only some transfected bacterial 
RNAs led to an activation of NFκB, whereas others were immunological silent (Fig.  4-26 [A]). NFκB 
activation was independent of the gram-type of the respective bacteria since Bacillus subtilis RNA 
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strongly induced NFκB, but Moraxella catharralis RNA led to no induction of NFκB. These findings 
exclude possible LPS contaminations as a source of activation. However, strong species-dependent 
effects indicated the participation of contaminants within the activating bacterial RNA preparations, 
although RNaseA treatment resulted in an abrogation of NFκB activation similar to the effects 
observed in immune cells (Fig.  4-26 [B]).  
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Fig.  4-26 Species-specific recognition of bacterial RNA in HEK293Tcells 
[A] HEK293T cells were transfected with 10 µg/ml of the indicated bacterial RNA preparations. NFκB activation was determined 
by Dual Luciferase Assay. Candida albicans RNA preparation served as eukaryotic RNA control, Poly(IC) as specific ligand for 
TLR3 (n=3, mean +SD). [B] HEK293T cells were either transfected with 10 µg/ml E.c. RNA preparation or with equal amounts of 
further on-column purified Escherichia coli RNA preparations, number of purification steps is indicated. Additionally, cells were 
transfected with 10 µg/ml isolated 16S ribosomal RNA. RNaseA-treated Escherichia coli RNA served as a negative control (n=3, 
mean +SD). 
 
This idea was further supported by the fact that, in contrast to human PBMCs (Fig.  4-15 [B]), 16S 
ribosomal RNA of Escherichia coli showed a much weaker potential to activate NFκB in HEK293T 
cells compared to the total RNA preparation (Fig.  4-26 [B]). Purification of the total RNA by one 
additional on-column washing step indeed reduced NFκB activation. However, additional washing 
steps did not reduce NFκB activation further showing still highly elevated activation levels compared to 
the 16S ribosomal RNA fraction (Fig.  4-26 [B]). 
4.2.4.2 Analysis of possible contribution of contaminants to bacterial RNA stimulation 
To investigate whether contaminants might contribute to the immunostimulation induced by bacterial 
RNA, HEK293T cells were tested for the expression of the NOD1 and NOD2 receptor which sense the 
components of bacterial cell walls diamino-pimelic acid (DAP)197 and muramyl-dipeptide (MDP)198, 
respectively. It had been reported before that NOD1 and NOD2 ligands show synergistic effects on 
TLR stimulation70. HEK293T cells showed a high transcription of NOD1 and still detectable levels of 
NOD2 transcription (Fig.  4-27).  
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Fig.  4-27 Transcription of NOD1 and NOD2 in HEK293T 
Expression of NOD1 and NOD2 transcription levels was 
determined by quantitative RT-PCR. Values were normalized 
to transcription of the house-keeping gene GAPDH (n=3, 
mean). 
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Costimulation of the weak NFκB inducer Staphylococcus aureus RNA with MDP-dpm which 
represents a ligand for both, NOD1 and NOD2, resulted in a slightly elevated NFκB activation. 
However, even transfection of such high amounts as 10 mg/ml MDP-dpm did not result in NFκB 
activation levels as high as detected for Escherichia coli RNA (Fig.  4-28 [A]). Staphylococcus aureus 
RNA substituted with RNaseA-treated and therefore non-active Escherichia coli RNA did not alter 
NFκB activation significantly (Fig.  4-28 [B]). These results show that residual NOD1 and NOD2 ligands 
within the RNA preparations are not responsible for the high levels of NFκB upon stimulation with 
bacterial RNA in HEK293T cells. Further, digested Escherichia coli RNA was not able to reconstitute 
high levels of NFκB activation if cotransfected with weak inducing Staphylococcus aureus RNA 
indicating that residual contaminants do not seem to play the major role for immunorecognition in 
HEK293T cells. Cotransfection of Escherichia coli RNA and digested Escherichia coli RNA did not 
alter the NFκB activation significantly, proving that residual RNAseA is not degrading the 
cotransfected bacterial RNA. Importantly, Staphylococcus aureus RNA-induced NFκB activation 
showed a reduction in activation upon RNaseA treatment. 
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Fig.  4-28 Neglectable effects of contaminants on bacterial RNA-mediated NFκB activation in HEK293T cells 
[A] HEK293T cells were transfected either with 10 µg/ml of the indicated bacterial RNA or with increasing amounts (0.1, 1.0, 10 
mg/ml) of the NOD1 and NOD2 ligand MDP-dpm. Staphylococcus aureus RNA was cotransfected with the same amounts of 
MDP-dpm. NFκB activation was measured by Dual Luciferase Assay (n=3, mean +SD). [B] HEK293T cells were transfected 
with 10 µg/ml RNA of Escherichia coli (black bars) or Staphylococcus aureus (white bars). Bacterial RNA (bRNA) was either 
untreated, digested with RNaseA (+RNase) or digested Escherichia coli RNA (dig.E.c.) was added in equal concentration (n=3, 
mean +SD). (n.d., not detected). 
 
4.2.5 Summary 
In this study we could show that bacterial RNA represents an immunostimulatory pattern. Bacterial 
RNA strongly triggers a type-I interferon response in human PBMCs which was dependent on 
endosomal maturation and could be blocked by a TLR7-specific inhibitor. Surprisingly, TNF-α 
secretion in human PBMCs upon bacterial RNA transfection was independent of both. Murine FLT3L-
derived pDC-like cells from TLR7-deficient mice were unresponsive to bacterial RNA. However, in 
GM-CSF-derived mDC-like cells TLR3, 7, 8 and 9 were dispensable for IL-12p40 induction by 
bacterial RNA. Even non-professional immune cells were able to mount a NFκB response upon 
stimulation with bacterial RNA. The viral RNA sensor proteins RIG-I and MDA5 were ruled out to be 
responsible for this reactivity. Whereas the inflammasome adaptor protein ASC and a functional type-I 
interferon receptor were necessary for IL-1β secretion in myeloid dendritic cells these proteins were 
dispensable for IL-12p40 induction by bacterial RNA. Further, possible immunostimulatory 
contaminants were shown to play only a minor role for bacterial RNA-mediated immunorecognition. 
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Our results show that besides the activation of TLR7 and the inflammasome, bacterial RNA activates 
additional receptors similarly as it has been reported for the recognition of bacterial DNA. Although the 
encapsulation of bacterial RNA was necessary for immunostimulation endosomal maturation was 
dispensable indicating that the receptors are located in the cytosol 
4.3 Ligand specificity of RIG-I 
RIG-I recognizes a wide variety of RNA viruses44. Sensing of viral RNA has been linked in several 
reports to the presence of double-stranded RNA (dsRNA) intermediates that occur during the process 
of viral replication6,29,34,126. Recently, it was further shown that RIG-I mainly recognizes dsRNA up to a 
maximum length of approximately 2000 bp131. However, the recognition of dsRNA by RIG-I was 
challenged by two reports showing that rather the terminal 5’-triphosphate of viral RNA molecules 
serves as the major target structure for RIG-I recognition127,128. In fact, one of the reports stated that 
any RNA lacking a 5’-triphosphate could not serve as a substrate for RIG-I128. The role of dsRNA 
recognition by RIG-I and the contribution of the 5’-triphosphate thus remains to be characterized in 
more detail. We addressed the question whether double-strandness and presence of a terminal 5’-
triphosphate represent two independent target structures for RIG-I-mediated RNA recognition. If RIG-I 
is triggered by dsRNA independently of any 5’-triphosphate, we further hypothesized that signalling 
intensity would increase with the length of the dsRNA ligand due to a higher number of putative 
binding sites for RIG-I. 
4.3.1 Characterization of RIG-I expressing Huh7.5 cells 
To investigate RNA induced triggering of RIG-I we used the Huh7.5 cell line which carries a dominant 
negative mutation in the RIG-I protein199. Huh7.5 cells were reconstituted with wild type RIG-I (Huh7.5 
RIG-I wt) (Marco Binder, Heidelberg) as previously described173, resulting in functional RIG-I 
signalling. IRF3 activation was determined by measuring ISG56 reporter activity. Huh7.5 cells were 
per-se non-responsive to stimulation with Poly(IC) in ISG56 reporter assays. This indicated the 
absence of endogenously expressed TLR3 which was additionally confirmed by Microarray analysis 
(data not shown). Reconstitution with functional RIG-I resulted in 32-fold higher ISG56 reporter activity 
upon transfection with Poly(IC) (Fig.  4-29 [A]). There was no sensitivity towards the synthetic single-
stranded RNA molecules Poly(C) and Poly(I). According to the manufacturer’s informations Poly(C), 
Poly(I) and Poly(IC) are synthesized from nucleotide-diphosphates and are therefore not harboring 
any terminal 5’-triphosphate. Additionally, Poly(C) and Poly(I) are not capable to form any secondary 
structures and therefore do not produce any possible target structures for RIG-I. Further, we tested the 
sensitivity of Huh7.5 RIG-I wt cells towards the highly immunostimulatory component LPS and shrimp 
alkaline phosphatase (SAP) which we were going to use in future experiments. Huh7.5 cells showed 
no sensitivity to both (Fig.  4-29 [B]). 
Due to the non-responsiveness to LPS, a contribution of TLR4 on ISG56 activity in Huh7.5 could be 
ruled out. To confirm that Poly(IC) stimulation is independent of any 5’-triphosphate we incubated 
Poly(IC) with SAP prior to transfection. Poly(IC)-induced ISG56 promoter activation was not altered by 
SAP pretreatment. Additionally, unaltered ISG56 activity upon SAP pre-treatment indicated that 
phosphatase treatment did not influence the integrity of Poly(IC) otherwise.  
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Fig.  4-29 Reconstituting RIG-I signalling in Huh7.5 cells 
[A] Huh7.5 cells (white bars) and Huh7.5 reconstituted with wild type RIG-I (black bars) were transfected with 1 µg/well of the 
indicated inducers. ISG56 reporter activity was determined by Dual Luciferase Assay. (n=2, mean +SD). [B] Huh7.5 cells 
reconstituted with wild type RIG-I were transfected with 1 µg/well Poly(C), Poly(IC), Poly(IC) pretreated with 10 U SAP, 100 
ng/well LPS or 10 U SAP. ISG56 reporter activity was determined by Dual Luciferase Assay. Values are expressed as multiples 
of Poly(C)-induced ISG56 activity. (n=2, mean +SD)   
 
4.3.2 Recognition of different RNAs by RIG-I 
4.3.2.1 Double-stranded RNA represents a target structure for RIG-I 
The fact that Poly(IC) but neither Poly(I) nor Poly(C) triggered IRF3 signalling in Huh7.5 RIG-I wt cells 
indicated that double-stranded RNA conformation might serve as a target structure for RIG-I. We 
therefore tested 58 nucleotide long RNA in vitro transcripts corresponding to the Rabies Virus (RV) 
leader RNA (Karl-Klaus Conzelmann, Munich) or 9600 nucleotide long in vitro transcripts of 
replication-incompetent full-length genomes of HCV (Con1/∆GDD) (Marco Binder, Heidelberg). RNA 
molecules were either single-stranded or annealed to the corresponding antisense strand prior to 
transfection. To exclude a differential influence of the terminal 5’-triphosphates on RIG-I mediated 
signalling, we used equal amounts of single- and double-stranded RNA molecules in terms of mass, 
respectively, to yield the same molarity of 5’-ends. When Huh7.5 RIG-I wt cells were transfected with 
the different RNA ligands we measured ISG56 reporter activity in every condition (Fig.  4-30).  
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Fig.  4-30 Stimulation of RIG-I by single- and double- 
 stranded RNA ligands 
Huh7.5 RIG-I wt cells were either transfected with 10 ng/well 
HCV in vitro transcript (HCV(ivT)) or with 20 ng/well RV leader 
RNA (RV). RNA ligands were either single-stranded (white 
bars) or annealed with the respective antisense strands to 
duplexes (black bars) prior to transfection. ISG56 reporter 
activity was determined by Dual Luciferase Assay. For better 
comparability, values are expressed as multiples of ssRNA- 
induced ISG56 reporter activity. (n=2, mean +SD).  
However, for both RNA ligands, RIG-I showed an increased sensitivity for the double-stranded 
conformation. As mentioned above, the respective single- and double-stranded RNA ligands harbored 
the same total number of terminal 5’-triphosphates since transfection was performed with equal 
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masses of RNA. A differential contribution of the 5’-triphosphate was therefore ruled out. Taken 
together, the results indicated that dsRNA represents a target structure for RIG-I on top of the 
recognition of the 5’-triphosphate. Further, the contribution of the double-strand seems to increase 
with the length of the ligand indicated by the differential activity of the 58 and 9600 nucleotide long 
RNAs.  
However, comparability of the two RNA ligands is limited since both are completely different in terms 
of sequence and possible secondary structures. Although there is not much known about the influence 
of certain sequence motifs on RIG-I signalling, a recent report indicated that certain uridine-rich 
sequence stretches within the HCV genome are preferrentially detected by RIG-I132. 
4.3.2.2 Sensitivity to RIG-I increases with the ligand length 
In order to address the issue of length-dependent recognition of dsRNA by RIG-I, we decided to 
generate a set of RNA ligands with overlapping sequences and increasing size. HCV in vitro 
transcripts were considered to be not favourable due to extensive secondary structure               
formations200-202. We therefore decided to use the coding sequence (CDS) of endogenous TLR3 as 
template for the generation of the in vitro transcripts. Extending from position 1271 of human TLR3 
cDNA in vitro transcripts ranging from 40 nucleotides up to 1600 nucleotides in length were generated, 
gel purified and finally validated by capillary electrophoresis (Fig. 4-31). Additionally, the 40-mer was 
synthesized commercially to bear a hydroxyl-group at the 5’-end instead of a 5’-triphosphate. 
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Fig.  4-31 Capillary electrophoresis image of in vitro  
 transcripts 
In vitro transcripts of 40, 100, 200, 400 and 1600 nucleotides 
in length were analyzed by capillary electrophoresis. RNA 
strands were transcribed in sense (s) and in antisense 
orientation (as). Commercially synthesized 40-mer RNA 
oligonucleotides are depicted as 40*. (Arrow indicates the 25 
nt internal calibration marker). 
Synthesized as well as in vitro transcribed RNA molecules were detected at the expected size and 
showed high integrity. Further side products from the in vitro transcription reaction were shown to be 
removed completely during the purification procedure. 
To address substrate specificity of RIG-I in a quantitative fashion we decided to perform titration 
experiments with the generated in vitro transcripts after being annealed to form dsRNA. Since all in 
vitro transcripts harbor a triphosphate at each 5’-end, dsRNA was transfected in equal molarities to 
ensure that the extent of a possible contribution of the 5’-triphosphate was identical. In fact, sensitivity 
of RIG-I signalling to dsRNA was increased with increasing ligand length (Fig.  4-32 [A]). Surprisingly, 
maximum signalling was slightly reduced with increasing size of the dsRNA ligand. However, this fits 
to a recent report which showed that RIG-I mediated signalling decreases with increasing length of the 
dsRNA ligand at saturating ligand concentrations131.  
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Fig.  4-32 Length-dependent recognition of dsRNA by RIG-I 
[A] Huh7.5 RIG-I wt cells were transfected with dsRNA of the indicated sizes generated by in vitro transcription and annealed to 
complete dsRNA. Ligand concentration was titrated over the indicated concentration range. ISG56 reporter activity was 
determined by Dual Luciferase Assay. Values are shown for 100ds and 400ds in vitro transcripts and depicted as multiples of 
Poly(C)-induced ISG56 reporter activity. Determined substrate concentration for half-maximal signalling (K50) for 100ds in vitro 
transcript is indicated (n=3, mean ± SD). [B] Substrate concentrations for half-maximal signalling were plotted versus the 
substrate length (n=3, mean ± SD). [C] Sensitivity of RIG-I to dsRNA was defined as 1/K50 and plotted versus the substrate 
length (n=3, mean ±.95% conf.). 
 
However, despite the slight decrease of maximum signalling strength, ligand titration clearly showed 
that sensitivity of RIG-I to dsRNA was increased substantially with the length of the ligand. RIG-I was 
most sensitive to the 1600 nucleotide long dsRNA substrate. Half-maximal signalling for 400 
nucleotide long RNA was measured at a substrate concentration (K50) of about 1.5 fmol/well whereas 
the K50 of 100 nucleotide long dsRNA was at about 0.02 pmol/well, thus showing a 30-fold lower 
sensitivity of an only 4-fold smaller ligand to RIG-I. Plotting the determined K50 of the different dsRNA 
samples versus the length of the respective ligands again showed that signalling of RIG-I to dsRNA 
was drastically increasing with increasing ligand length (Fig.  4-32 [B]). The reciprocal of the 
determined K50 values was defined as sensitivity of RIG-I to its ligand. Highest sensitivity was reached 
from approximately 800 basepairs on. Half-maximal sensitivity was reached at 340 basepairs. 
Importantly, the total number of 5’-triphosphates was identical among all transfected dsRNA ligands 
excluding the possibility that the observed differential signalling activity was generated by the 5’-ends. 
Taken together, these experiments extent the view on RIG-I substrate specificity. Besides the 
recognition of the terminal 5’-triphosphate, RIG-I detects the presence of dsRNA. Further, the 
disproportionately high increase in sensitivity towards longer dsRNA strongly indicates that ligand 
binding to RIG-I occurs rather in a cooperative than linear manner. 
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4.3.2.3 Contribution of the terminal 5’-triphosphate 
Next, we wanted to investigate the influence of the terminal 5’-triphosphate in relation to the 
recognition of double-stranded conformation of the RNA ligands. The results from the experiments 
above showed that dsRNA is recognized length-dependently while keeping the number of 
5’-triphosphates constant. Additionally, assuming that terminal 5’-triphosphates are recognized 
independently of the length of the ligand suggested that the fraction of the signal due to the terminal 
5’-triphosphate would be higher for shorter dsRNA ligands.  
1600 400 200 100 40 40 synth.
0
20
40
60
80
100
120 mock
+ SAP
[A]
* *
Inducer length [bp]
Lu
ci
fe
ra
se
 a
ct
iv
ity
 [%
 o
f c
on
tro
l]
 
 
200 nt
1
*
2
[B]
 mock + SAP
0
20
40
60
80
100[C]
dp
m
 [%
 o
f m
oc
k 
tre
at
ed
]
 
 
Fig.  4-33 Influence of the 5’-triphosphate on RIG-I signalling 
[A] In vitro transcripts of the indicated length were either phosphatase (gray bars) or mock treated (black bars) prior to 
annealing. Concentrations for half-maximal signalling (K50): 0.6, 1.5, 4.5, 20 and 10000 fmol/well for 1600, 400, 200, 100 and 
40 bp dsRNA ligands, respectively. Synthetic double-stranded 40-mer served as positive control. ISG56 activity was 
determined by Dual Luciferase Assay. Values were normalized to the untreated control for better comparability. (n=2, 
mean +SD). (*, p<0.05, as compared to mock-treated RNA ligand). [B] The integrity of the RNA ligands was tested. 200 nt 
long single-stranded RNA was either phosphatase treated as above (1) or not (2) and applied to capillary gel electrophoresis. 
(*, indicates the internal calibration marker). [C] Efficiency of phosphatase treatment was determined by in vitro transcription 
with γ-32P-labeled GTP and subsequent dephosphorylation. Residual radioactivity was measured and is depicted in 
disintegrations per minute (dpm). Values were normalized to the untreated control.  
 
Therefore the dsRNA ligands from the experiments above were either incubated with shrimp alkaline 
phosphatase (SAP) or mock treated prior to transfection. Transfection was performed with the 
substrate concentrations for half-maximal signalling (K50) which had been determined in the 
experiment above. Using K50 avoided that the signalling saturation level was passed and therefore the 
detection of quantitative signalling differences was ensured. In fact, the presence of a 5’-triphosphate 
showed a significant contribution to RIG-I signalling for shorter dsRNA. Dephosphorylation of double-
stranded 40 bp and 100 bp in vitro transcripts reduced signalling by 87% and 51%, respectively. 
However, when ligands of 200 nucleotides or longer were used, the influence of the 5’-triphosphate 
became negligible (Fig.  4-33 [A]). Signalling of dephosphorylated double-stranded 40-mer was 
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comparable to the signalling activity of synthetic double-stranded 40-mer which harbors a 
hydroxyl-group instead of a triphosphate at the 5’-end. Using capillary gel electrophoresis we could 
show that the integrity of the dsRNA ligands was not compromised by the phosphatase treatment (Fig. 
 4-33 [B]). In order to check the efficiency of the phosphatase treatment we dephosphorylated 5’-γ-32P 
radiolabeled in vitro transcribed RNA and determined residual incorporated radioactivity after 
purification. We observed a decrease of radioactivity by 98% compared to the untreated control (Fig. 
 4-33 [C]) showing that phosphatase treatment was highly efficient. These residual 5’-triphosphates 
might explain the slightly higher activity of dephosphorylated in vitro transcribed 40-mer compared to 
the synthetic RNA oligonucleotide (Fig.  4-33 [A]). 
4.3.2.4 Recognition of single-stranded RNA by RIG-I 
As already described, the recognition of single-stranded RNA (ssRNA) was proposed to require the 
presence of a terminal 5’-triphosphate127,128. In the previous experiments, ssRNA represented a 
weaker ligand than dsRNA (Fig.  4-30). To test the sensitivity of RIG-I to ssRNA we decided to perform 
titration experiments as with the dsRNA above. We transfected Huh7.5 RIG-I wt cells with either 
single-stranded or double-stranded 100 nucleotide in vitro transcribed RNA in equal molarities (Fig. 
 4-34). Double-stranded RNA reached signalling saturation at about 1 pmol/well whereas single-
stranded RNA of the same length was barely active at this concentration. However, also single-
stranded RNA induced comparable ISG56 reporter activity upon transfection at 1000-fold higher ligand 
concentration. Although transfected dsRNA harbors twice as many triphosphorylated 5’-ends 
compared to the ssRNA this could not explain the enormous difference in RIG-I mediated recognition. 
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Fig.  4-34 Comparison of single-stranded and double-
 stranded RNA ligand recognition by  RIG-I 
100 nucleotide in vitro transcribed RNA was used for 
transfection at the indicated concentrations either in a 
single-stranded conformation (white bars) or in double-
stranded conformation (black bars). ISG56 reporter activity 
was determined by Dual Luciferase Assay. 
(n=2, mean +SD). 
To investigate the influence of the 5’-triphosphate and the length of ssRNA ligands on RIG-I 
recognition, ssRNA ranging from 100 to 1600 nucleotides was phosphatase-treated and used for 
transfection. Compared to the 100 nucleotide dsRNA all ssRNAs showed weaker induction of IRF3 
signalling (Fig. 4-35). Dephosphorylation of the ssRNA resulted in a significant signal abrogation for 
ssRNA ligands up to a length of 200 nucleotides. Transfection with dephosphorylated ssRNA longer 
than 200 nucleotides resulted in a reduction but not significant abrogation of signalling indicating that 
also ssRNA represents a target structure for RIG-I. Importantly, as already observed for dsRNA 
ligands the recognition of ssRNA was length-dependent. Single-stranded RNA tends to form double-
stranded stretches ( 4.1.8). Therefore the length-dependent signalling increase might be caused by a 
higher extent of double-stranded stretches in longer RNA molecules. In contrast to dsRNA recognition, 
the 5’-triphosphate contributes also to the recognition of RNA ligands longer than 200 basepairs. 
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Importantly, the influence of the 5’-triphosphate decreased with increasing substrate length 
comparable to the findings for the recognition of dsRNA. The stronger contribution of the 5’-
triphosphate for ssRNA induced signalling is very likely to be caused by the lower extent of double-
stranded target structures compared to dsRNA. The fact that signalling of dephosphorylated double-
stranded 100 nt in vitro transcript was not altered compared to the untreated control was due to the 
applied ligand concentrations which were far in saturation for dsRNA (Fig.  4-32). 
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Fig.  4-35 Contribution of length and 5’-end 
 on ssRNA recognition by RIG-I 
1 pmol/well of in vitro transcribed ssRNA (ss) of 
the indicated lengths were used for transfection. 
ssRNA was either phosphatase treated (white 
bars) or not (black bars). 100 nucleotide dsRNA , 
0.1 µg/well Poly(IC) and 1 µg/well Poly(C) were 
used as controls. ISG56 reporter activity was 
determined by Dual Luciferase Assay. (n=2, 
mean +SD). (n.d., not detected, n.s., not 
significant, *, p<0.05, as compared to the mock-
treated RNA ligand). 
Taken together, these reporter experiments clearly showed that RIG-I is triggered by 
5’-triphosphorylated single- and double-stranded RNA ligands. Further, we could show that dsRNA is 
recognized also in the absence of a terminal 5’-triphosphate identifying double-strandness as a 
second target structure for RIG-I. Sensitivity of RIG-I to dsRNA was strictly length-dependent and the 
contribution of the 5’-triphosphate vanished if substrate length exceeded approximately 200 basepairs. 
Surprisingly, 400 nt or longer ssRNA also represented a ligand for RIG-I even in absence of a 
5’-triphosphate. However the 5’-triphosphate contributed to RIG-I mediated signalling also for longer 
ssRNA ligands which contrasted the observation for dsRNA. 
4.3.3 RIG-I-ligand interactions 
The results from the ISG56 reporter assays showed that RIG-I possesses a higher sensitivity to longer 
dsRNA substrates indicating that RIG-I binds to dsRNA in a length-dependent manner due to a higher 
number of putative binding sites. In order to validate the results of the reporter studies and to prove 
quantitative binding of RIG-I to dsRNA, we aimed to study RIG-I:RNA interactions in biochemical 
assays.  
4.3.3.1 Expression and purification of recombinant RIG-I protein 
Recombinant RIG-I was expressed with a Glutathione-S-Transferase tag (GST) in Sf9 cells and was 
affinity purified with glutathione 4B sepharose; finally wild type RIG-I was liberated by proteolytic 
cleavage and analyzed by SDS-PAGE (Fig.  4-36). Efficiency of RIG-I expression was tested by 
coomassie staining of the eluate fraction and verified by western blotting. The eluate fractions 
contained RIG-I in high purity and the protein showed the expected size. Uncleaved RIG-I_GST or 
degradation products of RIG-I were not detectable. 
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Fig.  4-36 Analysis of recombinantly expressed RIG-I 
[A] Coomassie staining of selected fractions of the protein purification process: (1) total lysate, (2) soluble fraction, (3) post-
binding supernatant and (4) cleaved eluate. [B] Western blot of selected fractions of the same protein purification: (1) total 
lysate, (2) soluble fraction, (3) insoluble fraction, (4) post-binding supernatant and (5) cleaved eluate. RIG-I_GST was 
detected at 132 kDa and cleaved RIG-I at 106 kDa.  
4.3.3.2 Functionality of recombinant RIG-I 
Functional RIG-I protein has been described to harbor a central domain with high homology to the 
DexD/H box and therefore to be capable to selectively unwind certain dsRNAs under consumption of 
ATP129,130,133. Recombinant RIG-I protein was therefore tested for ATPase activity upon incubation 
with different substrates (Fig. 4-37). We observed consumption of ATP when RIG-I was incubated with 
either Poly(IC) or double-stranded 400 basepair in vitro transcript. Non-responsiveness upon 
incubation without ATP ensured that no free pyrophosphate was present within the reaction mixture. 
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Fig.  4-37 ATPase activity of recombinant RIG-I 
2 pmol of RIG-I were incubated for 30 minutes at 37oC with 
either 0.5 pmol in vitro transcript or 500 ng Poly(IC) and 
Poly(C), respectively. 1 mM ATP was either added to the 
reaction mixture (black bars) or not (white bars). ATPase 
activity was determined in a photometer at 620 nm 
wavelength. (mean +SD), (n.d., not detected, n.t., not 
tested). 
Further, ATPase activity was low with single-stranded RNA substrates. Activity with the 400 nt single-
stranded in vitro transcript was more than 10-fold lower compared to the respective double-stranded in 
vitro transcript. The ATPase activity was regarded as evidence for the functionality of the recombinant 
protein. To test whether same molarities of dsRNA of different lengths induces ATPase activity of 
RIG-I differently, we incubated RIG-I protein with different concentrations of double-stranded in vitro 
transcripts with increasing length (Fig. 4-38). We observed a length-dependent ATPase activity with 
dsRNA substrates over the tested concentration range. Paralleling the results of the ISG56 reporter 
assays, RIG-I showed a higher sensitivity to longer substrates resulting not only in more sensitive 
signalling but also in higher ATPase activity.  
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Fig.  4-38 Length-dependent ATPase activity 
2 pmol of RIG-I were incubated with three 
double-stranded in vitro transcripts of 40, 100 
and 400 basepairs in length over the indicated 
concentration range. ATPase activity was 
determined in a photometer at 620 nm 
wavelength. (mean ±SD).  
4.3.4 Summary 
In this study we could show that double-stranded conformation of RNA serves as a recognition motif 
sufficient to trigger RIG-I. In reporter based titration assays with well defined RNA ligands we detected 
a drastical increased sensitivity of RIG-I to longer dsRNA ligands. Further, the contribution of the 5’-
triphosphate for signalling was shown to be relevant for shorter dsRNA molecules up to a length of 
approximately 200 basepairs. For longer dsRNA substrates the influence of the 5’-triphosphate 
reached non-significant levels indicating that the contribution of the 5’-triphosphate might be 
overestimated for the recognition of long viral RNA sensing. Taken together, these findings show that 
RIG-I binds besides the 5’-triphosphate also dsRNA in a putatively cooperative manner.  
Besides the recognition of dsRNA, RIG-I also binds to ssRNA. Surprisingly we also observed RIG-I-
mediated signalling with dephosphorylated ssRNA. However, sensitivity of RIG-I was far below the 
levels detected for dsRNA recognition. Similar to dsRNA, recognition of ssRNA was also length-
dependent. A minimum length of approximately 400 nucleotides was required for efficient signalling 
indicating that ssRNA might form partial duplex structures which are sensed by RIG-I. Our 
observations identified dsRNA as a separate recognition motif for RIG-I and help to understand 
controversially discussed aspects of RNA recognition by RIG-I. 
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5 Discussion 
5.1 siRNA-mediated immunostimulation 
The discovery that synthetic short interfering RNA duplexes (siRNA) activate the RNA interference 
machinery without triggering an interferon response in mammalian cells was considered a 
breakthrough for the development of siRNA-based therapeutics140,161. Consequently, these findings 
were nominated “breakthrough of the year” by Science magazine203. Closer investigations revealed 
that naked siRNA does not necessarily induce an IFN response in vivo96. However, it became 
apparent that systemic application of siRNA in combination with delivery agents such as cationic 
lipids, under certain circumstances showed severe side-effects, such as the induction of a type-I 
interferon response. Certain, but not all, siRNAs induced a so far hardly predictable interferon 
response97-99 which could be attributed to the activation of TLRs in plasmacytoid dendritic 
cells83,85,99,186. Of note, for the application of siRNAs in therapeutic trials the induction of an interferon 
response should be avoided or minimized. Otherwise siRNAs could share the fate of antisense 
oligonucleotides (asODNs) which mostly did not pass clinical trials despite of intriguing in vitro 
results166. One reason for the failure of asODNs was that it was not realized that CpG-containing 
asODNs induce activation of TLR9. Thus, CpG-mediated TLR9 activation, which can easily be 
avoided, led to failure of a whole class of substances. 
It was hypothesized that recognition of siRNA by TLR7/8, TLR3 or PKR83,98,204 are molecular 
processes that could be separated from RNA interference which in turn would allow to establish more 
specific pharmaceuticals. It is now clear that siRNAs induce immunostimulation in a sequence-
dependent manner83,85. This issue has been investigated in detail for single-stranded RNA 
oligonucleotides. The exact mechanism of TLR7-mediated RNA recognition is unclear so far but it has 
been shown that immunoactivation is induced by certain immunostimulatory sequences. Although 
much effort has been undertaken to identify these immunostimulatory sequence motifs, similar to 
approaches already described for the recognition of DNA oligonucleotides78, it became rapidly clear 
that in contrast to DNA the recognition of RNA did not rely on easily identifiable sequence motifs. So 
far, it has been suggested that certain GU-rich sequence motifs would induce the observed 
immunoactivation81,83,85. In contrast to these reports, others showed that rather the excessive 
presence of uridine residues was responsible for immunorecognition by TLR786. It was further 
assumed that the avoidance of certain sequences, if better defined, would separate siRNA-mediated 
immunostimulation from RNA interference. However, so far it is barely possible to link the sequence to 
the immunostimulatory potential of siRNAs. The restriction of RNA-sensing TLRs to endosomal 
compartments is believed to be the reason that endogenous RNA molecules are not recognized. In 
addition to the existence of immunostimulatory sequences within RNA molecules and the 
compartimentalization of the receptors, the absence of nucleotide modifications which naturally occur 
very abundantly in endogenous RNA has been addressed as a motif for immunorecognition89. Various 
naturally occuring nucleotide modifications have been shown to suppress immunostimulation (e.g. 
pseudouridine) whereas others showed no significant influence (5’-methylcytidine)89,90,182,205.  
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5.1.1 Sequence-dependent recognition of siRNAs 
The here presented results confirm that siRNAs are able to induce an interferon response in human 
PBMCs. It could be shown that the siRNA-induced interferon-α secretion is mediated by TLR7 in 
plasmacytoid dendritic cells similar to the already described recognition of single-stranded RNA 
oligonucleotides81. TLR7 dependency was further validated using TLR7-knockout mice. Since it has 
been reported previously that siRNA duplexes do not separate when entering endosomal 
compartments but rather stay in a double-stranded conformation101 it can be assumed that TLR7 binds 
not only single-stranded RNA ligands but is also triggered by short double-stranded RNA substrates 
as already described for TLR3109. Recent reports demonstrated that TLR3 forms dimeric structures 
upon binding of dsRNA which are required for activation115,116. Further, it became evident that the 
immunostimulatory potential of various siRNAs differed significantly suggesting a sequence-
dependent recognition since all siRNAs were synthesized similarly and did not differ in length. 
Transfection with different RNA oligonucleotides, either avoiding or favouring previously suggested 
uridine or guanosine-uridine rich immunostimulatory motifs, indeed resulted in a differential induction 
of interferon-α secretion in human PBMCs. 
RNA oligonucleotides with a low amount of either guanosine or uridine residues showed in general a 
low ability to induce interferon-α in contrast to oligonucleotides with a high content of the respective 
nucleotides. However, oligonucleotides EGFP1as and EGFP1s containing no more than the 
statistically expected number of guanosine and uridine residues in a random order surprisingly 
showed a high potential to induce interferon-α. These results indicated that the sequence of the 
transfected oligonucleotide might not be the only target structure for immunorecognition principles of 
TLR7. 
5.1.2 Nucleotide modifications within the minor groove of RNA duplexes 
  reduce immunostimulation 
Within this work it could be shown that the introduction of modified nucleotides into RNA 
oligonucleotides resulted in an altered type-I interferon secretion. RNA oligonucleotides containing 2’-
deoxy and 2’-O-methoxy residues revealed that the 2’-position of the ribose is very relevant for 
immunorecognition. 2’-deoxyuridine including thymidine but none of the other deoxy-modified 
nucleotides was identified to significantly reduce interferon-α secretion ( 4.1.4.1). In agreement with 
this observation 2’-O-methyl-uridine and, additionally, 2’-O-methyl-adenosine abolished 
immunostimulation. From the literature it is also known that 2’-O-methyl-guanosine reduces 
immunostimulation, thus our results now contribute to the notion that the 2’-position of the ribose is 
critical for TLR7-mediated recognition91,92,206. However, the 2’-O-methyl derivate of cytosine showed 
no effect in terms of altered interferon secretion. This confirms again that immunorecognition also 
depends on certain immunostimulatory sequence motifs which are very likely to comprise no cytosine 
residues. 
The substraction as well as the methylation of the hydroxyl group at the 2’-position of the ribose 
removes a possible hydrogen bonding donor. Both modifications alter the minor groove within an RNA 
duplex. On the other hand, nucleotide modifications which alter the nucleobase and therefore the 
major groove of an RNA duplex did not influence the extent of immunorecognition. Neither 
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5’-methylcytidine-containing EGFP1as which harbors a sterically demanding methyl-group at the site 
of major groove recognition nor 7’-deazaguanosine-containing EGFP1as which omits a nitrogen as a 
possible H-bond acceptor showed any effect in terms of interferon-α secretion (Fig.  5-1).  
Taken together, the results support the conclusion that immunorecognition of RNA depends on 
recognition within the minor groove whereas alterations of the major groove show only negligible 
effects assuming that siRNA forms a duplex structure. Thus, the minor groove of an RNA duplex 
seems to be the target structure for TLR7-mediated recognition in contrast to most DNA protein 
interactions which are mediated by major groove recognition. However, RNA duplexes can form A-
type helices which in contrast to B-type DNA helices exhibit a larger minor groove, thus allowing for 
better protein interactions. The potential to reduce immunostimulation by 2’-deoxyuridine and 
thymidine residues was comparable and quite effective. Introduction of thymidine residues in two 
further functional siRNA molecules revealed that modification of uridine residues displays a universal 
strategy for the reduction of interferon-α secretion in human PBMCs. This observation is now 
confirmed by recent reports showing that 2’-deoxyuridine-containing RNA strands reduce 
immunostimulation100,206.  
dU m5C                         dT nG
 
Fig.  5-1 Structures of 2’-deoxyuridine, 5’-methyl-cytosine, thymidine and 7’-deazaguanosine 
Uridine was replaced by 2’-deoxyuridine (dU) or thymidine (dT) missing a hydroxylgroup at the 2’-position of the ribose affecting 
the recognition within the minor groove (encircled in red). Modifications facing the major groove as the methylgroup at the 5’-
position of the uridine nucleobase (dT), an additional methylgroup at the 5’-position of the cytosine nucleobase (m5C) or missing 
nitrogen at the 7’-position of the guanosine nucleobase (nG) do not alter immunostimulation (encircled in blue).  
 
Transfection of 2’-deoxyuridine- as well as thymidine-containing RNA oligonucleotides at high 
concentrations such as 1 µg/ml still induced residual interferon-α secretion in human PBMCs. In 
contrast to this observation, 2’-O-methyl-adenosine and 2’-O-methyl-uridine-containing RNA 
oligonucleotides were completely inactive even at the highest concentrations applied. This observation 
is in agreement with other reports showing that 2’-O-methyl-uridine residues convert RNA 
oligonucleotides to become antagonists in terms of TLR7-mediated signalling91,92. In contrast to the 
tested uridine and adenosine residues as well as contrasting reports investigating the influence of 
guanosine on immunostimulation, 2’-O-methyl-cytosine showed no significant effect on 
immunostimulation. In parallel 2’-deoxy-cytosine residues reduced immunostimulation to some extent 
but still to a much lower extent than 2’-deoxy-uridine residues. This indicates that cytosine residues 
are not part of any possible immunostimulatory motif.
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5.1.3 2’-O-methyl-modifications inhibit TLR7 signalling 
The differences between 2’-O-methyl-modifications and 2’-deoxy-modifications became more obvious 
when investigating the immunostimulatory potential of double-stranded RNA duplexes. 2’-O-methyl-
adenosine modified RNA oligonucleotides were already completely silent in terms of interferon-α 
secretion if only the leading-strand of an siRNA duplex was modified. Thus, the immunostimulation of 
the unmodified passenger-strand was suppressed indicating that 2’-O-methyl-modifications act in a 
dominant-negative manner on TLR7 signalling. In contrast, 2’-O-methyl-uridine modifications showed 
only a reduction in interferon-α secretion comparable to 2’-deoxy-uridine-modified RNA if incorporated 
in the leading-strand of an siRNA. Additionally, it was reported that 2’-O-methyl-uridine also inhibits 
TLR9 activation by type A CpG-oligodeoxynucleotides in human and mice, thus lacking TLR7/8 
specificity91. This identifies thymidine modifications as immunologically silent in contrast to 2’-O-
methyl-adenosine-modifications. In agreement with this observation cotransfection of EGFP1as and 
dT-modified EGFP1as resulted in a reduction of interferon-α of about 50% showing that the dT-
modified RNA oligonucleotide did not influence the triggering of TLR7 by the unmodified EGFP1as. In 
contrast, cotransfection with 2’-O-methyl-adenosine-modified EGFP1as completely abrogated 
immunostimulation of unmodified EGFP1as. Introduction of thymidine residues in both strands of an 
siRNA duplex further decreased interferon-α secretion in human PBMCs indicating that residual 
activity had indeed been induced by the unmodified passenger-strand of the duplex. Importantly, the 
residual immunological activity of the RNA duplex with thymidine in both strands was only observed in 
concentrations which were far above of those needed for RNA interference activity. Taken together, 
these results show that thymidine modifications represent silent modifications in terms of 
immunorecognition which contrasts findings for 2’-O-methyl-derivates that dominantly inhibit TLR7 
signalling. Clinically, our findings might be important, since thymidine modifications would still allow 
intact TLR7 signalling and recognition of other ligands (e.g. viral ssRNA)207. Antagonistic activity on 
TLR7 signalling induced by 2’-O-methyl-adenosine would not be desirable in this context.  
5.1.4 Nucleotide modifications influence RNAi differentially 
Next, it had to be assessed whether the immunological relevant modifications influence RNA 
interference. Indeed, the tested modifications showed significant differences in terms of RNA 
interference. Whereas thymidine modifications in the leading-strand of an siRNA duplex showed only 
marginal reduction of gene-silencing activity compared to the unmodified siRNA duplex, 2’-deoxy-
uridine substitutions were already less efficient. Introduction of thymidine residues into two further 
antisense strands of functional siRNA molecules also showed no significant reduction of gene-
silencing activity suggesting a general principle. The lower ability of 2’-deoxy-uridine residues 
compared to thymidine residues in terms of gene-silencing might be explained by a higher stability of 
the thymidine-containing duplex. Even introduction of thymidine residues in the second strand of an 
siRNA duplex, which was necessary to completely block immunostimulation, did not alter the ability to 
suppress gene expression. In sharp contrast to these findings, 2’-O-methyl-uridine-modified and 
especially 2’-O-methyl-adenosine modifications showed a lower efficiency in gene silencing. 
Therefore, the introduction of 2’-O-methoxy derivates, although showing a strong reduction in terms of 
interferon secretion are not favourable for the introduction into siRNA molecules due to their lower 
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ability in gene-silencing activity. It has been reported that the 2’-hydroxyl-group of the ribose is not 
essential for RNA interference208 with exception of sterically very demanding groups (e.g. methylation) 
which might influence the RNAi machinery. Especially modifications in the leading-strand of an siRNA 
duplex are well tolerated and even not naturally occuring modifications such as 2’-fluoro modifications 
are able to induce efficient gene-silencing209. The position of modified nucleotides for gene-silencing 
activity of the respective siRNA duplex depend on the kind of modification210,211 but in general it is 
thought that modifications in the middle of a duplex are not well tolerated212. Our results suggested 
that thymidine residues are a valuable tool to design functional siRNA molecules and simultaneously 
inhibit unwanted side-effects like interferon-α secretion. 
5.1.5 TLR7 might detect double-stranded structures 
Ligand recognition of RNA in double-stranded conformation by TLR3109 was also recently implicated 
for DNA recognition of TLR9. It was shown that CpG-containing DNA in forced double-stranded 
conformation is preferentially recognized by TLR9 due to higher ligand stability compared to single-
stranded DNA ligands213,214. Further, a recent report demonstrated that similar to TLR9, N-terminal 
cleavage of TLR7 is required for ligand binding and activation. Additionally, TLR7 and TLR9 belong to 
the same subfamily of TLRs and show high sequence homology and the same number of LRRs with 
irregular insertions215,216. The high homology of TLR7 and TLR9 suggests the possibility that the same 
mechanisms of receptor activation are operative. In turn this would indicate that TLR7, similar to 
TLR9, might recognize RNA preferentially in double-stranded conformation.  
The important role of uridine residues for immunorecognition was demonstrated by the significant 
reduction of type-I interferon secretion if modified at the 2’-position of the ribose. Further, the here 
presented results, in addition to several other reports, demonstrated that uridine plays a pivotal role for 
immunorecognition86,92,100. Uridine residues tend to the form duplex structures since they are not only 
able to bind to adenosine but also to guanosine residues185. Taken together, there is some indication 
that TLR7-mediated recognition is induced by the presence of uridine residues within double-stranded 
RNA stretches.   
Indeed, hyperchromicity assays within this work confirmed that the immunostimulatory RNA 
oligonucleotide EGFP1as has the propensity to form secondary structures. We detected two different 
transition points for EGFP1as indicating secondary structure formation. The lower detected 
temperature transition was significantly reduced in dT-modified EGFP1as. This indicates indirectly that 
secondary structure formation could be critical for immunorecognition. Further indication for this 
conclusion resulted from the fact that RNA oligonucleotides with a low ability to induce interferon-α 
secretion displayed no or low formation of intramolecular duplex structures when analyzing the 
sequences by hyperchromicity assays or structure prediction programs. Investigations of 
intramolecular and intermolecular structure formation as well as uridine content confirmed that all RNA 
oligonucleotides with a high ability to induce interferon-α owned a high content of uridine residues 
within possible secondary stem-loop structures. Although the frequency of immunorelevant 
modifications was shown to influence the potential of type-I interferon secretion89, partial substitution 
of uridine residues within two different immunostimulatory RNA oligonucleotides did not result in 
significant differences regarding interferon-α secretion. Neither thymidine insertions within predicted 
stem-loop structures nor within sequences predicted to form no secondary structures resulted in a 
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significant reduction of interferon-α secretion. These findings indicate that uridine residues in general 
might be detected by TLR7 rather than exclusively in stem-loop structures. On the other hand, the 
substitution of only some uridine residues might not be sufficient to suppress immunostimulation since 
alternative secondary structures, besides the predicted ones, might form.  
 
Taken together, the here presented results show that immunorecognition of siRNA is induced in a very 
similar manner as already described for recognition of single-stranded RNA oligonucleotides81. It 
became evident that published immunostimulatory sequences contributed to the extent of interferon-α 
secretion but sequence motifs are not the only origin of immunostimulation. Additionally, nucleotide 
modifications at the 2’-position of the ribose, as they occur in high frequency in endogenous RNA (e.g. 
2’-methoxy-modifications in messenger RNA)90 are critical for TLR7-mediated recognition. This gives 
strong evidence that rather the minor groove than the major groove is the site of recognition. 
Thymidine residues were identified as favourable modifications within siRNA molecules since they 
altered RNA interference only slightly compared to all other tested immunorelevant modifications but 
reduced immunoactivity. In contrast to thymidine residues, 2’-O-methyl-adenosine substitutions 
completely inhibited TLR7 signalling. This modification showed a strong reduction in RNA interference 
efficiency and was therefore considered not useful for siRNA applications, but could be used for 
specific TLR7 inhibition. In parallel to the other nucleic acid sensing TLRs 3 and 9, evidence is 
presented that TLR7 also recognizes its ligand in double-stranded conformation. 
5.2 Immunorecognition of prokaryotic RNA 
Additionally to siRNA mediated immunorecognition, this work focused on the investigation of the 
mechanisms of prokaryotic RNA recognition. Prokaryotic DNA has been described in several reports 
as a target for immunorecognition principles. It has been demonstrated that prokaryotic DNA is sensed 
in a TLR9-dependent manner78. Additionally, strong evidence has been given for the presence of a 
cytosolic DNA receptor78,137,217. However, in contrast to the well-described recognition of viral RNA, the 
mechanisms of bacterial RNA recognition are barely understood. At the beginning it was even unclear 
whether prokaryotic RNA is active in terms of immunostimulation. Although bacterial RNA carries 
various non-self structures such as an altered nucleotide modification pattern89, a 5’-triphosphate in 
the messenger RNA187 and stretches of double-stranded conformation which allow for the interaction 
with different PRRs, the contribution of the respective receptors remained elusive. Further, species–
dependent recognition as it has been described for the recognition of bacterial DNA79 was not 
investigated so far.  
Viral RNA has been shown to represent an immunostimulatory pattern which induces a type-I 
interferon response. Recognition has been associated with the sensing by receptors belonging to the 
TLR and RIG-like receptor class44,192. The principles to distinguish non-self RNA from host-derived 
RNA are structural differences found in the RNA molecules127,131. Recognition of viral RNA by 
professional immune cells has been shown to be mediated by the RNA-sensing TLRs 3, 7 and 8109,192. 
Recognition of endogenous RNA is limited by the restriction of these TLRs to endosomal 
compartments which get only into contact with RNA molecules that have been taken up via the 
endocytotic pathway. Besides this compartimentalization it has been shown that nucleotide 
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modifications as they occur in eukaryotic RNA are able to reduce immunostimulation89,90. Further 
structural differences such as a shorter poly-A tail of prokaryotic RNA have been identified as a target 
structure for TLR-mediated recognition218. Besides the recognition by TLRs, viral RNA has been 
shown to be sensed by the cytoplasmic RNA sensor proteins RIG-I and MDA5. These proteins target 
structures that are characteristic for viral RNA, such as double-stranded conformation131 or the 
presence of an accessible 5’-triphosphate127.  
5.2.1 TLR7-mediated recognition of prokaryotic RNA 
In this work, it could be shown that similar to viral RNA, bacterial RNA is also recognized in a TLR7-
dependent manner by plasmacytoid dendritic cells (pDCs). It has been shown that this cell-type shows 
enhanced endosomal uptake and retains received molecules for a longer time within the endosomal 
compartment28. Further, pDCs show strong expression of the endosomal TLRs 7 and 9 making this 
cell-type to a predestinated sensor for non-self nucleic acids191,219. Additionally, these cells are strong 
producers of type-I interferons due to their constitutive expression of IRF724. Bacterial RNA in this 
work now has been shown to be an inducer of IFN-α. Interestingly, the potential to induce IFN-α was 
rather similar between the different tested bacterial species. Immunostimulation did neither correlate 
with the gram-type of the tested bacteria nor with possible contaminants since RNAseA digestion 
resulted in a nearly complete abrogation of IFN-α secretion. Although there is indication that TLR7 
recognizes certain sequence motifs within RNA oligonucleotides81,83 this seems to play only a minor 
role for whole bacterial RNA preparations.  
Sequence analysis of the ribosomal RNA (rRNA) of the different bacterial species did not show any 
superior abundance of immunostimulatory sequence motifs in any of the tested species when aligning 
bacterial rRNA sequences with published immunostimulatory sequence motifs.  
This contrasts findings for the recognition of bacterial DNA by TLR9 which has been shown to 
correlate directly with the content of CpG dinucleotides within the sequence79 indicating that RNA 
sensing is not limited to certain sequence motifs. Stimulation with non-self RNA of eukaryotic origin as 
for example Candida albicans resulted in a significant lower IFN-α secretion. This might be due to the 
higher content of nucleotide modifications within eukaryotic RNA220 which has been described to be 
relevant for TLR-mediated RNA sensing89. Ribosomal RNA which represents approximately 80% of 
the total cellular RNA was isolated and tested for IFN-α secretion. Immunostimulation with 16S rRNA 
showed the same dose-dependent IFN-α secretion as the respective total RNA of Escherichia coli 
identifying ribosomal RNA as one of the major immunostimulatory component within bacterial RNA. 
TLR7-mediated recognition of bacterial RNA was proven by cotransfection with the TLR7-specific 
inhibitor 2mA91,167 ( 4.1.7) which resulted in a complete abrogation of IFN-α secretion. TLR7-
dependency of bacterial RNA induced IFN-α secretion was additionally validated by the use of TLR7 
knockout mice and reduction of IFN-α by inhibition of endosomal maturation through chloroquine 
treatment.  
5.2.2 Prokaryotic RNA triggers (a) receptor(s) apart from TLR7 
Surprisingly, it could be observed that bacterial RNA is sensed by one or multiple further receptors 
apart from TLR7. Besides IFN-α, bacterial RNA induced the secretion of TNF-α in human PBMCs 
Inhibiton of TLR7 by cotransfection with 2mA abrogated RNA oligonucleotide induced TNF-α secretion 
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as expected but did not alter bacterial RNA induced TNF-α secretion. Further, a significant contribution 
of any possible contaminant was ruled out since TNF-α secretion vanished upon RNaseA digestion. 
This observation excluded TLR7 as the responsible receptor for bacterial RNA induced TNF-α 
secretion in human PBMCs. The responsible receptor system was identified to reside in the cytosol 
since endosomal maturation showed no influence on activation and bacterial RNA had to be delivered 
to the cytosol with appropriate transfection reagents (e.g. Lipofectamine). In a similar way, bacterial 
RNA also induced IL-12p40 in murine mDC-like cells. In contrast to IFN-α secretion in human PBMCs, 
RNA preparations of gram-negative bacteria showed an increased immunostimulatory potential 
compared to RNA of gram-positive origin which was possibly attributed to residual amounts of LPS 
within the RNA preparations of gram-negative bacteria. However, RNA digestion in any case resulted 
in a significant reduction of IL-12p40 secretion. Similar to TNF-α secretion in human PBMCs the IL-
12p40 secretion in murine mDC-like cells was independent of TLR7. The remaining nucleic-acid 
detecting TLRs 3 and 9 were also ruled out by use of the respective knockout mice. Additionally, 
chloroquine treatment did not alter bacterial RNA induced IL-12p40 secretion indicating that the same 
cytosolic receptor system inducing TNF-α in human PBMCs might be responsible for IL-12p40 
secretion in murine mDC-like cells. Although a participation of the endosomally located murine TLR8 
in bacterial RNA sensing was not specifically investigated, it could be excluded since intact endosomal 
signalling was dispensable for bacterial RNA recognition.  
5.2.3 Viral RNA receptors and NALP3 are dispensable for prokaryotic RNA –
  induced NFκB activation 
Bacterial RNA shares some structural features with viral RNA. Bacterial messenger RNA harbors a 
terminal 5’-triphosphate which has been shown to be a target structure for RIG-I127. Also, partial 
double-stranded stretches could serve as target structures for RLR-mediated recognition. Transfection 
of Huh7.5 cells expressing either functional RIG-I or MDA5 with bacterial RNA did not result in any 
detectable ISG56 transcription although the respective viral RNA ligands resulted in the expected 
activation. Additionally, RLRs are known to trigger besides IRF3 also NFκB activation6, however, 
NFκB activation was neither detectable upon transfection with bacterial RNA nor with viral RNA in 
Huh7.5 cells. These observations excluded the RIG-like receptors as being responsible for cytosolic 
bacterial RNA recognition.  
The NALP3 inflammasome is known to induce caspase-1 activation which leads to the processing of 
pro-IL-1β to IL-1β55. Besides various other ligands, bacterial RNA has been described to activate the 
NALP3 inflammasome135 supporting the idea of further RNA-sensing cytosolic receptor systems. In 
our experiments the inflammasome adaptor molecule ASC which has been shown to be essential for 
inflammasome-mediated signalling was necessary for bacterial RNA-mediated IL-1β secretion and, 
interestingly, this was additional dependent on functional IFNAR1 signalling. Similar observations have 
been reported for cytosolic Francisella induced secretion of IL-1β by activation of the inflammasome 
which was also dependent on IFNAR1136. In contrast to dependency of IL-1β secretion on ASC, the 
observed induction of IL-12p40 after bacterial RNA transfection was independent on ASC protein. 
Therefore a further cytosolic receptor system, besides the already described RLRs and the 
inflammasome has to reside in the cytosol mediating the recognition of bacterial RNA. 
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5.2.4 Bacterial RNA induces a general danger signal 
In addition to the recognition of bacterial RNA by professional immune cells such as dendritic cells we 
observed that bacterial RNA induced a strong and robust NFκB response in the HEK293T cell line. In 
contrast to the tested immune cells above, the recognition of bacterial RNA by HEK293T cells was 
restricted to only some RNA preparations. RNA of gram-negative bacteria with the exception of 
Moraxella catharralis strongly induced NFκB whereas most RNAs of gram-positive origin with the 
exception of Bacillus subtilis induced NFκB only weakly. The observed effects were still attributed to 
the RNA since RNaseA digestion abrogated activation completely. Similar to the experiments with 
immune cells neither additionally transfected nucleic acid sensing TLRs nor endogenously expressed 
TLR3 and RIG-I could be linked to bacterial RNA recognition. It has been reported that bacterial 
contaminants activating TLRs and NLRs simultaneously could result in a synergistic activation70. We 
therefore tested a possible contribution of NOD1 and NOD2 receptors which are both expressed in 
HEK293T cells but could not detect a significant influence. Further phenol/chloroform purification of 
bacterial RNA showed only a minor reduction of the immunostimulatory potential indicating that 
putative residual contaminants did not play a pivotal role for recognition. Moreover, digested 
immunostimulatory Escherichia coli RNA could not reconstitute immunoactivation of the weak 
immunostimulatory Staphylococcus aureus RNA proving that the observed effects are indeed 
attributed to the RNA.  
It is noteworthy that professional immune cells and especially pDCs make use of the TLRs to 
recognize microbial nucleic acids leading to a specific immune response. The recognition principles 
are highly specific and sense certain sequence motifs in RNA oligonucleotides as well as the content 
of nucleotide modifications. In contrast, cytosolic receptor systems are expressed much more broadly 
and less specific. The finding that bacterial RNA is detected by an unknown cytosolic receptor within a 
broad range of cell-types parallels previous findings of the cytosolic recognition of bacterial DNA. It 
was shown that independently of a specific sequence, DNA triggers a cytosolic receptor221,222. In fact, 
much attention has since then been focused on the identification of cytosolic recognition principles of 
nucleic acids. The discovery of the DNA-sensing receptor DNA-dependent activator of IFN-regulatory 
factors (DAI)80 firstly showed that besides the TLRs additional cytosolic receptors are involved the 
recognition of non-self DNA. Additionally the Trex1 protein which was originally described to be 
involved in DNA repair was shown to sense single-stranded DNA retroelements leading to the 
induction of type-I interferons217. The identification of new cytosolic DNA-sensing receptor systems 
supports the idea of similar recognition systems for the sensing of non-self RNA. Double-stranded 
DNA has recently been shown to induce the secretion of IL-1β mediated by the newly identified 
receptor AIM2. Further, it has been demonstrated that AIM2 binds to the adaptor protein ASC forming 
an inflammasome which in turn activates caspase-1 similar to the well-described RNA sensing NALP3 
inflammmasome223. Taking into account that the recognition of DNA and RNA follows comparable 
mechanisms and that there are several cytosolic receptor systems recognizing non-self DNA strongly 
suggests the existence of further RNA sensing receptors. 
The biological relevance of the cytosolic nucleic acid recognition for host defense is not fully 
understood yet. The fact that bacterial RNA is sensed over a broad range of different cell-types 
including non-immune cells such as HEK293T cells suggests that cytosolic RNA sensing serves rather 
as a general danger signal than as a specific immune signal as it is induced by the TLR system. 
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Induction of the cytosolic recognition system could be a signal that the cells are already inevitable 
infected and lost. Type-I intererons in case of viral RNA or viral DNA and NFκB activation in case of 
bacterial RNA, followed by chemokine induction (e.g. IL-8), attracts further cells and alarms 
neighboring cells. This could be regarded as a general cell-autonomous defence response as it is 
currently discussed and which is also a topic that has been addressed by the 
“Sonderforschungsbereich 670” in Cologne.  
5.3 Ligand specificity of RIG-I 
In contrast to bacterial RNA recognition, viral RNA recognition has been investigated in more detail. 
RIG-I and MDA5 have been identified as the two major receptors for cytosolic viral RNA.    
Two recent reports demonstrated that RIG-I is not detecting double-stranded RNA but instead RNA 
bearing a 5’-triphosphate, be it single- or double-stranded127,128. On the other hand, it has been shown 
that the C-terminal RD domain of RIG-I comprises a basic cleft which binds 5’-triphosphorylated RNA 
as well as double-stranded RNA. In contrast to ssRNA, binding of dsRNA was independent of a 
terminal 5’-triphosphate indicating that double-strandness might display a second target structure 
within vRNA recognition by RIG-I129. However, recognition and signalling of RIG-I upon dsRNA binding 
remained controversially discussed. 
In order to characterize the role of dsRNA recognition by RIG-I and to analyze the influence of a 
5’-triphosphate, we used an RIG-I signalling negative cell line (Huh7.5) overexpressing functional RIG-
I protein (Huh7.5 RIG-I wt)173 which proofed to be a highly sensitive tool for measuring RIG-I activity 
and to quantify RIG-I signalling. In ISG56 reporter assays Huh7.5 RIG-I wt cells showed high 
sensitivity to Poly(IC) stimulation. Since Poly(IC) is synthesized from nucleotide-diphosphates and 
therefore harbours no 5’-triphosphate there was a first indication that RIG-I is sensing also double-
stranded RNA structures in the absence of a 5’-triphosphate. Further, no RIG-I-mediated signalling 
was detected upon transfection with Poly(C) or Poly(I) which are due to their sequence unable to form 
secondary structures. A possible participation of TLR3 had been ruled out because microarray 
analysis revealed no endogenous expression. Additionally, LPS which is known to be a highly potent 
ligand of TLR4 and to be a very present contamination even at concentrations as high as 100 ng/well 
showed no activity in the reporter assays. 
5.3.1 Double-stranded RNA is recognized by RIG-I 
Transfection of Huh7.5 RIG wt cells with either short (58 nt) or long (9600 nt) in vitro transcripts of 
Rabies Virus leader sequence (RV) and Hepatitis C Virus (HCV), respectively, resulted in ISG56 
activation. ISG activation by the single-stranded transcripts could nicely be explained with the 
presence of terminal 5’-triphosphates. Signalling activity upon transfection with double-stranded RV 
RNA was not significantly elevated compared to the single-stranded RV RNA. In contrast to the short 
RV duplex (58 bp), we observed a strongly increased signalling of the HCV RNA duplex (9600 bp) 
compared to the single strand. These results indicated that double-stranded RNA conformation indeed 
represents a second target structure for RIG-I besides the terminal 5’-triphosphate. Assuming that 
dsRNA is recognized by RIG-I regardless of any 5’-triphosphate, it appears plausible that the length of 
the double-strand is crucial for the extent of signalling activity leading to the hypothesis that double-
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strand recognition by RIG-I depends on the length of the ligand. Although signalling was drastically 
increased by transfection with longer dsRNA, comparability was limited since both ligands differ in 
sequence. Sequence-dependent recognition by RIG-I is not well investigated. However a recent report 
showed that RIG-I activity of viral ssRNA is determined by the presence of uridine (U)- or adenosine 
(A)-rich sequences that can be hundreds of bases apart from the 5’-end132. Additionally uridine-rich 
sequence stretches within the HCV genome were identified of being preferentially recognized by RIG-
I132. On the other hand, an increasing number of guanosine (G) residues were shown to reduce 5’-
triphosphate induced signalling224. However recognition of certain sequences by RIG-I might have only 
a minor influence since the 5’-triphosphate was shown to be sufficient for signalling activity.  
In order to investigate length-dependent dsRNA recognition by RIG-I in detail, we decided to generate 
in vitro transcripts increasing in size with overlapping sequence to minimize sequence-specific effects 
on signalling. Further, we purified the in vitro transcripts by gel excision to ensure the absence of 
otherwise frequent side-products of the in vitro transcription reaction. Thus, the generated RNA 
substrates possessed a defined size, high purity and were controlled for integrity. 
5.3.2 Sensitivity of RIG-I to dsRNA is length-dependent 
Transfection of Huh7.5 RIG-I wt cells with dsRNA ligands ranging from 40 to 1600 basepairs showed 
no significant increase in maximal signal strength. The final levels of signalling activity were rather 
slightly decreased upon transfection with longer dsRNA ligands. These results were in agreement with 
a recent report showing that RIG-I detects shorter dsRNA substrates whereas MDA5 is the major 
sensor for long dsRNA131. Notably, mainly Poly(IC) was used the cited work which was digested for 
different amounts of time resulting in dsRNA analogs of different length. Digested Poly(IC) was 
validated by gel electrophoresis but it was not ensured that residual side products were present within 
the sample and this should be considered when interpreting the reported results. Further, Poly(IC) of 
different length was transfected in equal mass and not molarity resulting in an increasing number of 
shorter Poly(IC) molecules and thereby limiting the comparison of the ligand length. Finally, ligands 
were transfected in saturated concentrations and only maximal signalling was measured instead of 
sensitiviy of RIG-I to the ligand. The slight decrease in maximal signalling upon transfection in 
saturated concentrations might rather be caused by the fact that the adaptor molecule IPS-1 is 
attached to the mitochondrial membrane and is therefore not fully accessible for all RIG-I molecules 
bound to a very long RNA molecule. Shorter RNA molecules would not bind as many RIG-I proteins, 
resulting in lower sensitivity, but all of them could bind to the respective adaptor IPS-1 due to smaller 
complex size. 
Carefully, performing titration experiments with clearly defined transcripts here showed that sensitivity 
of RIG-I to dsRNA increasing in size was dramatically enhanced. Assuming that RIG-I binds to dsRNA 
structures, it appears feasible that longer dsRNA stretches would offer more accessible receptor 
binding sites resulting in the observed increase in sensitivity. Moreover, we determined the substrate 
concentration for half-maximal signalling (K50) for the respective dsRNA molecules and defined the 
reciprocal (1/K50) as sensitivity of RIG-I to its ligand. Sensitivity of a 400 basepair duplex compared to 
a 100 basepair duplex was increased 15-fold although ligand length was only 4-fold higer. These 
results strongly indicated that RIG-I might in fact bind to dsRNA in a cooperative manner. This 
suggests that the affinity of RIG-I to bind to dsRNA increases with the presence of already bound RIG-
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I. In support to the results from the reporter assays, we observed enhanced ATPase activity of 
recombinantly expressed RIG-I upon incubation with dsRNA ligands of increasing size. The role of the 
RIG-I-owned ATPase activity for immunorecognition has been discussed controversially. However, 
mutations of the ATP-binding site resulted in a complete loss of signalling but ligand binding of dsRNA 
and 5’-triphosphorylated RNA was not influenced6,133. However, the current opinion is that ligand 
binding and ATPase activity are both required for the formation of an active RIG-I complex.  
Importantly, the total number of 5’-triphosphates was identical among all transfected dsRNA ligands 
excluding the possibility that the observed differential signalling activity was generated by the 5’-ends. 
Taken together, double-stranded conformation of RNA was identified as a recognition motif for 
RIG-I-induced signalling activity. Further, these findings indicate cooperative binding of RIG-I to 
dsRNA as concluded from the observed disproportional increase in sensitivity of RIG-I towards longer 
dsRNA ligands. For half-maximal sensitivity a minimum ligand length of approximately 340 basepairs 
is required suggesting that the biological function of RIG-I is in fact the sensing of long dsRNA 
molecules. The detection of terminal 5’-triphosphorylated structures might support the recognition but 
is very likely to play a minor role for signalling in response to longer dsRNA. The 5’-triphosphate might 
be the initial motif which is recognized when viral RNA genomes enter the cell. During viral replication, 
the double-stranded RNA replication intermediate might present the second motif for RIG-I leading to 
an increase of signalling and thereby reducing the relevance of the 5’-triphosphate. 
5.3.3 Contribution of the terminal 5’-triphosphate to RIG-I signalling 
Length-dependent binding of RIG-I to double-stranded RNA implicated that this binding would diminish 
the relative contribution of the 5’-end with increasing ligand length. We hypothesized that the 
relevance of the 5’-end would be important for short dsRNA ligands, as confirmed by several reports 
but would vanish with increasing substrate length. To investigate the role of the 5’-end we 
dephosphorylated the RNA strands before annealing. Dephosphorylation was shown to be highly 
efficient and not to affect ligand integrity. Transfection was performed with dsRNA substrates either 
mock- or phosphatase-treated with the determined concentrations for half-maximal signalling. We 
observed that the contribution of 5’-triphosphate-mediated signalling decreased with the substrate 
length, reaching non-significant levels from about 200-400 basepairs on. 
These results show that double-stranded conformation and the 5’-triphosphate display two 
independent target structures for RIG-I-mediated signalling. Double-stranded ligands shorter than 100 
basepairs are preferentially detected by the presence of the 5’-triphosphate whereas longer ligands 
are detected mainly by the double-strand configuration which offers more putative binding sites and 
therefore making the 5’-end dispensable (Fig. 5-2). Again, dsRNA substrates, being 200 basepairs or 
longer in size, present sufficient double-stranded conformation for full signalling activity at ligand 
concentrations for half-maximal signalling. These results implicate that the role of the 5’-triphosphate 
might be overestimated and the recognition of double-stranded RNA underestimated. On the other 
hand, several reports showed that RIG-I-mediated recognition of viral RNA genomes (e.g. influenza) 
strictly depends on the presence of a terminal 5’-triphosphate127,128. In fact, recognition of the 5’-
triphosphate might be the initial cellular response upon entering viral RNA, whereas double-strand 
recognition by RIG-I represents a response to replicating virus. Therefore, both recognition motifs 
would be relevant for cellular defence during different steps of viral infection. 
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Fig.  5-2 Model for dsRNA recognition by RIG-I 
(1) Small dsRNA is recognized by RIG-I in the 
presence of 5’-triphosphates (PPP). (2) Longer 
dsRNA molecules (approximately 100 bp) enable 
RIG-I to bind also to double-stranded stretches 
leading to a partially 5’-triphosphate-independent 
signalling. (3) dsRNA molecules from 200-400 bp on 
provide binding sites for more RIG-I molecules and 
thereby reduce the relative contribution of the 5’-
triphosphorylate-induced signalling. 
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5.3.4 Single-stranded RNA is a ligand for RIG-I 
Several reports showed that 5’-triphosphorylated and double-stranded RNA binds to the C-terminal 
domain (CTD) of RIG-I129,130. A basic cleft within the CTD was identified to be responsible for binding. 
In fact, single-stranded RNA without a terminal triphosphate was shown not to bind within this cleft 
excluding non-phosphorylated single-stranded RNA as a possible ligand for RIG-I. However, all 
reports dealt with RNA in vitro transcripts far below 100 nucleotides in length. In fact, in our 
experiments reporter activity upon transfection with 100 nucleotide in vitro transcript resulted in an 
approximately 1000-fold lower activity of the single-strand compared to the duplex. Still, also the 
single-stranded in vitro transcript showed dose-dependent signalling indicating a specific recognition. 
Regarding the length-dependent recognition of double-stranded RNA substrates, we suggest a similar 
mechanism for the recognition of single-stranded RNA. Indeed, upon transfection with ssRNA in 
equimolar concentrations but increasing in size we observed a length-dependent signalling activity. 
Importantly, the total number of 5’-triphosphates was identical indicating that also ssRNA harbors 
possible recognition sites for RIG-I binding apart from the 5’-end. Dephosphorylation resulted in 
signalling abrogation for ssRNA ligands shorter than 400 nucleotides. Transfection with 
dephosphorylated ssRNA of 400 nucleotides and larger reduced signalling activity but only to a non-
significant extent, compared to the phosphorylated control. 
Although these observations strongly indicate that ssRNA harbors additional target structures, ssRNA 
binding to the CTD of RIG-I was never demonstrated. Additionally, the propensity of single-stranded 
RNA to form partial double-stranded structures which is enhanced by unconventional wobble base-
pairing is well-described185. Thus, it appears very likely that in vitro transcribed ssRNA tends to form 
partial double-stranded structures length-dependently which might be recognized by RIG-I even in the 
absence of a terminal 5’-triphosphate (Fig.  5-3). 
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Fig.  5-3 Model for ssRNA recognition by RIG-I 
(1) RIG-I binds to the 5’-triphosphate (PPP) of short ssRNA 
molecules. (2) Upon dephosphorylation, RIG-I does not bind to 
ssRNA leading to signal abrogation. (3) ssRNA exceeding 400 
nucleotides in length tends to form double-stranded structures 
which serve as binding sites for RIG-I restoring signalling 
activity. 
 
The biological role of ssRNA recognition has to be regarded critically since in contrast to a 5’-
triphosphate or double-stranded conformation, endogenous RNA (e.g. messenger RNA) would also 
act as a target for RIG-I-mediated recognition. Although not much is known about the influence of 
naturally occurring modifications on RIG-I recognition, it has been shown that uridine modifications, 
such as pseudouridine or 2’-O-methyl-uridine reduce RIG-I-induced type-I interferon secretion 
significantly127. This suggests that discrimination between self and non-self RNA is not only 
determined by the presence of double-stranded or 5’-triphosphorylated molecular structures but also 
by the content of nucleotide RNA modifications similar to the recognition of RNA by TLR789.  
Additionally, it is known that ssRNA inside a cell is covered by different RNA-binding proteins 
preventing the formation of duplex structures. Thus, the relevance of ssRNA recognition by RIG-I 
remains elusive. 
Substrate specificity of the cytosolic vRNA sensor RIG-I has attracted much attention in the course of 
the last few years. Our results show that in contrast to recent reports127,128, RIG-I RNA recognition is 
not restricted to RNA substrates bearing a terminal 5’-triphosphate but that also unphosphorylated 
dsRNA is sensed by RIG-I. Both target structures, double-stranded conformation and 5’-triphosphate, 
rather complement each other and both contribute to RIG-I-mediated signalling. Further, sensitivity of 
RIG-I to dsRNA enhances with the length of the ligand reducing the relative contribution of the 5’-end. 
From a substrate length of 200-400 basepairs on, the double-stranded conformation represents the 
major RNA motif making the contribution of the 5’-end negligible. 
This might also help to understand why RIG-I affects susceptibility of mice to japanese encephalitis 
virus (JEV)44, a flavivirus whose genome carries a cap at its 5’-end. Additionally, the identification of 
double-stranded conformation as an independent target structure for RIG-I is supported by the fact 
that also ssRNA from a length of 400 nucleotides on is sensed by RIG-I in the absence of a 
5’-triphosphate which is very likely caused by intramolecular folding of the ligand RNA. Viral RNA 
genomes can be several thousands of nucleotides in length are detected by the 5’-triphosphate. 
However, during replication the generated long double-stranded replication intermediate might be 
sensed predominantly giving the 5’-end only a minor role for signalling. Both, the 5’-end and the 
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double-stranded conformation, represent distinct recognition motifs for RIG-I, but might act at different 
stages of the infection.  
5.3.5 Outlook 
Regarding siRNA-mediated immunostimulation, it could be shown within this work that TLR7 is the 
responsible receptor for the observed off-target effects in terms of type-I interferon secretion. Further, 
it was demonstrated that the 2’-position of the ribose is of crucial importance for immunostimulation. 
As this position would face the minor groove of an RNA duplex and because further evidence is given 
that stimulating RNA indeed adopts a duplex structure, the results give hints towards a possible 
mechanism of receptor ligand interaction. Interestingly, substitution of uridine residues to thymidine 
resulted in a significant reduction of type-I interferon in human PBMCs without affecting RNAi. Thus, 
this substitution was identified as a suitable tool for the design of immunological silent siRNAs.  
However, there was indication that RNA molecules with uridine residues within stem-loop structures 
as they occur by intra- and intermolecular folding might be preferentially recognized by TLR7. Further 
investigation of the positional influence of the thymidine residues would allow for a more precise 
design of immunologically silenced siRNA molecules. The requirement of RNA duplex formation for 
receptor ligand interaction could further be investigated by the introduction of modifications that 
interfere with base-pairing (e.g. 3’-N-methyl-thymidine) and therefore inhibit the formation of duplex 
structures. Followed by the in vitro experiments, it would be highly interesting whether thymidine 
substitutions show the same effects in in vivo experiments giving the possibility to apply siRNA without 
severe side-effects.  
Besides TLR7-mediated recognition of RNA, it could be demonstrated that bacterial RNA recognition 
differs from so far described recognition principles. On the one hand, bacterial RNA is sensed similar 
to RNA oligonucleotides by TLR7 in pDCs leading to the induction of type-I interferons. On the other 
hand, it could be shown that bacterial RNA is sensed by a further cytosolic receptor leading to strong 
NFκB activation. All so far described RNA sensors could be ruled out, including the recently described 
viral RNA receptors RIG-I and MDA5. Recognition of bacterial RNA by NALP3 leading to the induction 
of IL-1β could be confirmed but was shown to be dispensable for secretion of IL-12p40. These results 
indicate that similar to DNA, further cytosolic receptor systems have to be operative also for bacterial 
RNA. Pull-down approaches with immobilized bacterial RNA would possibly lead to the identification of 
the responsible receptor or of involved adaptor molecules. This would allow to describe a new 
signalling pathway for bacterial RNA recognition. Alternatively, a genome-wide siRNA approach using 
reliable NFκB reporters could lead to the identification of the receptor including involved signalling 
molecules. The diverse nucleotide modifications occurring in different frequency and abundance in 
prokaryotic RNA compared to eukaryotic RNA could be examined regarding their potential to mediate 
or inhibit immunostimulation. This would allow for a molecular explanation of recognition of bacterial 
RNA. 
Substrate specificity of RIG-I has been in the focus over the last few years. Within this work, it could 
be demonstrated that the described 5’-triphosphate is not the only target structure for RIG-I but that 
RNA in double-stranded conformation represents a second independent target structure. The 
sensitivity to dsRNA of increasing size is significantly enhanced, indicating that the biological role of 
RIG-I is rather the sensing of long dsRNA than of the terminal 5’-end. Further, the performed reporter 
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assays implicate that RIG-I might bind in a cooperative manner to double-stranded RNA structures 
explaining the significant length-dependency. To fully elucidate the ligand requirements of RIG-I, the 
experiments could be validated by biochemical approaches. Gel filtration experiments with the 
recombinantly expressed RIG-I protein and different RNA ligands could allow to determine the number 
of RIG-I proteins binding to a certain dsRNA substrate. Alternatively, RIG-I ligand interaction could be 
studied using atomic force microscopy as recently performed to study the differential ligand 
requirements of RIG-I and MDA5, respectively131. The relevance of ATPase hydrolysis by RIG-I for 
signalling activity remains not fully understood although a recent report showed that a terminal 5’-
triphosphate is required for translocation of RIG-I on dsRNA225. Experiments with RIG-I carrying a 
mutation in the ATP-binding site (K270A) would elucidate the role of the ATPase activity for signalling 
activity upon transfection with different RNA ligands.
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